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Abstract
The molecular clock has been conserved from cyanobacteria to mammals and is believed to
align behavioral and biochemical processes with the diurnal cycle. This cellular mechanism
has been an advantage to increase the ﬁtness of organisms through the ability to anticipate
food availability or predator presence. It has been recently suggested that the molecular clock
is used to optimize the energy consumption of cells and accumulating evidence has revealed
that the circadian clock is intimately interconnected with the metabolic cycle. The nature of
these interconnections is yet not clear at the transcriptional level, and the contribution of
cis-regulatory modules has not been elucidated.
The emergence of novel high-throughput technologies, in the ﬁeld of next generation sequenc-
ing, as ChIP-seq, and DNase I-seq, unveiled chromatin landscape with an unprecedented
resolution. These techniques allow a genome-wide investigation of accessible chromatin
regions and DNA-binding proteins such as transcription factors, as well as histones mod-
iﬁcations or Polymerase II (Pol II) presence. Accessible chromatin regions of the genome
are implicated in diverse processes, such as gene regulation through enhancers and promot-
ers, insulation of genomic domains or alternative splicing. For instance, these regions are
important in the differentiation process during development. They allow cell-type speciﬁc
programs that are controlled by tissue-speciﬁc transcription factors and chromatin modiﬁers.
The tissue-speciﬁc regulation of the circadian clock remains unclear. Therefore, we com-
pared genome-wide BMAL1 binding and chromatin accessibility in the liver and in NIH3T3
ﬁbroblasts.
Moreover, For the ﬁrst time, our study explores the dynamics of accessible regions every 4
hours over one day in mouse liver. In this study, we show that a substantial fraction of these
accessible sites are oscillating during a diurnal cycle with a circadian period. Furthermore,
these sites are coordinated in time and space (with respect to their genomic location) using
Pol II transcription and some histone modiﬁcations, such as histone 3 lysine 27 acetylations
(H3K27ac).
We observed that these accessible regions are enriched in the proximity of actively transcribed
genes, and that they are dynamically affected by the binding of transcription factors such as
BMAL1. We investigated wild-type (WT) and Bmal1−/− genotypes, in night restricted feeding
regimen and in Light-Dark cycle, to study the circadian clock regulatory network underlying
diurnal transcription. Our analysis revealed that a certain fraction of genes was still ﬂuctuating
with a 24h period in Bmal1−/− genotype. We observed that these genes were related to fatty
acid, or steroid metabolism, suggesting food entrainment. Unexpectedly, a large proportion
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of genes with a diurnal behavior in the Bmal1−/− context were not cycling in the WT and
were related to insulin signaling, TCA cycle, proteolysis and amino acid or sugar metabolism.
In order to investigate the transcriptional control of these biological processes, we applied a
penalized generalized linear model to infer the activity of transcription factor binding motifs
in oscillating accessible sites using Pol II loadings at the transcription start sites of nearby
genes. We were able to recapitulate the known regulatory elements of the circadian clock,
notably E-box, D-Box, and ROR-responsive elements (RRE) in the WT genotype. On the other
hand, we found that Forkhead box (FOX), glucocorticoids responsive elements (GRE), C-AMP
Response Element (CRE) were the main contributors of the regulation of oscillating genes in
Bmal1−/−. Finally, using a mixture model to detect footprints with a base pair resolution, we
studied the dynamics of the accessibility overlapping E-box. Our last analysis suggested that
BMAL1/CLOCK is binding on double E-boxes with a spacer of 6 or 7 bp in a hetero-tetramer
conﬁguration. A 3D structure model further supported this binding mode.
In Summary, we used DNase I-seq, ChIP-seq of H3K27ac and Pol II to study the circadian
chromatin landscape in a 4h time-resolved experimental design. We uncovered the underlying
circadian transcriptional regulatory network and, we dissected the chromatin accessibil-
ity around BMAL1 binding sites at a base pair resolution, which led to an unappreciated
mode of binding of BMAL1/CLOCK in a hetero-tetramer conformation on double E-boxes.
Lastly, we found tissue-speciﬁc factors that might contribute to tissue-speciﬁc binding of
BMAL1/CLOCK.
Key words: Circadian clock, chromatin accessibility, ChIP-seq, metabolism, nutrient response
cycle, mouse liver, Bmal1 knockout, DNase I hypersensitive sites, transcriptional regulation,
tissue-speciﬁcity, NIH3T3 ﬁbroblasts
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Résumé
L’horloge moléculaire est un mécanisme présent depuis la cyanobactérie jusqu’aux mam-
mifères. Ce mécanisme cellulaire est censé aligner le comportement ainsi que les processus
biochimiques au cycle journalier. Il a représenté de formidables avantages en termes d’évo-
lution en permettant d’améliorer la survie d’un organisme grâce à sa capacité à anticiper la
présence de prédateurs ainsi que la disponibilité de la nourriture. Il a été récemment suggéré
que l’horloge moléculaire permet aussi d’optimiser la consommation d’énergie des cellules.
Un nombre croissant d’études permettent d’établir un lien entre cette horloge interne et le mé-
tabolisme. En revanche, la nature de cette relation n’est pas claire au niveau transcriptionnel
et la contribution de sites régulateurs en cis n’a pas été expliquée.
L’avènement de nouvelles technologies de séquençage à haut débit, comme les techniques de
ChIP-seq ou deDNase-seq, ont révélé la complexité de la chromatine à un niveau de résolution
sans précédent. Ces techniques permettent d’étudier l’accessibilité de la chromatine et de
découvrir les sites de ﬁxation des facteurs de transcription. Elles permettent aussi de révéler
les modiﬁcations épigénétiques comme les marques d’histones ou la présence de l’ARN
polymérase II à l’échelle du génome. Ces régions accessibles du génome sont impliquées dans
divers processus biologiques, notamment la régulation de l’expression des gènes au travers
des sites promoteurs et ampliﬁcateurs (enhancers), la séparation de domaines génomiques
grâce aux insulateurs ou encore l’épissage alternatif des ARN messagers. Ces régions jouent un
rôle important lors de la différentiation cellulaire pendant le développement. Elles permettent
des programmes spéciﬁques aux tissus, contrôlés par des facteurs de transcription ainsi que
des modiﬁcateurs de la chromatine.
Malgré son importance, la régulation des processus biologiques spéciﬁques aux tissus par
l’horloge interne reste méconnue. Aﬁn de progresser dans la compréhension de ce méca-
nisme, nous avons comparé, d’une part, les différents sites de liaison de BMAL1, d’autre part,
l’accessibilité de la chromatine à l’échelle du génome dans le foie et dans les ﬁbroblastes
NIH3T3.
Notre étude est la première à explorer la dynamique de ces régions accessibles, lors d’un
échantillonnage de foie de souris prélevé toutes les 4 heures sur une période d’une journée. Ce
travail met en évidence les oscillations d’une faction non négligeable de ces sites lors du cycle
diurne. De plus, l’on voit qu’ils sont coordonnés dans le temps et le long du génome. Leur
accessibilité est également en phase avec l’ARN polymérase II et l’acétylation des histones 3
sur la lysine 27.
Nous avons observé qu’il existe davantage de ces régions accessibles à proximité de gènes
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activement transcrits, et qu’elles sont dynamiquement affectées par la liaison de facteurs de
transcription tels que BMAL1. Aﬁn d’étudier la régulation de la transcription circadienne,
nous avons comparé les génotypes de type sauvage (WT) ainsi que des souris mutées pour le
gène BMAL1 (Bmal1−/−) en ne leur fournissant de la nourriture que de nuit et en alternant
douze heure d’exposition à la lumière et douze heure d’obscurité. L’analyse a révélé que
dans le contexte Bmal1−/−, une faction des gènes ﬂuctuent toujours avec une périodicité
de 24 heures. Ces gènes sont impliqués dans le métabolisme des acides gras ainsi que des
stéroïdes, ce qui suggère une synchronisation par la nourriture. De manière inattendue, une
large partie des gènes ﬂuctuant dans le contexte Bmal1−/− n’oscille pas dans le type sauvage.
Ces gènes participent au métabolisme des sucres et des acides aminés, au cycle de Krebs, à la
signalisation liée à l’insuline ainsi qu’à la protéolyse.
Nous avons appliqué un modèle linéaire généralisé et pénalisé aﬁn d’étudier la régulation
transcriptionnelle de ces processus biologiques. Il s’agissait d’inférer l’activité des motifs de
liaison des facteurs de transcription sur l’ADN dans les régions accessibles en utilisant le
signal de la RNA polymérase II aux sites d’initiation de la transcription des gènes actifs à
proximité. Nous avons détecté les principaux motifs connus de l’horloge dans le type sauvage,
notamment les boîtes E (E-box), les boîtes D (D-box) ainsi que les éléments répondant à ROR
(RRE). De plus, nous avons découvert que dans les souris Bmal1−/−, les principaux motifs
actifs étaient les boîtes F (Forkhead box, FOX), les éléments de réponse aux glucocorticoïdes
(GRE) et les éléments de réponse aux AMP cycliques (CREB). Enﬁn, en utilisant un modèle
mixte pour détecter les empreintes des facteurs de transcription sur le signal DNase avec une
résolution à la paire de base, nous avons étudié la dynamique de l’accessibilité autour des
boîtes E. Notre analyse suggère que BMAL/CLOCK peut se lier à deux boîtes E séparées par six
ou sept paires de bases dans une conﬁguration d’hétéro-tétramères. Un modèle de structure
en 3D sous-tend ce mode de ﬁxation.
En résumé, nous avons utilisé les techniques de DNase I-seq et de ChIP-seq pour Pol II et
H3K27ac aﬁn d’étudier la dynamique de la chromatine lors du cycle circadien avec un échan-
tillonnage toutes les quatre heures. Nous avons découvert le réseau circadien de régulateurs
transcriptionnels et avons disséqué le mode de liaison de BMAL1 à la chromatine, ce qui
nous a conduit à découvrir un mode de liaison à l’ADN méconnu de BMAL1/CLOCK avec
une conformation en hétéro-tétramère. Enﬁn, nous avons détecté des facteurs propres à un
tissu qui participent probablement à la ﬁxation spéciﬁque de BMAL1 à ce dernier le long du
génome.
Mots-clefs : horloge circadienne, accessibilité de la chromatine, ChIP-seq, métabolisme, cycle
de réponse à la nourriture, foie de souris, sites hypersensibles à la DNase I, régulation trans-
criptionnelle, spéciﬁcité tissulaire, ﬁbroblastes NIH3T3.
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1 Introduction
1.1 Chronobiology: the study of periodic events in living organisms
1.1.1 Early circadianpioneersdiscoveredendogenousnear 24h rhythms inplants
Jean-Jacques d’Ortous, Lord of De Mairan (1678–1771) wrote the ﬁrst publication, in the
ﬁeld of chronobiology [74] almost three centuries ago, and is still cited in scientiﬁc articles.
He studied a sensitive plant which was given an evocative name of Mimosa pudica. The
branches and leaves of Mimosa pudica always turn in the direction of where there is most
light. He observed that the leaves and their peduncles fold themselves away and contract
around sunset, in a similar manner as they do when the plant is touched or shaken. More
importantly, this phenomenon takes place even when the plant is not in the sun or outdoors.
This phenomenon is less pronounced when the plant is always kept in a dark place. The
plant still opens up during the day and closes for the night at the same time every evening.
De Mairan performed his experiment towards the end of summer and repeated it several
times. The leaves rhythm persisted despite their lack of perception of night and day. This
persistence is the signature of what would be known as circadian rhythms from the Latin circa
(around) and diem (day) based on the terminology initiated by Franz Halberg in 1959. De
Mairan suggested that diurnal variations in temperature, likewise in light, could synchronise
circadian rhythms. Indeed, these two oscillating environmental factors are considered as
“time givers” or "zeitgebers" of circadian rhythms. In the same epoch as De Mairan, Carl von
Linne (1707–1778) constructed a “ﬂoral clock” noting the predictability of petal opening and
closing times of various species of ﬂowers (ﬁgure 1.1). Afterward, The Swiss botanist Augustin-
Pyramus de Candolle (1778–1841) was the ﬁrst to show that when plants are deprived of
natural light, their “plant sleep” follows a circadian rhythm. Moreover, The German botanist
and physiologist Wilhelm Pfeffer (1845–1920) performed similar experiments on many plant
species, thereby conﬁrming that leaf movements are not simply determined by the earth’s
rotation. Indeed, the leaf movements are not performed in an exactly 24-hour period and vary
from species to species [67, 84, 168, 180].
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Figure 1.1 – The ﬂower clock was designed by Carl von Linne in 1745. The left part of the ﬁgure
(6 AM–12 PM) depict when the petals of different species are opening; the right part (12 PM–6
PM) presents when the petals are closing. Reproduced from [306].
1.1.2 Modern chronobiology: the study of biological rhythms in mammals, in-
sects, fungi and bacteria
Erwin Bünning provided the ﬁrst evidence for the genetic basis of circadian rhythms gen-
eration by showing that period length is heritable in bean plants [45]. He also delivered a
prominent hypothesis that circadian oscillators can be used to monitor seasonal changes
in addition to measuring daily cycles and pointed out the adaptive importance of tracking
seasonal changes. Thus, the ﬁeld of circadian rhythms began from intense observation of
plants. At the same epoch, the ﬁrst observations of endogenously driven rhythms in bacteria
[228], single-cell eukaryotes [127], insects [30], birds [179], rodents [276], primates [303],
and humans [14] were discovered [180].
A major breakthrough in characterizing the genetic basis for rhythms generation was made by
RonaldKonopka and Seymour Benzer in 1971 using amutant screen inDrosophilamelanogaster
[172]. Mutagenized ﬂies were investigated for the persistence of two circadian behaviors: loco-
motor activity and pupal eclosion. Flies presented one of three categorical mutant phenotypes:
a shortening of the circadian period, a lengthening of the circadian period, or arrhythmia. All
phenotypes were associated with a single locus, now referred to as the Period gene. Two years
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after this discovery in fruit ﬂies, the Frequency gene was shown to be essential for rhythms to
persist in the ﬁlamentous fungus Neurospora crassa [97]. These unexpected results revealed
that single-gene mutations could perturb a complex behavior and, together with the discovery
of a heritable timing mutation in hamsters by Martin Ralph and Michael Menaker [262], pro-
vided the motivation for conducting a large-scale mutant screen in mice [225]. Subsequently,
using a collection of strategies, dozens of clock genes have been identiﬁed in both prokaryotic
and eukaryotic systems, including cyanobacteria, fungi, plants, insects, and mammals. Even
human rhythms are signiﬁcantly impacted by clock gene mutations [260]. An impressive com-
mon principle appears from inspecting these various clock gene systems. All organisms seem
to have evolved transcriptional/posttranslational feedback loops to establish high-amplitude,
near 24-hour, rhythms production. The development of real-time bioluminescent and ﬂuores-
cent reporters, in combination with to the identiﬁcation of speciﬁc clock genes, has allowed
the spatial resolution required to track rhythmicity at the single cell [129]. Such resolution is
essential to study how individual oscillators are coupled within a population of rhythmic cells.
However, there was a critical lesson to be learned from a decisive experiment performed using
clock components of cyanobacteria. In 2005, Nakajima et al. [235] reconstructed a circadian
oscillator in a test tube using only ATP and cyanobacterial proteins. This experiment showed
that it is possible to construct a near 24-hour oscillator in the absence of gene transcription.
Moreover, a non-transcriptional oscillator have been recently observed in human red blood
cells, where peroxiredoxins, highly conserved antioxidant proteins, undergo 24-hour redox
cycles, which persist for many days under constant conditions [244, 91].
1.1.3 Concepts and deﬁnitions in chronobiology
This section will put forward several important concepts and deﬁnitions in chronobiology.
These deﬁnitions are essential to the understanding of the circadian ﬁeld and the variety of
related research area.
Chronobiology
Chronobiology is a domain of biology that studies periodic (cyclic) event in living organisms
and their adaptation to solar- and lunar-related rhythms. These cycles are known as biological
rhythms. Chronobiology derives from the ancient Greek "chronos", meaning "time", and biol-
ogy, which refers to the science of life. Chronobiological studies consist non-exhaustively of
physiology, genetics, molecular biology and behavior of organisms within biological rhythms
mechanics. Other aspects of chronobiology cover development, reproduction, evolution, and
ecology [73].
Circadian rhythm
A circadian rhythm is any biological process that displays an endogenous, entrainable oscilla-
tion with a period of about 24 hours.
Infradian rhythm
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An infradian rhythm is a biological rhythm with a period of oscillations longer than 24 hours.
For instance, seasonal cycle (or circannual rhythm), or monthly variations as circalunar
rhythm (one lunar cycle 29.5 days) or menstrual cycle.
Ultradian rhythm
An ultradian rhythm is a biological rhythm with a period of oscillations shorter than 24 hours.
For example, the developmental oscillator in somite segmentation in mouse embryo has a
period of 2 hours. This process is called the segmentation clock [160].
Period
The period is the length of time separating two consecutivemaxima in a periodic signal. (ﬁgure
1.2).
Phase
The phase is the instantaneous state of an oscillation within a period. It corresponds to the
fraction of the wave cycle (measured in angular units) that has elapsed relative to the origin.
The acrophase can be described as the time at which the peak of a rhythm occurs (ﬁgure 1.2).
In general in this work we use the term phase to refer to the acrophase.
Amplitude
We deﬁned the amplitude as the ratio between the peak and the trough of a waveform cycle
using the log2 scale. Though in general, the amplitude is deﬁned as half the value of the range
of oscillation (the distance between the mesor and the peak, ﬁgure 1.2).
Mesor
The mesor is deﬁned as the average value around which the variable oscillates. The mesor is a
circadian rhythm-adjusted mean based on the parameters of a cosine function ﬁtted to the
raw data (ﬁgure 1.2).
Period
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Figure 1.2 – Illustration of phase, amplitude, period and mesor deﬁnitions
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Phase shift
A phase shift is any change that occurs in the phase of a rhythm (e.g. in a gene, protein,
metabolite), typically following a perturbation.
Phase resetting curve (PRC)
Phase resetting is a behavior observed in different biological oscillators and plays a role in
creating synchronization (or re-synchronization with the environment in the example of
jet- lag). Phase resetting curves (PRCs) are measured by administering a precisely timed
perturbation (light cues, food cues, drugs) to an oscillator and measuring the ensuing phase
shift (ﬁgure 1.3). In other words, the PRC illustrates a change in the cycle phase of an oscillation
induced by a perturbation as a function of the phase at which it is received. PRCs can be
divided into two groups based. Type 1, or weak resetting, indicates perturbations in which the
ﬁnal phases cover all phases. Type 0, or strong resetting, indicates perturbation in which the
ﬁnal phases only cover a subset (typically a subinterval) of all phases [28].
original phase new phase
? Amplitude 
? Period 
? Phase 
(Phase Shift)
environmental
light cycle
internal
circadian time
typ
e 
1
type 0
old CT
ne
w
 C
T
Phase-Resetting Types
dead zone
Time of the perturbation
Phase-Resetting Curves Perturbation effect 
phase delay zone
phase advance zone
Figure 1.3 – Illustration of circadian disruption and phase resetting types. The phase response
curve can be represented by plotting the time of the phase shift vs the perturbation. A PRC
may include a "dead zone" where the perturbation has no effect, a "phase delay zone" or
"phase advance zone". Modiﬁed from [28, 113].
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Transcriptional-translational delayed feedback loop (TTFL)
The transcriptional-translational delayed feedback loop is a gene regulatory network motif.
In its minimal form an oscillation in gene expression can be produced and sustained. In a
minimal TTFL, a protein A activates a gene b. The protein B is produced and represses the
gene a. After amoment as gene a is not transcribed and the protein A is degraded, the gene b is
not activated anymore. When the protein B is degraded the gene a is not repressed and can be
transcribed again (ﬁgure 1.4). Delays are crucial in order to obtain an oscillatory behavior, and
includes transcription to mRNA, splicing and post-transcriptional modiﬁcation, translation
to protein and post-translational modiﬁcations followed by trans-location to the nucleus.
Mathematical models of TTFL represent an important area of the circadian research. TTFL
are used to perform in silico knockout studies in order to understand core clock perturbation
effects [305, 29, 194].
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Figure 1.4 – Illustration of the transcriptional-translational delayed feedback loop principle.
Entrainment
The entrainment is deﬁned as the coupling of an endogenous rhythm to an environmental
oscillator with the result that both oscillations have the same periods. In addition, the phase of
the endogenous rhythm is affected by entrainment. For instance in Light-Dark (LD) conditions
the circadian clock is entrained by light cues and consequently the period is exactly 24 hours.
In contrast to the Dark-Dark (DD) condition, where the period is slightly longer.
Zeitgeber
Zeitgeber is a german word meaning “time giver”. A cue (such as light or food) that entrains the
circadian clock [89]. ZT refers to “zeitgeber time” and ZT0 typically corresponds to the switch
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between dark and light, whereas CT refers to "Circadian Time". CT is used in free running
conditions (no entrainment cues).
Temperature compensation A deﬁning property of the circadian rhythm is that the period
of the circadian rhythm is kept relatively constant within a physiological range of tempera-
tures, which imply that the oscillator is temperature compensated. The mechanisms behind
temperature compensation and temperature entrainment are not fully understood, neither
biochemically nor mathematically [33].
Clock controlled genes (CCGs) Clock controlled genes are downstream core clock genes in
the regulatory networks. These CCGs contain transcription factor binding sites (TFBS) related
to the clock in their promoter or nearby enhancers.
Chronotype The chronotype is deﬁned as the mid-sleep time. It allows to compare an indi-
vidual to the population. A morning person has an early chronotype (larks proﬁle) and an
evening person has a late chronotype (owl proﬁle). The chronotype can be assessed using
standard questionnaires as the Munich Chronotype questionnaire (MCTQ) [282].
Actogram
Actograms are used to represent the rhythm of an organism over the 24-h cycle. An actogram
consists of digitized activity values that are displayed as a double plot, where a line contains
data for that day as well as the preceeding day (ﬁgure 1.5). This visualization is used to monitor
wheel-running activity of mice, or sleep/wake cycle in humans [89].
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D
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Figure 1.5 – Actogram of human activity measured using a smartphone over one month. The
grey/black squares represent the intensity of the activity at a certain time (see appendix A.2).
1.1.4 Human chronobiology
Our innate inclination for mornings or evenings is determined by the phase of our circadian
rhythms. A recent study performed a genome-wide association study (GWAS) of self reported
morningness on 90000 individuals, followed by analyses of biological pathways and related
phenotypes. Hu et al. identiﬁed 15 signiﬁcantly associated loci, including seven established
circadian genes. Circadian and phototransduction pathways were enriched in their results. In
addition,they reported that morningness was associated with insomnia, sleep phenotypes,
body mass index and depression [140]. Several GWAS have also suggested interrelationship
between clock gene variations and metabolism. For instance, Cry2 was shown to be associ-
ated with a propensity to type 2 diabetes [86], while Clock haplotypes were associated with
metabolic syndrome and obesity [297]. Single nucleotide polymorphisms (SNP) in Clock are
associated with high plasma ghrelin concentration, obesity, altered eating behaviors, evening
preference, short sleep [104, 105]. Intriguingly, recent GWAS studies also indicated that mela-
tonin, a circulating hormone whose diurnal expression is tightly controlled by the circadian
clock, and its G-protein-coupled receptors MTNR1A and MTNR1B are associated with the
development of type 2 diabetes and impaired insulin secretion [86, 208, 288]. Melatonin,
whose receptors are present in both the pancreatic islets and the SCN, has been shown to
affect a collection of physiological processes, including glucose metabolism, insulin secretion
and sleep [254].
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Furthermore, a familial advanced sleep-phase syndrome was reported in 1999 as a short-
period (FASPS) circadian rhythm variant in humans (ﬁgure 1.6) [260]. In this study, the
authors have investigated three kindreds with a profound phase advance of the sleep–wake,
melatonin and temperature rhythms associated with a very short period. The mutation
segregates as an autosomal dominant with high penetrance. These kindreds served as a well-
characterized familial circadian rhythm variant in humans and contributed to the genetic
analysis of human circadian physiology.
Figure 1.6 – Free-running period of the circadian sleep–wake and temperature rhythms in one
FASPS subject. Sleep–wake rhythms of a 69-year-old female, studied in time isolation for 18 d.
Data are double-plotted. Sleep data (ﬁlled bars) are derived from polygraphically-recorded
sleep. Chi-squared periodogram analysis showed a free-running period of 23.3 h during the
18-day recording interval. Modiﬁed from [260].
To better understand the genetic basis of temporal organization in humans, a questionnaire
was developed to document individual sleep times, self-reported light exposure, and self-
assessed chronotype, considering work and free days separately [284]. This questionnaire
is known as the Munich Chronotype Questionnaire (MCTQ). The authors of the study sum-
marized the results of 500 surveys completed in a pilot experiment in 2003. Individual sleep
times depicted large differences between work and free days, except for extreme early types.
During the workweek, late chronotypes accumulated a substantial sleep debt, for which they
counterbalanced on free days by prolonging their sleep by several hours. For all chronotypes,
the quantity of time spent outdoors in broad daylight signiﬁcantly impacts the timing of sleep:
Increased self-reported light exposure advances sleep [284].
In a follow-up study using the MCTQ done by the same research group, they wanted to explore
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what zeitgebers entrain the human clock in real life by exploiting the common discrepancy
between social time and sun time. At the time of the study, their MCTQ database comprised
more than 40,000 individuals (including 22000 Germans). The results of the study showed that
the human clock entrains to sun time (ﬁgure 1.7). Within a given time zone, people live with
respect to a common social time — which tells them, for example, when to go to work. Dawn
and dusk, however, progress from East to West, generating a continuum in sun time. This
continuum creates differences between, for instance, the actual mid-dark phase and midnight
according to local clock time. In general, exposure to natural light decreased statistically in
the bigger the city thereby weakening the strength of this zeitgeber.The fact that inhabitants of
even larger cities are less coupled to sun time could be due to less exposure to outdoor light,
resulting in a weaker zeitgeber strength of the natural light–dark cycle. Light and darkness
even play a role when humans are entirely entrained by social cues: when we sleep, we close
our eyes and in most cases, avoid light. That social cues alone cannot entrain the human
circadian clock — without concurrent (behavioral) light changes [283].
A B
C
Figure 1.7 – A) The geographical distribution of the German places of residence of the study
participants (N = 21,600). B) The dependence on the longitude of normalized chronotype
of people living in areas with up to 300,000 inhabitants, representing 82% of the German
population. C) The dependencies of average chronotype on longitude for nine towns with
populations between 300,001 and 500,000 (gray symbols) and 11 cities with more that 500,000
inhabitants (black symbols). All correlations are also highly signiﬁcant for the respective raw,
un- binned datasets. For reference, the slopes of the shaded areas in (B,C) reﬂect approximate
discrepancies in dawn times at the different longitudes on June 21st. Standard error of the
mean is present for all data points but often is smaller than the size of the dots. Reproduced
from [283].
The effects of social cues on sleep remain largely unquantiﬁed. A recent study showed how
a smartphone app can accurately collect data on sleep habits around the world [336]. The
10
1.1. Chronobiology: the study of periodic events in living organisms
authors observed that social pressures increase and/or cover biological signals in the evening,
leading participants to delay their bedtime and shorten their sleep. They observed that a
country’s average bedtime, but not average wake time, predicted sleep duration. Moreover,
they conﬁrmed that women schedule more sleep than men and that users reporting that they
are more exposed to outdoor light go to sleep earlier and sleep more than those reporting
indoor light. Finally, they conﬁrmed that age is the primary determinant of sleep timing and
that age plays a critical role in the variability of population-level sleep habits.
A second smartphone app-based study revealed that erratic diurnal eating patterns in humans
can be modulated for health beneﬁts [112]. A diurnal rhythm of eating-fasting improves
health, but the eating pattern of humans is rarely measured. Thanks to their app, they were
able to monitor ingestion events in healthy adults with no shift-work for several days. Most
subjects ate frequently and erratically throughout wakeful hours, and overnight fasting du-
ration paralleled time in bed. They reported a bias toward eating late, with an estimated
<25% of calories intake before noon and >35% after 6 p.m. “Metabolic jet lag” arising from
weekday/weekend changes in eating pattern similar to travel across time zones was frequent.
The daily consumption duration (95% interval) exceeded 14.75 hr for half of the cohort. When
overweight individuals with >14 hr consumption duration ate for only 10–11 hr daily for 16
weeks supported by a data visualization (raster plot of dietary intake pattern called “feedo-
gram”) that they developed, study participants decreased their body weight, reported being
energetic, and improved sleep.
The link between social jet lag and obesity has been extensively studied [88]. Social jet
lag quantiﬁes the differences that often arises between circadian and social clocks, which
induces chronic sleep loss. Besides, the circadian clock regulates energy homeostasis, and its
perturbation such as social jet lag, may participate to weight-related pathologies. A large-scale
epidemiological study showed that beyond sleep duration, social jet lag is associated with
increased BMI [281]. They demonstrated that living “against the clock” may be a factor leading
to the epidemic of obesity. This is crucial in pending considerations on the implementation of
Daylight Saving Time and on work or school schedules, which all contribute to the amount of
social jet lag accrued by an individual. They suggested that improving the correspondence
between biological and social clocks will help the management of obesity.
Circadian clocks affect nearly all facets of our physiology and behavior, including rest–wake
cycle, cardiovascular activity, hormone secretion, body temperature and metabolism (ﬁgure
1.8). In summary, circadian desynchrony, a characteristic of shift work and sleep disruption
in humans, also leads to metabolic pathologies [28]. Together, these epidemiologic and
association studies highlight the clinical importance of interrelationships between melatonin,
glucose homeostasis, circadian rhythms, and sleep.
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Figure 1.8 – The circadian clock controls suitable metabolic responses within peripheral
tissues over the diurnal cycle. For instance, the liver clock promotes gluconeogenesis and
glycogenolysis during the sleep/fasting period, while it promotes glycogen and cholesterol
synthesis during the wake/feeding period. Correct functioning of peripheral clocks keeps
metabolic processes in sync with the environment, which is necessary for maintaining the
health of the organism. Different tissues depict distinct clock-controlled functions; In addition,
clock defect in certain tissues will provoke opposing effects on the metabolic function as
revealed by changes in nutrient conditions. Aging, diet, and environmental perturbations such
as shift work may also impact the integration of circadian and metabolic systems. Reproduced
from [28].
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1.2 Chromatin structure and accessibility
Since we aimed at investigating the transcriptional regulation of the clock, I have to present some
general concepts about chromatin structure and transcriptional regulation, before describing
the molecular organization of the circadian clock. In addition, technologies to investigate the
chromatin landscape such as ChIP-seq and DNase I-seq will be introduced in this section.
1.2.1 Chromatin structure and transcriptional regulation
Transcription is a highly regulated process (ﬁgure 1.9). It starts with the recognition of a
piece of genomic DNA, deﬁned as the promoter of a gene, by a set of transcription factors,
which modify the local chromatin structure and recruit RNA polymerase II to produce mRNA
[299]. Transcription factors (TF) bind to speciﬁc transcription factor binding sites (TFBS)
that are either close or distant to a transcription start site (proximal/distal regulation). Sets
of TFs can cooperate on cis-regulatory modules (CRM), stretches of DNA of about 100-1000
bp, to achieve speciﬁc regulatory events. One cis-regulatory element can regulate several
genes, and one gene can have several cis-regulatory modules. Interactions between bound
transcription factors and cofactors stabilize the transcription initiation process to allow gene
expression [170]. The regulation conferred by sequence-speciﬁc binding is highly restrained
by the three-dimensional structure of chromatin [50].
The basic units of chromatin are nucleosomes, which are formed by octamers of core his-
tone proteins. Eukaryotic genomes are tightly wrapped around nucleosomes to achieve the
10,000–20,000-fold compaction necessary to ﬁt a genome into the small volume of the nucleus
but that must also allow proteins involved in transcription, replication, and repair to access
DNA [342]. A thermodynamic equilibrium model has been used to describe experimentally
observed genome-wide in vivo nucleosome occupancy arrangements. In this model, both
nucleosomes and transcription factors have a constitutive afﬁnity for DNA sequence, which is
dependent on sequence composition [264]. Transcription factors compete with nucleosomes
for DNA, and the thermodynamic equilibrium deﬁnes the conﬁguration of nucleosomes and
transcription factors. In addition, nucleosome presence is shaped by kinetic elements; in
particular by chromatin-remodeling factors using the energy driven from ATP hydrolysis to ac-
tively inﬂuence DNA-histone interactions [62]. Several mechanisms of chromatin remodeling
have been put forward, including nucleosome sliding, nucleosome eviction, and looping of
DNA away from the histone core [207, 304]. Important aspects of the chromatin environment
may include post-translational histone modiﬁcations, the composition of the nucleosomes
themselves, and the binding of other protein complexes. Histone post-transcriptional mod-
iﬁcations may affect transcription factor binding by enhancing the afﬁnity of transcription
factor related protein complexes for the modiﬁed histones or by diminishing the afﬁnity of the
histone for DNA.
The improvements ofmethods such as Chromatin Immuno-Precipitation followed by sequenc-
ing (ChIP-seq, ﬁgure 1.10), for the genome-wide mapping of individual histone modiﬁcations
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Figure 1.9 – Transcription factors (TFs) bind to speciﬁc locations (transcription-factor binding
sites; TFBS) that are either proximal or distal to a transcription start site. Sets of TFs can act in
functional cis-regulatory modules (CRMs) to achieve speciﬁc regulatory events. Interactions
between bound TFs and cofactors stabilize the transcription-initiation complex to enable
gene expression. The regulation that is allowed by sequence-speciﬁc binding TFs is highly
dependent on the three-dimensional structure of chromatin. Reproduced from [340]
or DNA binding proteins, has enabled the detection of correlations between histone modiﬁca-
tion patterns or transcription factor binding and distinct states of gene activity [71, 358, 27].
Undoubtedly histone modiﬁcations can serve as a marker for a particular gene activity (or
inactivity), but the question of causality remains (ﬁgure 1.11).
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Figure 1.10 – Illustration of the ChIP-seq principle. The schema of the different methods (top
panel of each part) and the matching data signature (such as read density) that is used for
regulatory element investigation (bottom panel of each part) are presented. A) Chromatin
immunoprecipitation followed by deep sequencing (ChIP–seq) uses antibodies to ﬁnd the
location of transcription factor binding sites genome-wide. B) Nucleosomes that ﬂank active
enhancers carry characteristic histone modiﬁcations that can be identiﬁed by ChIP–seq using
speciﬁc antibodies. C) Enhancers are brought into close proximity of their respective target
promoters through the formation of chromatin loops, which are established by cohesin and
Mediator complexes. ChIP–seq can detect the contact points of cohesin and Mediator at
promoters and enhancers, and has been used to predict enhancers. Modiﬁed form [71]
The role of distal cis-regulatory elements, such as enhancers, and their interactions with
promoters, is not well characterized in the circadian context. The identiﬁcation of a core
regulatory network of cis-regulatory modules, promoters, and corresponding transcription
factors will provide a comprehensive picture of the regulation and the interplay between
metabolism and internal clock.
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Figure 1.11 – Histone modiﬁcation and chromatin organization. Promoters, gene bodies,
enhancers and boundary elements are illustrated on a schematic genomic region. Active pro-
moters are marked by histone H3 lysine 4 dimethylation (H3K4me2), H3K4me3, acetylation
(ac), and histone variant H2A.Z. The structure of the nucleosome core may also determine
nucleosomes as being more or less permissive to transcription factor binding. Histones that
constitute nucleosomes cores variants, such as H2A.Z, have been reported to alter nucleosome
properties [153]. Transcribed regions are enriched for H3K36me3 and H3K79me2. Repressed
genes may be placed in large regions of H3K9me2 and/or H3K9me3 or H3K27me3. Enhancers
are relatively enriched for H3K4me1, H3K4me2, H3K27ac and for the histone acetyltransferase
p300. The transcriptional repressor CTCF binds many sites that may act as insulators, bound-
ary elements or structural scaffolds. These various features of chromatin help to organize the
DNA and determine functional elements. Reproduced from [358]
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1.2.2 Measuring chromatin accessibility using DNase I hypersensitivity
DNase I hypersensitivity is a measure of chromatin accessibility and its dynamics. It provides a
general method for predicting cell-type speciﬁc cistromes. DNase I hypersensitive sites (DHS),
small regions of chromatin of 200-1000 bp, which are extremely sensitive to cleavage by DNase
I, typically occur in nucleosome-depleted regions and often arise as the result of transcription
factor binding. DNase I digestion followed by high throughput sequencing has developed
into a powerful technique to identify genome-wide DHS [199, 124, 302]. Because transcrip-
tion factor binding sites favor DNase I hypersensitivity yet DNAse I-seq does not require a
factor speciﬁc antibody, DNA sequence motif analysis on DHS data has been highlighted as a
method to identify the binding sites of multiple transcription factors in a single experiment
[257, 37]. While DNA sequence motifs may not be entirely predictive of transcription factor
binding across the entire genome, they are good predictors within regions of open chromatin
[131]. Thus, DNase I hypersensitivity patterns are likely to be dependent on the structure
of TF-DNA interactions and the chromatin environment at binding sites. Furthermore, at
a high sequencing depth, it is possible to identify depleted narrow regions in the DHS core,
corresponding to protein footprints of 8-30 bp [138, 57] (ﬁgure 1.12). Differential DNase I
hypersensitivity analysis proved the utility of quantitative analysis of chromatin accessibility
differences between condition to predict transcription factor activity [131].
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Figure 1.12 – Principles of a DNase I footprinting experiments. A) The classical DNase I foot-
printing method was executed in vitro and combined puriﬁed protein or nuclear extract with
a radiolabeled DNA probe. A shallow DNase I digestion resulted in a series of fragments that
were separated using gel electrophoresis. B) DNase I-seq combines exposure of nuclei to
DNase I, puriﬁcation of small DNase I–released fragments, and massively parallel sequenc-
ing of fragment ends (DNase I cleavage sites) to generate a digital signal of per-nucleotide
cleavages genome-wide. C) DHSs versus TF footprints. An accessible site is detected as a DHS
enriched for sequencing reads in DNase I-seq signal. In the DHS, one or more narrow sites may
be identiﬁed as putative TF footprints thanks to the local protection from DNase I cleavage.
The identity of TFs is inferred from the sequence underlying the corresponding protected
regions. Represented here are two example TFs with different DNA-binding dynamics that
inﬂuence the degree of protection from DNase I cleavage at the binding sites. The DNase I
cleavage pattern can be present over motif elements with deep, very shallow or no footprints.
Modiﬁed from [331, 224]
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1.3 The organization of the mammalian circadian clock
This section will introduce the structure of the mammalian molecular clock, Moreover, a review
of recent transcriptomics and functional genomics studies as well as computational research
(modeling and promoter sequence analysis) of the transcriptional regulation of circadian genes
will be presented. Finally, molecular mechanisms that are implicated in the cross-talk between
the circadian clock and the metabolism will be described.
1.3.1 The hierarchical organization of the mammalian clock
In mammals, the main zeitgeber is the light signal. Daylight is detected by photoreceptors in
the retina and transmitted to the suprachiasmatic nucleus (SCN) in the anterior hypothalamus
by the retinohypothalamic tract (RHT). Reception of the light signal rapidly induces the
expression of the mPer1 or mPer2 genes in a time-dependent manner. Thus, light input at
the onset of the night activates both mPer1 and mPer2, whereas mPer1 only is activated if a
stimulus is provided at the end of the night. This activation is mediated through pathways
implying cAMP, Ca+2 and phosphorylated CREB which activates the Per genes [272].
The SCN is the master circadian oscillator, where the rhythm is generated, and then converted
to systemic signals such as hormones like the glucocorticoids, which affect the metabolic
processes and behavior of the entire animal [280] (ﬁgure 1.13). Ablation of the SCN leads to a
loss of phase coordination between the different tissues [351]. Therefore, SCN is crucial for
the proper function of the circadian clock in the whole animal.
Indirect signals such as temperature cycles can also induce synchronization. The peripheral
oscillators are sensitive to temperature entrainment via the heat-shock response pathway.
Several studies showed that heat-shock protein (HSP) and the transcription factor heat-shock
factor 1 (HSF1) are involved in the mechanism of clock resetting by temperature cycles [291,
175].
Another indirect signal such as feeding rhythm can entrain peripheral oscillators such as in the
liver. The intracellular redox state (assessed by the NADH/NAD+ ratio) is a direct measure of
the nutritional state of a cell. The redox state affects the activity of the core clock transcription
factor BMAL1/CLOCK through the interaction with the NAD+ dependent deacetylase SIRT1
[15].
In addition, the presence ofmammalian peripheral clocks has been demonstrated by recording
gene expression in cultured ﬁbroblasts or tissue explants [25]. The circadian clock is involved
in the regulation of several biological processes. For instance sleep-wake cycles, heartbeat,
blood pressure, renal plasmaﬂow, body temperature, sensorial perception, and the secretion of
many hormones ﬂuctuate during the day in a coordinated manner [128]. These physiological
changes persist under constant conditions, which suggests their regulation by one or more
circadian regulators.
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The hierarchical synchronization of the peripheral clocks supports the coordination of the
different tissues. However, due to tissue-speciﬁc functions, the group of clock-controlled
genes are different between tissues. The molecular mechanisms underlying tissue speciﬁcity
are not determined yet but, several studies showed signiﬁcant differences in the nature, the
number and the phase of the rhythmic transcripts in various tissues [312, 248, 5, 355]
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Figure 1.13 – The hierarchical structure of the mammalian clock. Central and peripheral
clocks coordinate external cues with behavior and metabolic outputs. Light entrains the
master pacemaker in the SCN, which in subsequently synchronizes extra-SCN and peripheral
clocks. Brain clock outputs involve behavioral rhythms such as sleep and feeding. In the
other hand, peripheral clock outputs consist of metabolic rhythms such as glucose and
lipid homeostasis. The hierarchical structure of the mammalian clock is described by “non-
autonomous” regulation of peripheral tissue clocksmeaning the regulation of peripheral tissue
oscillators through direct neural and humoral signals, and “autonomous” control indicating
the intrinsic regulation of local cellular oscillators independently of the brain clock. Modiﬁed
from [28]
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1.3.2 The mammalian molecular core clock
At amolecular level, the circadian oscillator consists of two interacting transcriptional-translational
feedback loops (ﬁgure 1.14). The PAS domain helix-loop-helix transcription factors BMAL1
and CLOCK are the principal constituents of a positive feedback loop [41, 167, 225, 139].
They form a heterodimer, which binds to the E-box with a consensus sequence 5’-CACGTG-3’.
This E-box is a DNA binding site, known as a cis-regulatory element of target genes such as
Period genes (Per1, Per2 and Per3) and Cryptochromes (Cry1 and Cry2). A negative feedback
loop is formed when CRYs and PERs form heterocomplexes, which are translocated back to
the nucleus and inhibit their own expression [182, 54, 191]. A secondary feedback loop is
mediated by the orphan nuclear receptors REVERBα and RORα, which are also controlled
by the CLOCK/BMAL1 heterodimer. There is a competition in the nucleus between REVERB
alpha and ROR alpha for binding to the ROR-responsive element (RRE) with a consensus
sequence 5’-AGGTCA-3’ preceded by a 5-bp A/T-rich sequence, in the Bmal1 promoter. RORα
activates the transcription of Bmal1, whereas REVERBα represses it [259, 4].
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Figure 1.14 – The key components of the mammalian transcription/translation delayed feed-
back loop (TTFL) model. Both BMAL/CLOCK(NPAS2) and REVERBs contribute to the produc-
tion of rhythmic transcription at the Per, Cry, and Reverb promoters. PER and CRY proteins are
degraded via F-box proteins, whereas REVERB depends on E3 ligases. Reproduced from [274]
In addition to these TTFL, the clock requires numerous post-translational modiﬁcations
to achieve a sufﬁcient delay to set a 24h period. Protein kinases, notably CK1 and CK1γ,
modulate the activity and/or stability of positive and negative components of the feedback
loop [203, 204, 332]. The general mechanism of the circadian clock and the genes required
for its maintenance are mostly conserved between different tissues. Nevertheless, circadian
output genes are tissue-speciﬁc, as one would expect given the diverse physiologies regulated
by the clock [146]. Metabolically active tissues, such as liver, have their own clock that
regulates tissue-speciﬁc functions [48].
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1.4 Circadian transcription and gene regulation
1.4.1 Transcriptome-wide studies of the circadian clock
To study circadian regulation of gene expression, several groups have performed transcriptome-
wide studies to detect circadian transcription, using mRNA microarrays, RNA-seq or nascent
RNA-seq time-series with two to four hours resolution over several cycles (or replicates) of 24
hours in mouse liver.
Roughly 2-20 percent of transcripts undergo circadian oscillation in the liver (table 1.1), includ-
ing enzymes and regulators of major metabolic processes [248, 312]. Though this percentage
depends mainly on the applied criteria, such as the set of genes (all the genes of the organism
or only the expressed genes in a given condition), cutoffs considered, experimental conditions,
such as feeding regimen and Light-Dark (LD) or Dark-Dark (DD), temporal resolution and
the number of replicates. However, even in the liver, the number of cyclic mRNAs with large
amplitudes (larger than two-fold) is relatively low.
Table 1.1 – Non-exhaustive list of circadian transcriptome studies in mouse liver based on a
collection of techniques. About 2-20 percent of transcripts undergo circadian oscillation in
the liver.
Method(s) #rhythmic
genes
Reference
Microarray 335 Panda et al. (2002) [248]
Microarray 575 Storch et al. (2002) [312]
Microarray 716 Miller et al. (2007) [227]
Microarray 3667 Hughes et al. (2009) [144]
Microarray 2997 [333]
RNA-seq 1160 Vollmers et al.(2009) [334]
Microarray 2828 Eckel-Mahan et al. (2012) [90]
RNA-Seq 3408 Koike et al. (2012) [171]
PoI II ChIP-Seq 892 Le Martelot et al. (2012) [188]
Microarray 885 Le Martelot et al. (2012) [188]
Nascent-Seq 822 Menet et al. (2012) [223]
RNA-Seq 1204 Menet et al. (2012) [223]
RNA-Seq 1630 Du et al. (2014) [83]
RNA-Seq and Microarray 3186 Zhang et al. (2014) [355]
GRO-Seq 1261 Fang et al. (2014) [95]
RNA-Seq 4544 Atger et al. (2015) [17]
In a landmark publication, Panda et al. compared the circadian oscillation in the liver and
the suprachiasmatic nuclei (SCN) of the hypothalamus. They observed that about 650 genes
were oscillating in both tissues, while the overlap between the two set of genes was quite
low with only 27 genes. Nutrient metabolism, in liver, appeared as an important target of
circadian regulation. Furthermore, genes related to metabolism of sugar were expressed
22
1.4. Circadian transcription and gene regulation
during feeding in the early evening, and enzymes for cholesterol biosynthesis peaking at night,
when nutrients are absorbed. In particular, so-called "rate-limiting" steps were shown to
be subject to a precise circadian control [248]. Panda et al. suggested that both core clock
mechanisms and feeding cues regulate these circadian patterns of gene expression.
Storch et al. compared the heart and the liver and transcriptome usingmRNAmicroarray. They
observed that about 10% of all expressed genes in those tissues depict a circadian oscillation.
They found that the overlap between the oscillating transcripts in both tissues was low, notably
a core set of 37 genes with similar circadian regulation in both tissues. The authors observed
that the distributions of circadian phases in the two tissues are considerably different as well
as the downstream biological processes enriched in their gene ontology analysis.
In addition, Miller et al. compared liver and skeletal muscle from WT and Clock mutant mice
[227]. In WT tissue, they observed that a large percentage of expressed genes were transcrip-
tion factors that were rhythmic in either muscle or liver, but not in both, suggesting that
tissue-speciﬁc output of the pacemaker is regulated at a transcriptional level. The comparison
between WT and Clock mutant mice tissues revealed that the Clock mutation affects the
expression of many genes that are rhythmic in WT tissue, but also deeply affects many non-
rhythmic genes. In both liver and skeletal muscle, a signiﬁcant number of CLOCK-regulated
genes were associated with the cell cycle and cell proliferation.
Another study by Hughes et.al compared oscillating transcription from mouse liver, NIH3T3,
and U2OS cells [144]. The authors reported a 100-fold difference in the number of cycling
transcripts in autonomous cellular models of the oscillator versus tissues harvested from
intact mice. Moreover, they observed two clusters of genes that cycle with a period of 12 hours
and 8 hours in liver, but not cultured cells. They conﬁrmed that 12-hour oscillatory transcripts
occur in several other peripheral tissues as well including heart, kidney, and lungs and the
reported that these harmonics are lost in cell cultures, as well as under restricted feeding
conditions.
Vollmers et al. were interested in understanding the main drivers of oscillations in hepatic
transcripts in dark-dark conditions [333]. They wanted to study the contribution of the
endogenous oscillator and the food intake. To address this question, they used distinct feeding
and fasting experimental conditions on wild-type (WT) and circadian clock-deﬁcient mice.
They monitored temporal patterns of feeding and hepatic transcription. They reported that in
the absence of feeding, only a small subset of transcripts continued to exert circadian patterns.
Conversely, temporally restricted feeding restored rhythmic transcription of hundreds of genes
in oscillator deﬁcient mouse liver. They concluded that both temporal pattern of food intake
and the circadian clock drive rhythmic transcription.
In recent past, Eckel-Mahan et al. compared the hepatic circadian transcriptome with a
comprehensive dataset of over 500 metabolites identiﬁed by mass spectrometry [90]. They
observed that many metabolites depict clock-controlled oscillation, including those within
the amino acid and carbohydrate metabolic pathways as well as the lipid, nucleotide, and
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xenobiotic metabolic pathways.
Menet et al. have investigated rhythmic transcription by quantifying genome-wide nascent
mRNA produced around the clock in mouse liver [223]. They compared nascent mRNA
with the amount mRNA expressed. Although the authors found that many genes exhibit
rhythmic mRNA expression in the mouse liver, about 70% of them did not show comparable
transcriptional rhythms. As in Le Martelot et al. They conclude that the post-transcriptional
regulation must have a critical role in the circadian system. In addition, Menet et al. observed
that the inﬂuence of CLOCK:BMAL1 differed from what was expected, which suggests that
it collaborates with several other transcription factors to control the transcription of target
genes.
As post-transcriptional mechanisms seems to contribute to mRNA abundance rhythms. Du
et al. have investigated how microRNAs (miRNAs) affect the core clock and clock-controlled
gene expression using mice with an inducible defect in miRNA biogenesis [83]. The au-
thors observed that cyclic transcription paired with miRNA-mediated regulation was a fre-
quent phenomenon that affected up to 30% of the rhythmic transcriptome and served to
post-transcriptionally adjust the phases and amplitudes of rhythmic mRNA accumulation.
Nevertheless, only few mRNA rhythms were actually generated by miRNAs. They hypothesized
that miRNAs function to adapt clock-driven gene expression to tissue-speciﬁc requirements.
Using a similar technique to nascent mRNA sequencing called Global Run-On sequencing
(GRO-seq) Fang et al. studied the underlying mechanisms of multiple phases of gene expres-
sion in the liver [95]. Their examination of enhancer RNAs (eRNAs) that cluster in speciﬁc
circadian phases lead to the identiﬁcation of functional circadian enhancers driven by dis-
tinct transcription factors (TFs). In addition, on a global scale some components of the TF
cistromes, such as D-box, E-box, and RRE, that function to orchestrate circadian gene ex-
pression were identiﬁed. Integrated genomic analyses also revealed putative mechanisms by
which a single circadian factor controls opposing transcriptional phases.
Another impressive study was performed by Zhang et al. to elucidate the role of the circadian
clock in mouse physiology and behavior [355]. The authors performed RNA-seq and mRNA
microarray to quantify the transcriptomes of 12 mouse organs around the clock. They reported
that 43% of all protein coding genes showed circadian rhythms in transcription one or more
tissue, but mainly in an organ-speciﬁc fashion. In most organs, the authors reported the
characteristical bi-modal phase distribution with many oscillating genes peaking during
transcriptional "rush hours" preceding dawn and dusk (as in Vollmers et al. and Le Martelot et
al.). Moreover, by looking at the genomic landscape, the authors reported that rhythmic genes
clustered together, were longer, and had more spliceforms than non-rhythmic genes. Systems-
level analysis depicted a complex rhythmic orchestration of gene pathways throughout the
body. In addition, they observed rhythmic expression of more than 1,000 known and novel
noncoding RNAs (ncRNAs). Importantly, the authors claim that the majority of drugs and
World Health Organization essential medicines directly target the products of rhythmic genes,
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which may represent a turning-point for advancement in chronotherapy.
More recently, Atger et al. measured transcription, accumulation, and translation, of mouse
liver mRNAs under light–dark conditions and ad libitum or night-restricted feeding in WT
and Bmal1 knockout animals [17]. The authors reported that rhythmic transcription mostly
leads to rhythmic mRNA accumulation and translation. Comparison of wild-type and Bmal1
KO mice conﬁrmed that circadian clock and feeding rhythms have large effect on rhythmic
gene expression, Bmal1 deletion affecting both transcriptional and post-transcriptional levels
unexpectedly.
1.4.2 Genome-wide studies of the circadian chromatin landscape
Thanks to the development of recent sequencing-based technologies, as Chromatin Immuno-
Precipitation followed by sequencing [27], it is possible to study the chromatin landscape at a
genome-wide scale, including transcription factor binding sites and histones modiﬁcations.
Several studies in the circadian ﬁeld used this approach in order to investigate the transcrip-
tional regulation of the core clock as well as transcription factor related to feeding/fasting
cycle.
For instance, Koike et al. [171] performed an impressive large-scale study using ChIP-seq
for genome-wide temporal proﬁling of core clock factors such as BMAL1, CLOCK, CRY1,
CRY2,PER1, PER2 and NPAS2. Moreover, they measured PolII loadings (RNAPII-8WG16) and
elongating PolII (RNAPII-Ser5P), as well as coactivators p300 and CBP, and histone variants,
such as H3K27ac, H3K9ac, H3K4me3, H3K4me1, H3K36me3, and H3K79me2. In addition,
they performed a whole transcriptome RNA-seq with the same temporal resolution. The
phase of activity of the transcriptional regulators displayed expected speciﬁcity, with CLOCK,
BMAL1 and NPAS2 binding at ZT6-ZT8, PER1, while PER2 and CRY2 were reported at ZT15-
ZT17, and CRY1 binding at ZT0. For the circadian transcriptional control, Koike et al. suggest
that an activation phase from the early inducer BMAL1/CLOCK dimer recruits p300 and
promote histone acetylation at regulatory elements, including enhancersmarked byH3K4me1.
Subsequently, transcription then occurs with nascent transcription starting around ZT13 to
peak around ZT15, followed by a repression phase by PER1/2 and CRY2. In addition, they
showed that only 22% of cycling mRNA are driven by de novo transcription, suggesting that
both transcriptional and posttranscriptional mechanisms underlie the mammalian circadian
clock. Moreover, they found that circadian modulation of RNAPII recruitment and chromatin
remodeling occurs on a genome-wide scale.
At the same time, Vollmers et al. used genome-wide temporal proﬁles of H3K4me1, H3K4me3,
H3K36me3, H3K27ac, H3K9ac, DNA methylation and strand-speciﬁc RNA sequencing to study
epigenetic modiﬁcations associated with transcript oscillations [334]. They observed that 9%
of expressed transcripts undergo circadian oscillation, notably protein-coding genes as well as
lincRNAs,miRNAs and antisense transcripts such as asPer2. Transcripts phase distributionwas
bimodal with a cluster of genes expressed in the morning and a second cluster expressed in the
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evening. Robust transcript rhythms were correlated with rhythmic histone modiﬁcations in
promoters, gene bodies, or enhancers, while promoter DNA methylation levels were constant.
Coupling of cycling histone modiﬁcations with nearby circadian transcripts consequently
established a temporal relationship between enhancers, genes, and transcripts on a genome-
wide scale in mouse liver.
Le Martelot et al. performed a genome-wide analysis of PolII, H3K4me3 and H3K36me3,
combined with mRNA microarray [188]. PolII oscillations in the promoter were correlated
with Pol II loading in the transcribed region. In addition, H3K4me3 in the promoter depicted
a phase delay of 1.3 hours, while H3K36me3 signal oscillated at the end of a transcript with
a phase delay of 3 hours. Moreover, Pol II occupancy preceded mRNA accumulation by 3
hours, consistent with mRNA half-lives. They observed, as in Vollmers et al. that transcripts
phase distribution was bimodal with a group of genes expressed in the morning and a second
group expressed in the evening. Finally, they were able to distinguish three classes of genes
using modeling proﬁles of Pol II occupancy and mRNA accumulation. The ﬁrst one showing
rhythmicity both in transcriptional and mRNA accumulation, the second class with rhythmic
transcription but ﬂat mRNA levels, and a third with constant transcription but rhythmic
mRNAs. The last class suggested post-transcriptional regulation in the mouse liver.
Several studies have focused on one or more transcription factors or DNA binding proteins to
investigate the transcriptional regulation in the liver. Currentmodels of time-speciﬁc transcrip-
tion include the core clock transcription factors BMAL1/CLOCK that activate transcription
maximally at ZT8 [273, 171], as well as the nuclear receptors RORs and REVERBs, whose
targets are maximally transcribed around ZT20 [60, 43, 316]. Rhythmically active TFs also
include clock-controlled outputs, notably the PAR-bZIP proteins (DBP, TEF, HLF), maximally
active near ZT12 [277, 103]. Furthermore, diurnally ﬂuctuating systemic signals may drive
rhythmic TF activities, for example, HSF1 shuttles to the nucleus and activates transcription at
ZT14 [270, 291], and similarly, SRF shows activity at the night-day transition [109]. Moreover,
regulators controlled by feeding-fasting cycles include FOXO TFs that are active during the day,
CREB/ATF family members at the light-dark transition, and SREBP during the night [333, 111].
Finally, the glucocorticoid receptor (GR) signals the onset of behavioral activity (light-dark
transition) [266].
1.4.3 Chromatin remodelers and topological domains
Chromatin remodelers including histone-modifying enzymes, such as MLL1 [163], MLL3
[327] and JARID1A [79] have been lately associated with the circadian rhythm. In addition,
CLOCK has been shown to possess a histone acetyltransferase activity [80]. Constitutive
binding of BMAL1 in the presence of HDAC inhibitors was impaired which imply that proper
chromatin environment is needed for correct BMAL1 binding [313]. While Menet and col-
leagues reported that CLOCK:BMAL1 can exhibit a pioneer-like function and thus open the
chromatin [222]. These chromatin remodels or some pioneer factor are potentially responsi-
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ble for the mechanism of tissue-speciﬁc gene regulation in cooperation with core clock factor,
but it is still an open question. Finally, the 3D structure of the chromatin or more precisely
topological associated domains (TADs) have been shown to be dynamic along the circadian
cycle [3] although the precise mechanisms and the role of these TADs remain unclear.
1.4.4 Computational analysis of the transcriptional regulationof oscillating genes
Bozek et al. addressed the question of tissue and phase speciﬁcity using a large scale promoter
analysis of clock-controlled genes (CCGs) [38]. They performed a meta-analysis of microarray
data from mouse tissues, notably heart, liver, SCN, skeletal muscle, by looking at promoter
regions of 2065 CCGs for highly enriched transcription factor binding sites (TFBS). Many of
the enriched transcription factors displayed themselves circadian oscillations. As expected
TFBS associated with the clock were overrepresented such as CLOCK/BMAL1, DBP, HLF,
E4BP4, CREB, RORα and the lately described regulators notably HSF1, STAT3, SP1 and HNF4α.
Moreover, additional putative circadian transcriptional regulators were enriched such as
PAX-4, C/EBP, EVI1, IRF, E2F, AP1, HIF1 and NFY. In addition, GC-rich motifs (SP1, EGR,
ZF5, AP2, WT1, NRF1) and AT-rich motifs (MEF2, HMGIY, HNF1, OCT1) were signiﬁcantly
overrepresented in promoter regions of CCGs. The authors suggested putative tissue-speciﬁc
TFBS such as HNF3 (FOXA) for liver, NKX2.5 for heart or Myogenin for skeletal muscle.
In a subsequent study from the same authors, they used a similar approach but focused
on mouse liver [39]. Again motifs such as E-boxes (CLOCK/BMAL), D-boxes (DBP, HLF,
E4BP4) and cAMP responsive elements (CREB) appeared as enriched TFBS in the promoter
of circadian genes. In addition GC-rich motifs (SP1, ETF, NRF1), AT-rich motifs (TBP, FOX04,
MEF2), Y-box motifs (NF-Y, C/EBP) and cell cycle regulators (E2F, ELK1) were among the
enriched factors. In a subset of genes regulated by systemic signals such as hormones and
body temperature, they were able to detect motifs of the serum response factor (SRF) and the
estrogen receptor (ER). Finally, they conﬁrmed their predictions using published ChIP-seq
datasets by demonstrating that some of their predicted circadian transcriptional regulators
(C/EBP, E2F, HNF1, MYC, MEF2) targeted clock-controlled genes.
Two studies on core clock motifs, notably D-box, E-box and RRE, proved their phase-setting
ability [325, 326]. In the ﬁrst study, using computational approach and synthetic constructs,
the authors were able to produce high amplitude circadian oscillations in vitro and in silico.
Ukai-Tadenuma et al. performed an in vitro assay with mammalian cells to test the role of
motifs in promoter regions driving the expression of a reporter gene at a particular phase. They
hypothesized that the control of downstream output by the circadian cycle was determined
by the phase of expression of activators and repressors, targeting regulatory elements. The
activator and the repressor were placed under the control of three core-clock elements, notably
D-box, E-box or RRE. A morning phase for the activator (under E-box control) and a night-time
phase for the repressor (under RRE control) resulted in reporter oscillation at phase around
ZT8. Thus, they reproduced the endogenous gene regulation where a morning activator
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DBP (controlled by E-box) targets D-boxes under competition by the night-time repressor
E4BP4 (controlled by RRE), where the phase of D-box controlled expression was found to
be around ZT8 in this artiﬁcial system. Moreover, Authors could also reproduce a similar
output around ZT16 by expressing the repressor under E-box control in the morning (similar
to REVERB promoter) and the activator in the evening under D-box control (as RORα). This
experiment demonstrated how phase setting was the product of transcription factor binding
at promoters of target genes. Furthermore, the group was able to synthesize promoters
leading to unusual output phases by combining different phases for activators and repressors,
concluding that combinations of transcription factors with the three main phases in the
core-clock can generate a phase-speciﬁc transcriptional output at various times of the day.
In the second study, by investigating the Cry1 locus, and assessing the signiﬁcance of an
intronic RRE for the phase control of expression of Cry1 transcript, Udai-Tadenuma et al.
[326], showed that phase-speciﬁc expression could also occur from combinations of several
clock controlled elements. Adding an RRE to the luciferase reporter gene under control of
D-boxes or E-boxes in its promoter resulted in an output phase similar to a prediction from a
vector sum of the contributions of both regulatory elements. Such a vector additive model
could explain how phase-speciﬁc circadian control of output genes results in the variety of
phases observed in the mouse liver. This simple additive vector model is called the phase
vector model.
In addition, Rey et al. studied oscillations of BMAL1 binding in mouse liver [273]. The authors
applied a linear model approach to infer transcription factor activities for several factors which
were shown to be targeted by BMAL1 binding. This method used the mRNA expression of
BMAl1 target genes combined with transcription factor binding sites, determined by position
weight matrix scans (PWMs from SwissRegulon) in promoter regions. The results of this
analysis showed a circadian activity for DBP/HLF/TEF/E4BP4, REVERB/ROR, HIF1A, PPARa,
and BACH1 motifs.
A last interesting study from Westermark and Herzel focused on the mechanism producing
rhythms with a period of 12 hours [341]. They hypothesized that previously reported 12
hours rhythms in gene expression are the results of an interplay between components of the
circadian clock. Therefore, they constructed a theoretical model involving pairs of circadian
transcription factors. Using this model, they observed that the conditions required for these
12 hours oscillations include a certain circadian phase relationship between the two compo-
nent of the clock as well as a non-competitive binding to the promoters of regulated genes.
Finally, the authors demonstrated that binding sites for transcription factor pairs with phase
relationships predicted by theory were overrepresented in promoters of genes displaying 12 hr
rhythms using published mRNA microarray and position-weight matrices scan.
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1.5 Interplay between circadian clock and metabolism
1.5.1 Impairedmetabolic phenotypes associatedwithmutationsof core clockgenes
Liver-speciﬁc deletion of Bmal1 disrupts the rhythm of glucose metabolism (table 1.2) and
causes a low fasting glucose level [185]. Shimba and colleagues reported that BMAL1 is
an essential regulator of adipogenesis and lipid metabolism in matured adipocytes [300].
Embryonic ﬁbroblast cells deﬁcient in BMAL1 gene fail to differentiate into adipocytes except
with the introduction of an exogenous BMAL1 copy. Bmal1 knockout mice show increased
respiratory quotient, reduced fat storage, increased circulating fatty acid, and increased
ectopic fat formation in liver and muscles. Most of the genes implicated in adipocyte function
(e.g., PPARγ, C/EBPα, SREBP1c, and lipin1) are expressed at a low level in BMAL1 deﬁcient
mice, whereas the preadipocyte marker PREF-1 is expressed at a high level. The impaired
adipogenesis in BMAL1 knockoutmice prevent the increase of the adipose tissue uponnutrient
excess and thus lead to ectopic accumulation of fat in liver and muscles. Intriguingly, the
differences in adipose tissue size appear in adults but not juveniles of BMAL1 knockout mice,
linking a functional clock to aging.
In addition, hepatic overexpression of Cry1 inhibits gluconeogenesis and reduces blood
glucose levels [354], whereas a whole body double knockout of Cry1 and Cry2 leads to Glucose
intolerance and constitutively high levels of circulating corticorsterone [158]. Several other
clock mutants depict perturbed metabolic phenotypes. More intriguingly the whole-body
knockout of PPARγ coactivator-1α (PGC-1α), a metabolic regulator, exhibits an abnormal
circadian pattern of gene expression, suggesting a feedback mechanism of the metabolism to
the clock through PGC-1α.
In summary, genetic disruption of clock genes in mice perturbs metabolic functions of speciﬁc
tissues at distinct phases of the diurnal cycle.
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Table 1.2 – Metabolic phenotypes associated with mutations of key component of the circadian
clock in mice. Reproduce from [210]
Protein Mutation Metabolic Phenotype Reference
CLOCK whole-body
loss-of-
function
Attenuated feeding rhythm,
obesity, hyperphagy, hyperlipi-
demia, hyperglycemia, hepatic
steatosis, hypoinsulinemia
Turek et al. (2005),
Marcheva et al. (2010)
[324, 214]
BMAL1 whole-body
knockout
Glucose intolerance, hypoinsu-
linemia, increased respiratory
quotient, reduced fat storage, in-
creased circulating fatty acid, in-
creased ectopic fat formation in
liver and muscles, hypoinsuline-
mia
Lamia et al. (2008),
Shimba et al. (2011),
Andrews et al. (2010),
Marcheva et al.(2010)
[185, 300, 12, 214]
BMAL1 Liver-
speciﬁc
knockout
Hypoglycemia in the rest phase Lamia et al. (2008) [185]
CRY1 CRY2 whole-body
double
knockout
Glucose intolerance and consti-
tutively high levels of circulating
corticorsterone
Lamia et al. (2011) [158]
REVERBα
REVERBβ
whole-body
double
knockout
Hepatic steatosis, hyper-
glycemia, hyperlipidemia
Bugge et al. (2012), Cho
et al. (2012) [43, 60]
HDAC3 Liver-
speciﬁc
knockout
Hepatic steatosis Feng et al. (2011) [98]
PGC-1α whole-body
knockout
Abnormal diurnal rhythms of
activity, body temperature and
metabolic rate
Liu et al. (2007) [200]
AMPK whole-body
knockout
body temperature and
metabolic rate
He et al. (2003) [133]
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1.5.2 Clock controlled metabolism in mouse liver
The liver is a central metabolic organ where various processes occur during a diurnal cycle,
such as carbohydrate metabolism, protein metabolism, and lipid metabolism [47, 151]. Sev-
eral other liver functions controlled by the internal clock implies blood detoxiﬁcation [103]
through drug metabolism, blood homeostasis, through the production of albumin, a major
osmolar component of blood serum, immune function, through Kupffer cells (macrophages
located in the liver), and blood pressure regulation, trough production and secretion of
angiotensinogen [136].
Opposing metabolic processes, such as glycolysis/gluconeogenesis, and lipogenesis/fatty acid
oxidation, necessitates temporal separation; therefore circadian clock plays a signiﬁcant role
in the regulation of hepatic function. For example, the rate-limiting enzymes of glycolysis
and gluconeogenesis oscillate and peak in the early morning and early evening, respectively.
Metabolic phenotyping studies of clock mutant mice illustrate the importance of a functional
clock on liver metabolism [286].
Studies on the "rate-limiting" gluconeogenic enzyme, phosphoenolpyruvate carboxylase
(PEPCK), have revealed important links between metabolism and circadian cycle [286]. The
PEPCK activity is diurnal inmouse liver, implying rhythmic glucose production. The oscillation
of enzymatic activity is mainly due to a cyclic cellular accumulation of PEPCK since this
enzyme has a short half-life and the major control mechanism is mediated by transcriptional
regulation, through CREB and FOXO1 [116] (ﬁgure 1.15). Feeding/fasting cycles generate
daily oscillation of metabolic hormones, such as glucagon, glucocorticoid hormone, thyroid
hormone, and insulin. In addition, Glucagon activates CREB through the cAMP/PKA axis [8].
Glucocorticoid hormone activates the transcription of Pepck. Recently, Evans and colleagues
have characterized the glucocorticoid-dependent interaction between CRYs and glucocor-
ticoid receptor [158]. CRYs inhibit glucagon and glucocorticoid hormone signaling, which
constitute a negative feedback loop to the transcriptional control of Pepck. The REVERB/ROR
pair directly regulates Pepck expression. PPARγ coactivator-1α (PGC1α) exhibits circadian
gene expression and contributes to Pepck gene regulation by protein-protein interaction with
FOXO1 and ROR [46]. PGC1α, which is a transcriptional coactivator for the regulation of
energy metabolism, is also involved in circadian regulation and promotes the expression of
Bmal1 and RevErbα through the RRE site [200]. Thus, the core metabolic genes are tightly
related to the clock systems, and their activities undergo circadian changes.
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Figure 1.15 – A) Transcriptional control of hepatic gluconeogenesis under fasting conditions.
Under fasting conditions, elevated secretion of pancreatic glucagon initiate activation of PKA,
which phosphorylates CREB at the serine 133 residue, driving the increased association of
this factor with co-activator CBP/p300 onto the chromatin. Moreover, PKA dephosphorylates
CRTC2 at the serine 171 residue by inactivating SIK kinases and activating serine/threonine
phosphatases SMEK/PP4C and PP2B, inducing the nuclear localization and increased as-
sociation of CRTC2 with chromatin-bound CREB. These events induces the expression of
gluconeogenic genes such as PEPCK and G6Pase, during the early phase of fasting. Simultane-
ously, CREB/CRTC2 can increase the expression of PGC-1α and ERRγ, which are controlling
hepatic gluconeogenesis during the later phase of fasting. PRMP1 is implicated in the reg-
ulation of gluconeogenesis by modifying the arginine residues (Arg 248 and 250) of FoxO1
during this process. B) Transcriptional repression of hepatic gluconeogenesis under feeding
conditions. On the other hand, feeding induces the reduced plasma concentration of glucagon
and increases secretion of pancreatic insulin, which activates insulin signaling pathways in
the liver. Akt activation control subsequent SIK kinases activation, consequently increasing
phosphorylation of CRTC2. Simultaneously, Akt phosphorylates critical residues of FoxO1,
switching off the transcription of hepatic gluconeogenesis. In addition, transcriptional repres-
sors implicated in hepatic gluconeogenesis such as SHP, DAX-1, and TCF7L2 are expressed
under this condition, which allow the inactivation gluconeogenic genes as well as PGC-1α.
Reproduced from [240]
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Key metabolic factors like AMPK, SIRT1, PPARα, and PGC1α act as important regulators for
core circadian mechanisms (ﬁgure 1.16). AMPK, which is a nutrient sensor, play a role in the
destabilization of the CRY protein in the core of the circadian system [159]. Sirt1 is related to
anti-aging and is regulated by NAD+. Furthermore, Sirt1 regulates HAT activity of the CLOCK
protein [346] and promotes deacetylation and degradation of PER2 [15]. PPARα, which is a
nuclear receptor for lipid metabolism in the liver, binds with PER2 [294] and increases Bmal1
expression through a peroxisome proliferator-activated receptor (PPAR) response element in
the promoter of Bmal1 [149].
CLOCK BMAL1
ROR
REV-ERB
Metabolic Flux
NADNAMPT SIRT1
AMPK
LKB
ATP/AMP
Direct Outputs
TEF
HLF
E4BP4
REV-ERB
NHRs
Indirect Outputs
Proteasome
Histone modification /
Transcriptional Regulation
(FOXO, STAT3, PGC1??
Post-Transcriptional
Regulation
Other
NAD-dependent
sirtuins?
+
CORE CLOCK
Oscillating
Transcription Factors Oscillating 
RNAs
within
Metabolic
Networks
? glucose
? ATP/AMP
??O2
??glucocorticoids
??catecholamines
Gluconeogenesis
Mitochondrial biogenesis
Oxidative phosphorylation
Amino acid turnover
Lipogenesis
Bile acid synthesis
E-box Gene
CRY
PERCKI???
CRY
PER
P
P
FBXL3
CRY
P
DBP
PPAR?
PGC1?
?
Figure 1.16 – Direct and indirect outputs of the core clock mechanism. The core clock consists
of a series of transcription/translation feedback loops that synchronize diverse metabolic
processes through both direct and indirect outputs, including gluconeogenesis and oxidative
metabolism. The clock also receives reciprocal input from nutrient signaling pathways (in-
cluding SIRT1 and AMPK), which function as rheostats to couple circadian cycles to metabolic
ﬂux, especially in peripheral tissues. Reproduced from [28]
Perturbation of lipid homeostasis in the liver is involved in the development of obesity-related
metabolic diseases, such as hyperlipidemia, insulin resistance, coronary artery disease, non-
alcoholic fatty liver disease and diabetes. In recent years, molecular mechanisms of how
circadian clocks regulate lipid metabolism have been studied extensively. It has been known
for years that regulators of lipid metabolism oscillate in the liver [210]. Circadian clocks
directly or indirectly regulate these regulators. For example, Schibler and colleagues have
studied the modulation of SREBP in Reverbα KO mice. SREBP targets such as Hmgcr, Acas,
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Fas and Elov6 are involved in cholesterol and lipid metabolism. REVERBα repress Insig2,
which sequester SREBP to the endoplasmic reticulum membrane and thereby interfere with
the proteolitic activation of SREBP in the Golgi membrane. A rate-limiting enzyme of the
conversion from cholesterol to bile acid, known as Cyp7a1, is modulated by REVERBα. This
control is mediated by the stimulation of LXR by rhythmic production of oxysterols [189].
More recently SREBP binding sites have been identiﬁed genome-wide. Targets of SREBP
were divided into clusters based on their expression pattern. One of the clusters showed a
high enrichment of HNF4 binding sites and a phase shift of 8h compared to SREBP binding,
which strongly suggest cross talk between these factors. Interestingly the expression of targets
co-regulated by HNF4 and SREBP1 is strongly impaired in the Bmal1 KO mice [111].
Taken together, these researches done in the past decades revealed several key factors impli-
cated in the cross talk between the nutrient cycle and the circadian rhythm.
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1.6 Objectives
At the molecular level, the relationship between the circadian cycle and nutrient response
cycle (or metabolism) is poorly understood. Therefore, the CycliX consortium aimed at
characterizing the changes in genomic states and transcriptional programs that are implicated
in both cycles. The CycliX consortium studied the transcriptional and epigenetic basis of
diurnal rhythms in mouse liver genome-wide, using temporal DNA occupancy proﬁles of RNA
polymerase II (Pol II) as well as proﬁles of histone modiﬁcations [188]. Thus, they showed that
the epigenetic landscape is highly dynamic and globally remodeled during the 24-hour cycle.
Currently, the circadian transcriptional regulation is mostly explained by three groups of
transcription factors, bHLH proteins, such as BMAL1 or CLOCK, PAR b-Zip proteins, such as
DBP, TEF or HLF, and nuclear receptors, such as ROR or REVERB, respectively acting at ZT8,
ZT12, and ZT22. In addition, the contribution of the distal regulatory elements to circadian
regulation as well as the tissue-speciﬁc regulation of the circadian cycle remains unclear.
Therefore we aimed at:
• Investigating the chromatin accessibility, as well as RNA polymerase II and histone 3
lysine 27 acetylation genome-wide proﬁles over 24h in the circadian context.
• Identifying the cis-regulatorymodules and transcription regulators acting at themapped
cis-regulatory sites.
• Investigating genome-wide differences between Bmal1−/− and WT mice to understand
the contribution of the circadian cycle and the nutrient response cycle regarding diurnal
oscillations in mouse liver.
• Identifying of core clock and metabolism transcription factors as well as downstream
effectors.
• Explaining phase-speciﬁc regulation by transcription factors.
• Identifying putative tissue-speciﬁc transcription factors by comparing NIH3T3 cells and
the liver.
• Identifying putative co-regulatory elements involved in differential regulation of BMAL1-
CLOCK binding in different contexts, namely NIH3T3 cells and mouse liver.
1.7 Achievements
• Investigation of genome-wide DNase I hypersensitive sites (DHSs) in mouse liver. About
62000 DHSs were detected in mouse liver. In addition, 98000 Footprints were detected in
about 3/5 of DHSs. We observed that DHS around TSS tend to contain more footprints.
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• Study of the temporal dynamic of Pol II loadings, H3K27ac and DNase I signal at DHSs
in WT and Bmal1−/−. About 10 % of the DHSs depicted a circadian behavior.
• Analysis (and optimization) of transcription factor binding site using digital genomic
footprinting methods in WT and at ZT6 in Bmal1−/−. Chromatin accessibility was
dynamically inﬂuenced by the binding of transcription factors and DNase I cleavage
pattern reﬂected DNA binding of protein complexes such as a BMAL1:CLOCK hetero-
tetramer on double E-boxes.
• Study of putative BMAL1 cooperating transcription factor and tissue-speciﬁc factors in
liver and ﬁbroblasts. Our analysis revealed several putative BMAL1 co-regulators such
as NRF1 and ZEB1, and tissue-speciﬁc factors such as HNF4, CEBP, FOXA and GATA1.
• Analysis (and optimization) of putative circadian regulators and regulators implicated
in nutrient response cycle using a linear model approach in WT and Bmal1−/−. Our
genome-wide description of WT compared to BmalI KO mice revealed the importance
of GR, FOX, and CREB in clock impaired mice under night restricted feeding. Thus,
we observed a partial disorganization of transcriptional control in the absence of a
peripheral clock, which underlined the strong effect of nutritional synchronization.
Global Bmal1 knockout in mice lead to important effects on metabolism and behavior
that could be traced to dysregulation of BMAL1 target genes.
• Analysis of the contribution of distal regulatory element involved in the circadian tran-
scription regulation. We observed that about 47% of DHS are located at more than 10 Kb
from the closest active TSS. In addition distal DHSs up to 50 Kb improved the variance
explained by our penalized linear model in WT and Bmal1−/−.
• Inspection of diurnal biological processes such as lipid and sugar metabolism and their
regulation in WT and Bmal1−/−. Our analysis conﬁrmed the implication of SREBP,
ChREB, CREB and FOX in these processes.
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Context
In the past decade, the emergence of various next-generation sequencing technologies and
experimental procedures allowed querying our epi-genome and our gene expression with an
unprecedented precision at a genome-wide or transcriptome-wide scale. These experiments
includes chromatin immuno-precipitation followed by sequencing (ChIP-seq) [27] and DNase
I-sequencing (DNase I-seq) [64] to study respectively DNA-binding proteins and chromatin
accessibility. These techniques have gained a substantial interest thanks to consortiums like
ENCODE, which have produced a tremendous amount of data in a wide variety of tissue
and for a lot of different DNA-binding proteins [110, 237, 292, 311]. In the circadian ﬁeld
several groups have produced time series of liver ChIP-seq of histone marks as H3K27ac or
H3K4me3, as well as core clock transcription factor (TF) as BMAL1, CLOCK, PER1,2, CRY1,2
RORα,β,γ, REVERBα,β, or metabolism related TF like CREB, SREBP, FOX, and more [171,
111, 188, 94, 95, 273, 334]. These studies have unveiled the dynamic nature of the chromatin
landscape, upon time or stimulation or stress. Our goal in this project was to decipher the
transcriptional regulatory logic of the diurnal cycle using a high-quality dataset produced by
the CycliX consortium ,in WT and Bmal1−/− in mouse liver.
Most of the results presented in the following sections were produced for the paper in preparation
entitled "Transcriptional regulatory logic of the diurnal cycle in the mouse liver".
Abstract
Most forms of life exhibit temporal rhythms in gene expression that propel diurnal cycles
in physiology. These rhythms are controlled by transcription-translation feedback loops of
the core circadian clock and modulated by feeding-fasting rhythms. To better understand
the regulatory interplay between the circadian clock and feeding-rhythmic metabolism, we
examined DNase I hypersensitive sites (DHSs) in mouse liver during a diurnal cycle. DNase I
signals cycled at a substantial fraction of all DHSs, suggesting that DHSs harbor regulatory
elements controlling rhythmic transcription. Using ChIP-seq, we found that hypersensitivity
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cycled in phase with RNA polymerase II (Pol II) loading and H3K27ac. We exploited the DHSs
to design a penalized linear regression model to infer the activity of transcription regulators
using Pol II loading in WT and in Bmal1−/− mice. While our model identiﬁed most known
circadian regulators, we also found motifs for the transcription factors (TFs) CREB, SREBP,
FOX and GR, that exhibited diurnal activity both in WT and Bmal1−/− livers. Since these
TFs regulate genes that display circadian oscillations due to food entrainment under night
restricted feeding, our results suggest that these regulators are impacted by systemic cues or
food driven in Bmal1−/− mice. In addition, we observed that hypersensitivity was only mildly
affected genome-wide in arrhythmic Bmal1−/− mice, in contrast to BMAL1 binding sites that
exhibited a strong reduction of hypersensitivity. Interestingly, though, nucleotide resolution
DNase I footprints at locations harboring BMAL1 bound tandem E-box motifs changed in
shape over the diurnal cycle, suggesting a transient hetero-tetramer binding conﬁguration at
those loci between ZT6 and ZT10. Overall, DNase I mapping provided signiﬁcant additional
insights into the mechanisms of diurnal transcription regulation in mouse liver.
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2.1 Chromatin landscape in mouse liver
2.1.1 Genome-scale mapping of DNase I hypersensitivity in mouse liver
To comprehensively map putative regulatory elements genome-wide, we merged the seven
DNase I hypersensitivity time points and performed peak ﬁnding (Methods section 4.2). This
revealed 62’418 DNase I hyper sensitive sites (DHS), covering around 2% of the mappable
genome (taking a width of 600bp for each DHS), which is comparable to previous studies
across mouse tissues [352]. Because we aimed at associating DHSs with nearby genes to infer
regulatory relationships, we ﬁrst decided to remove from ENSEMBL annotations transcripts
that were not expressed in our samples. Similar to our previous approach [188], we used
histone modiﬁcations, Pol II proﬁles, and now also DNase I signals at transcription start
and end sites of annotated transcripts to train a supervised learning method (support vector
machine) that distinguishes expressed (active) from non-expressed genes (Methods section
4.8). To infer putative regulatory relationships, we then annotated each DHS to the nearest
active TSS. Distances between DHSs and TSSs followed a bimodal distribution, with a ﬁrst
mode around 100bp from the TSSs and a second 10kb from the TSS (Figure 2.1 A).
Consistent with previous reports [320, 330], one third of our DHSs were found within 1kb of
TSSs, while almost half were located more than 10kb from a TSS (Figure 2.1 B), suggesting
that the identiﬁed DHSs contained both promoter-proximal and distal control regions. For
the promoter proximal DHSs, the genomic distributions of DNase I cuts, Pol II, and H3K27ac
signals (centered on TSSs) were consistent with the accessibility of DNA being determined by
nucleosome displacement and Pol II complex assembly (Figure 2.1 C) [343]. At distal DHSs,
proﬁles of H3K27ac showed a dip in the peak center, consistent with occupation by TFs and
nucleosome displacement (Figure 2.1 D), while the weaker Pol II signals could reﬂect distal
assembly of the transcriptional complex [170], or interactions between enhancer regions and
the TSS through DNA looping [252, 263].
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Figure 2.1 – Genome-wide localization of DNase I accessibility. A. Histogram of the distance
between each DHS and the nearest active TSS. We observe a bimodal distribution, with a ﬁrst
mode corresponding to DHS in the promoter region (centered on 100bp from the TSS) and
a second mode centered on 10kb from the TSS. B. Repartition of DHS within three classes
depending on their distance from the nearest TSS: 47% are more than 10kb from a TSS and are
classiﬁed as distal, 28% are between 1kb and 10kb away and are classiﬁed as proximal, and
ﬁnally TSS DHS 1kb or less from a TSS represent 24% of all sites. C. Pol II, DHS and H3K27ac
average signal around TSSs and distal DHSs. Proﬁles were adjusted so that the maximum
around the TSS represents 100%. At the TSS, patterns of accessibility, Pol II loading and
acetylated histone occupation correspond to previously observed characteristics [320, 58, 35].
D. At distal DHSs, DNase I signal is 60% lower on average. H3K27ac proﬁles display even
further decrease. However they are also are suggestive of nucleosome displacement at the
center of the region. Corresponding centered signal of Pol II is also seen, albeit on average less
than one-tenth the intensity of TSS Pol II.
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2.1.2 DHS dynamics and correlation with Pol II and H3K27ac signals
To validate our assays, we examined the known circadian output gene Dbp, maximally tran-
scribed at ZT8, to determine whether cutting frequency at DHSs exhibited diurnal variation.
We detected several DHSs in the vicinity of Dbp, with high intensity and narrow signals sur-
rounded by low noise levels. We observed that DNase I hypersensitivity was oscillating around
Dbp locus (ﬁgure 2.2 A)
Ripperger et al. (2000) studied the Dbp locus using classical DNase I footprinting experiments
on gel (ﬁgure 2.2 B). DBP Intronic DNase I hypersensitive regions embody E-box motifs
that bind BMAL1/CLOCK. Because intragenic enhancer sequences appear to be essential for
robust circadian Dbp expression, the hypersensitive regions located downstream of the cap
site were investigated by [278] in greater detail. Ripperger’s study uncovered seven putative
Dbp regulatory sequences, of which two are located upstream (6 and 7) and four downstream
(1–4) of the transcription initiation site. The sensitivity towards DNase I digestion of four
of these regions (2, 4, 6, and 7) and that of the promoter region including the transcription
initiation site oscillate with the same phase as Dbp transcription and high amplitudes are
represented in green, whereas sites 1,3 and 5 with low amplitudes are represented in blue.
Three of the putative regulatory sequences (2, 4, and 7) contain E-boxes that are binding sites
for CLOCK and BMAL1. These sites were successfully detected in the current DNase-seq study
with similar properties and we conﬁrmed some of their hypothesis regarding BMAL1 binding
at sites 6,4,and 2 using BMAL1 ChIP-seq from G. Rey study.
As exempliﬁed by a DHS nearby the transcription start site (TSS) of Dbp, we observed that
DHSs were located in regions with lower H3K27ac signals in between H3K27ac-enriched
islands, suggestive of TF-induced nucleosome displacement [153, 131, 222]. Moreover, the
DNase I hypersensitivity changed diurnally, notably at the TSS where the oscillations in DNase
I hypersensitivity, Pol II, and H3K27ac peaked in sync at ZT10. However, all DHSs within 15 kb
of the Dbp TSS displayed oscillations with the same phase as the TSS, suggesting regulatory
relationships between these regions and gene transcription (see ﬁgure 2.3).
We next analyzed the Npas2 gene (see ﬁgure 2.4), another known clock target [32]. Npas2
is a target of RORs and peaks in the late night-time around ZT22 [66]. We detected several
DHSs along the transcribed region of Npas2 (Figure 2.4 A), including proximal (deﬁned as
1-10kb from a TSS) and distal (deﬁned as >10kb from a TSS) sites. The distal sites displayed
high amplitude oscillations of DNase I cuts and H3K27ac (Figure 2.4 B). Normalized signals
at the Npas2 TSS also peaked at the expected phase with maximal signal at ZT22 for all three
marks studied (Figure 2.4 c). Finally, all DHSs associated with Npas2 (those having Npas2
as their closest TSS), including numerous distal regions, likewise cycled with phases around
ZT22 (Figure 2.4 D). Together, observations at the Dbp and Npas2 loci show that DHSs were
detected genome-wide with high resolution, and that the temporal patterns of DNase I cuts
reﬂected diurnal activity of these elements at different times of the day.
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Figure 2.2 – DNase I accessibility at Dbp locus. DNase I hypersensitive sites within the Dbp
locus. A) Detected DHS using DNase I-seq at ZT02-ZT26, overlapped with BMAL1 ChIP-seq,
E-box prediction scores and previously detected hypersensitive sites by Ripperger et al. B)
Original Ripperger analysis of Dbp locus: Schematic representation of the Dbp gene with its
four exons (E1–E4) and three introns. The positions of the DNA hybridization probes and
the restriction fragments used in the indirect end-labeling experiments are indicated. The
approximate positions of the seven DNase I hypersensitive regions detected in both gels are
depicted on top of the cartoon. Left gel: Mapping of DNase I hypersensitive sites starting from
exon 4. Equal aliquots of liver nuclei harvested at the indicated times were treated with DNase
I (ZT23 to ZT19) or without DNase I (lane C, derived from ZT7). After exhaustive digestion
with EcoRV and BglII, the fragments were visualized using probe A. Right gel: Fine mapping of
DNase I hypersensitive sites in the 5’ moiety of the Dbp locus. The DNA was digested with
HindIII and probed with probe B [278].
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ZT02
ZT06
ZT10
ZT14
ZT18
ZT22
ZT26
TSS
TSS
Figure 2.3 – DNase I accessibility, Pol II and H3K27ac dynamics at Dbp locus. A) DNase I
hypersensitivity, Pol II, and H3K27ac enrichment at the Dbp locus. The DHS track shows a
nucleotide resolved cutting frequency while H3K27ac and Pol II ChIP-seq signals are smoothed
over 100bp. The seven time points are overlaid. B) A zoom-in around the DHS at the TSS
of Dbp reveals DHS enrichment dynamics around the clock. Both DHS and H3K27ac are
maximal at ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp
transcription. Note that DHS signal is strongest in between adjacent histones, probably
reﬂecting nucleosome displacement around transcription factor binding sites at the center
of highly accessible regions. C) Read counts (in log2 units) for DHS signal (in windows of +/-
300bp) centered on the Dbp TSS. Idem for Pol II and H3K27Ac ChIP-seq (in windows of +/-
1000bp) centered on the same DHS and cosine ﬁts show a common peak phase around ZT10.
Amplitudes are about 16 fold for Pol II, and approximately 4 fold for both DHS and H3K27ac.
D) Phases and amplitudes of all DHSs that are located in the neighborhood of the Dbp gene
(nearest-TSS association according to annotation). Each dot represents a region, with black
for a TSS (x alternative TSS), dark blue for a near-TSS DHS, light blue for a proximal DHS and
grey for a distal DHS. Log2-amplitudes are shown as distances from the center of the plot,
phases as radial position clockwise from ZT0 at the top, and -log10(p-value) determine the
size of the dots. We observed that all regions oscillate around a common phase at ZT10.
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Figure 2.4 – DNase I accessibility, Pol II and H3K27ac dynamics at Npas2 locus. A) DNase I
hypersensitivity, Pol II, and H3K27ac enrichment at the Npas2 locus. B) A zoom-in around
the DHS at the enhancer of Npas2 (starred) reveals DHS enrichment dynamics around the
clock. Both DHS and H3K27ac are maximal at ZT22. C) Read counts (in log2 units) for
DHS signal (in windows of +/- 300bp) centered on the Npas2 enhancer. Idem for Pol II and
H3K27Ac ChIP-seq (in windows of +/- 1000bp) centered on the same DHS and cosine ﬁts show
a common peak phase around ZT22. D) Phases and amplitudes of all DHSs that are located
in the neighborhood of the Npas2 gene (nearest-TSS association according to annotation).
Each dot represents a region, with black for a TSS (x alternative TSS), dark blue for a near-TSS
DHS, light blue for a proximal DHS and grey for a distal DHS. Log2-amplitudes are shown
as distances from the center of the plot, phases as radial position clockwise from ZT0 at the
top, and -log10(p-value) determine the size of the dots. We observed that all regions oscillate
around a common phase at ZT22.
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We next studied whether DNase I hypersensitivity, accumulation of Pol II, and H3K27ac quan-
tiﬁed at the identiﬁed DHSs displayed diurnal rhythms using harmonic regression (Methods
section 4.4). The number of cyclic regions identiﬁed at different signiﬁcance thresholds
(p=0.01, 0.05 and 0.1, harmonic regression) clearly indicated that Pol II and H3K27ac oscillated
at a larger number of DHSs compared to the DNase I signal itself, both for proximal (deﬁned
as 1-10kb) and more distal sites (>10kb) (Figure 2.5 A). To select high conﬁdence rhythmically
active regions, we assessed the combined rhythms of the three marks at each DHS using
Fisher’s method [188, 231], which yielded 4606 (7.3%, FDR<0.05) regions with diurnal patterns
of activity. For all three signals, the amplitude of the oscillations was larger at distal sites (the
median amplitude was twofold for DNase I and H3K27ac, and higher for Pol II) compared to
TSSs, and Pol II had larger amplitudes than either DNase I or H3K27ac (Figure 2.5 B). Moreover,
the phases (peak times) of the oscillations in DNase I signals were, except for some small
deviations, similarly distributed as gene transcription and H3K27ac with a weak evening peak
around ZT10 and a marked late night peak around ZT22 (Figure 2.5 C). We next considered
the phase relationships of the DNase I, Pol II and H3K27ac rhythms.
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As previously demonstrated, chromatin marks exhibit diurnal rhythms that are tied to tran-
scription [334, 171, 188, 277]. Similarly, enhancer RNAs (eRNAs) are transcribed in sync with
their cognate transcripts [95].
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Figure 2.5 – Rhytmicity assessment, phases and amplitudes of DHS in DNase I, Pol II and
H3k27ac signal. A) Number of DHSs with statistically signiﬁcant cycling DNase I signal (left),
H3K27ac-signal (middle) or Pol II signal (right) at three different thresholds (p<0.1, p<0.05
and p<0.01) partitioned according to their genomic location: TSS (1 kb), proximal (1-10 kb
from TSS), or distal (>10 kb from TSS). B) Comparison of relative amplitudes for DHSs in each
class (TSS, Proximal and Distal) and in each signal (Pol II, H3K27ac and DNase I). P-values
were combined using Fisher’s method and sites were selected with an FDR-corrected p-value
threshold of 0.05. Higher amplitudes were observed in distal and proximal regions compared
to TSS (t-test p< 2.2e-16). In addition, Pol II patterns had higher peak-to-trough ratios than
other signals. C) Circular histograms representing the distribution of phases for each mark at
DHS selected as in B. All signals display the characteristic evening peak between ZT20 and
ZT22, with DNase I peaking slightly in advance of other marks. The evening peak is also visible
for DNase I data but appear weakly enriched in Pol II and H3K27ac.
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We observed that DNA accessibility (DNase I cuts), Pol II, and H3K27ac displayed synchronous
oscillations at DHSs (Figure 2.6 A). Such relationships were maintained after removing DHSs
situated in the transcribed regions of active genes (data not shown), indicating that this is
not a mere consequence of transcriptional elongation [275]. To test whether distal and TSS
DHSs showed temporally correlated signals for each of the three signals, we examined pairs of
oscillating DHSs (FDR adjusted p-value < 0.1, Fisher’s combined test) of which one was located
near a TSS (< 1kb) and one in an intergenic region required to be positioned at least 2kb and
at most 20kb from any TSS. While no pair reached statistical signiﬁcance for DNase I signals,
probably reﬂecting that DNase I signals are noisier than the two other marks, we found 1611
pairs oscillating for H3K27ac and 630 for Pol II. The two phases were highly correlated with
phase differences lower than one hour (Figure 2.6 B), suggestive of enhancer-TSS interactions
[320].
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Figure 2.6 – Phase correlations of DHS in DNase I, Pol II and H3k27ac signal. A) Phase compar-
isons between DNase I, Pol II and H3K27ac at DHSs with a combined p-value threshold of 0.05.
Scatter-plots display a concentration along the diagonal (shown in grey). Circular correlation
values are indicated. Delays appear shorter than half an hour, which is within experimental
variations, suggesting that the three marks peak synchronously. B) Phase relationship between
intergenic accessible regions and their nearest TSS. Selection was done by combining p-values
for cosine ﬁts for each accessible regions and its nearest TSS for each signal and applying FDR
correction, with a threshold of 0.1. Respectively 1611 and 630 signiﬁcant pairs (intergenic
accessible regions - TSS) were observed for H3K27ac and Pol II signals. The scatter-plots dis-
play a distribution along the diagonal. Circular correlation values are indicated and are high.
This suggests that regulatory sites in the vicinity of active TSSs show coordinated temporal
changes.
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2.1.3 DNase I Footprint detection, localization and characteristics
To determine whether DHSs reﬂected DNA-bound transcription regulators, we searched for
short windows protected from cleavage, also called footprints, using a published method
[256] within a +/- 300 bp window around the center of each DHS. This identiﬁed previously
reported footprints as illustrated for the well-characterized promoter of the Albumin (Alb)
gene [196] ( Figure 2.7).
Scale
chr5:
DHS regions
10 kb mm9
90,880,000 90,885,000 90,890,000 90,895,000 90,900,000 90,905,000
Alb
WT DNAse ZTALL
2 -
0 _
Wellington score
0 -
-50 _
Scale
chr5:
100 bases mm9
90,889,800 90,889,850 90,889,900 90,889,950
Alb
3.5 _
0 
WT DNAse I ZT ALL
Wellington footprints
Lichtsteiner footprints
Wellington footprints
Figure 2.7 – DNase I accessibility and Footprint at Alb promoter. Albumin locus with a focus
on promoter region displaying the DHS signal (bottom, red), the Wellington detected foot-
print regions (top, black) and the experimentally veriﬁed protein binding sites in the region
(multicolor track, center). Many accessible intragenic regions in this locus does not display
any footprint, but show a high DNase I signal, probably due to intense transcription of this
gene in liver. The large protected region at the Alb TSS we detect in our data corresponds to
previously established transcription factor binding sites [196].
In the promoter region of Reverbα (Nr1d1), the detected footprints coincided with E-boxes
and high BMAL1 ChIP-seq signals (Figure 2.8 A). Overall, the vast majority (70%) of DHSs near
a TSS contained at least one footprint, while this proportion dropped to one half for the distal
and proximal DHSs (Figure 2.8 B). Since transcribed DNA is known to be DNase I sensitive
[310], the DHSs without footprints might reﬂect the process of transcription. To test this, we
analyzed the number of footprints in DHSs outside of promoter regions and further marked
with H3K36me3, a mark coinciding with transcribed gene bodies [119, 188]. Indeed, DHSs
without footprints were frequently (90%) linked with highly transcribed regions (Figure 2.8 C).
Thus, DHSs at TSS seem to contain more footprints than distal DHSs and highly transcribed
regions explain why some of our DHS do not exhibit a footprint.
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The region 8 Kbp upstream of Reverbα (Figure 2.9) revealed a distal DHS with several footprints
detected by Wellington algorithm [256]. This putative enhancer contains multiple predicted
TFBS using FIMO [114] with the PWMs from Wang study [338]. We found several E-box motifs
(with a similar consensus CACGTG sequence), such as USF, BHLHE40 or MAX, and other
motifs such as HNF4 or CEBPB. Using various ChIP-seq data-sets from the literature, such
as BMAL1 [273], HNF4A, CBP, CEBPA, p300, FOXA1 (also called HNF3α), FOXA2 and GABPA
[96], we observed that this distal DHS is bound (directly or indirectly) by several transcription
factors. This example illustrate the potential cooperative/competitive nature of the regulation
of TFs at accessible regions. TFs rarely act alone at enhancers, their functions should be
considered in a more integrated, combinatorial manner [308]. When the associated TFs are
expressed in overlapping spatial domains, this combinatorial binding can result in discrete
and precise patterns of transcriptional activity. For example, the recruitment of phase-speciﬁc
activators and repressors gives rise to more reﬁned expression patterns, such as a combination
of day-time elements (D box) within the Cry1-proximal promoter and night-time elements
(RREs) within its intronic enhancer gives rise to evening-time expression [326].
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Figure 2.8 – Location-dependent footprint characteristics of DHSs. A) Visualization of DHS
signal (red) around the Reverbα promoter with the footprints detected by Wellington analysis
annotated in black, on top. This region contains BMAL1 binding sites (blue) with one overlap-
ping an E-box, annotated on the bottom line, that is marked by a characteristic footprint in
which DNase I signal is virtually absent in the center, reﬂecting protection of the DNA from
digestion, whereas high signal is observed on the edges of the binding site. B) Distribution of
number of footprints within DHSs (+/- 300 bp around the peak center). TSS regions contain
more footprints on average. More than half the distal regions contain a footprint, strongly
supporting their identity as distal regulatory elements. C) Number of footprints detected in a
given DHS as a function of H3K36me3 enrichment.
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Figure 2.9 – Reverbα enhancer footprint characteristics. In a region 8Kbp upstream of Reverbα
a DHS with multiple footprints was detected. These footprints contain several E-box related
motifs, such as MAX, MYC, BHLH40 or USF (in blue). In addition, several predicted binding
sites for HNF4, ETS1, CEBPB, and GATA1 were detected. The overlap with various ChIP-seq
signal of BMAL1, HNF4A, CBP, CEBPA, p300, FOXA1, FOXA2 and GABPA revealed that multiple
transcription factors can bind to this accessible region.
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2.1.4 Genome wide impact of BMAL1 on DNA accessibility
We next sought to study how BMAL1 binding impacts DNA accessibility. We used a mouse
model inwhich BMAL1 is unable to bindDNA (Bmal1−/−) [300] and performedDHSmapping
at ZT6, near the maximal DNA binding activity of BMAL1 (Methods section 4.2). DNase I
hypersensitivity at BMAL1-bound sites (detected in ChIP-seq) [273], such as the Reverbα
locus, was markedly decreased in Bmal1−/−, whereas control (unbound) regions like the
Gsk3 promoter showed no difference (Figure 2.10 A). Genome-wide, using the same methods
as in wild-type mice (WT), we detected 56’201 DHSs at ZT6 in the Bmal1−/− animals. Of
those, more than 38’000 sites were shared with the DHSs in WT. The imperfect overlap might
largely reﬂect lower sampling when analyzing only one time point instead of the seven time
points used for WT. Indeed, the overlap when considering only ZT6 in the WT was comparable
(around 40’000 shared peaks).
Nevertheless, clear differences at DHSs with BMAL1 binding sites were observed. Namely,
regions bound by BMAL1 [273] in the WT showed fewer DNase I cuts in the Bmal1−/−
compared to the WT. This indicates that BMAL1 binding speciﬁcally impacts DNA accessibility
at its target sites (Figure 2.10 B), consistent with the proposed pioneering function of BMAL1
[222]. While DNase I signals at those sites were also signiﬁcantly lower at trough BMAL1
activity in the WT (ZT18), the KO showed even lower signals (Figure 2.10 C). The same analysis
at sites bound by the E-box binding protein USF1 [301] did not show similar differences
between WT and KO (Figures 2.10 D and E).
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Figure 2.10 – Genome wide impact of BMAL1 on DNA accessibility. A) The Reverbα (left) and
Gsk3a (right) promoters where DHSs are indicated with black ticks at the top. DNase I signal
(in red) is strongly reduced in the KO at BMAL1-bound sites (Reverbα promoter, as indicated
by Bmal1 ChIP-seq signal in blue) but is similarly enriched in WT and KO at sites not bound
by BMAL1 (at the Gsk3a) The vertical scale is the same for all 4 DNase I tracks, as well as for
both Bmal1 tracks.
B) Comparison of DNase I signal in Bmal1−/− versus WT at DHSs overlapping BMAL1 ChIP-
seq peaks at ZT6. Almost all DHSs containing a BMAL1 binding site display lower accessibility
in the Bmal1−/− suggesting fewer factors are bound to these regions at ZT6.
C) Boxplots showing DNase I intensity at the same sites as B, at peak (ZT6) and trough (ZT18)
activities of BMAL1 in the WT and at ZT6 in the Bmal1−/−. Sites appear less accessible in the
KO than during trough activity in the WT consistent with the lack of compensatory binding by
other factors in the Bmal1−/−.
D-E) Same as B-C using overlap with USF1 ChIP-seq peaks to select DHSs. This protein targets
similar motifs as BMAL1 (E-boxes). Lower signal in the KO is not observed at these sites.
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2.1.5 Digital genomic footprinting and transcription factor binding around the
clock
Owing to the 3D structures of protein-DNA interactions, genomic patterns of DNase I cleavage
around transcription factor binding sites display factor-speciﬁc footprints [138, 237, 236, 132,
314, 350]. A previous study showed that BMAL1 binds DNA rhythmically, and that strong
BMAL1 binding was frequently associated with tandem E-boxes [249] separated by 6 or
7 nucleotides bound by one or two BMAL1/CLOCK dimers, respectively [273]. Thus, we
analyzed DNAse I footprints at BMAL1 binding sites in function of time. Starting from BMAL1
ChIP-seq sites, we modiﬁed a mixture model for DNase I cuts to determine the optimal
boundaries of the footprints at each time point, as well as the probability that the factor is
bound to DNA (showed a footprint) for every site (see Methods section 4.6.1 and Appendix
section A.1). We then analyzed footprints in BMAL1 binding sites containing tandem E-boxes
separated by 6bp (E1E2-sp6). These DNA elements were previously shown to be bound in vitro
by two BMAL1/CLOCK dimers [273]. Here, both E-boxes in the E1E2-sp6 motif appeared to be
protected from digestion at ZT6, close to the maximal DNA binding activity of BMAL1, while
at ZT18 only the 5’ E-box displayed a footprint consistent with occupation by a transcription
factor (Figure 2.11).
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Figure 2.11 – Time-dependent footprint on double E-boxmotif with a spacer of 6bp overlapped
by BMAL1 binding sites. DNase I hypersensitivity proﬁle around double E-boxes with a spacer
of 6 bp (E1-E2 sp6). We selected E1-E2 sp6 motifs overlapping a BMAL1 ChIP-seq peak and
show the average of proﬁles classiﬁed as protected by the model. At ZT6, we observe that
nucleotides of both E-boxes of the site are less accessible than ﬂanking regions, indicating
occupation by hetero-tetramers of CLOCK:BMAL1. In contrast, at ZT18, the width of the
protected region is reduced by half, with the second, less conserved E-box no longer protected
from digestion. In the KO, only the ﬁrst E-box appears occupied.
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Moreover, the footprint at ZT18 was undistinguishable from that in the Bmal1−/−, suggest-
ing that other transcription factors bind BMAL1 sites when BMAL1 expression is low. The
proportion of E1E2-sp6 motifs showing a footprint indicative of two BMAL1/CLOCK dimers
varied across time points, with a maximum of 65% at ZT10, and minimum of 20% in the
Bmal1−/−. Also, the binding dynamics of BMAL1 at E1-E2-sp7 was largely similar to that
for E1-E2-sp6, though E1-E2-sp7 had both E-boxes predominantly protected only at ZT6,
suggesting spacer-speciﬁc binding dynamics. In contrast, the footprints at BMAL1 binding
sites with single E-boxes did not show signiﬁcant changes in time or in the Bmal1−/−, again
suggesting that other bHLH transcription factors compete with BMAL1. In fact, footprints of
the bHLH transcription factor USF1 were largely similar to that of BMAL1 sites with single
E-boxes, though the fraction of sites with clear footprints was reduced for USF1 compared to
BMAL1 (Figure 2.12).
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Figure 2.12 – Time-dependent footprint on single E-box of USF1 and BMAL1, and double E-box
footprint with a spacer of 7 bp. Base-pair resolution patterns of DNA accessibility at USF1,
BMAL1 single E-box, and BMAL1 double E-box motifs with a spacer of 7 bp, were studied
to reveal dynamic changes. Using our mixture model to ﬁt the width of protected regions at
transcription factor motifs, within DHSs, overlapped by a high ChIP-seq signal (Z-score > 2) we
computed the fraction, which appeared occupied at each time point. DNase I hypersensitivity
average proﬁle around each motif bound at ZT6, ZT18 and ZT6 in Bmal1−/−. The shape of
the footprint reﬂects the protein-DNA interaction architecture. The bound fraction and the
percentage of the maximum width are represented respectively in blue and green for each
motif at each time point and at ZT6 in Bmal1−/− context.
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Finally, we examined temporal footprints at DHSs bound by other well-studied circadianly
active TFs, ROR/REVERB, HSF1, SREBP and CREB (Figure 2.13). Interestingly, unlike for
BMAL1/CLOCK, the shapes of the footprints for those factors did not change with time, and
was also not affected in the Bmal1−/− condition. However, the fraction of sites showing
footprints coincided well with the maximal transcriptional activity of the different factors. For
example, footprints centered on REVERBα-bound ROR response elements (ROREs) showed
the largest proportion of footprints at ZT22, which coincides with the phase of maximal ROR
activity. We detected a low percentage of binding for ROREs, which is consistent with the fact
that nuclear receptors have a low residence binding times [314] and therefore display a lower
DNase I cleavage-protection pattern.
For HSF1, the number of footprints was maximal at ZT18, approximately four hours later than
the previously reported peak activity [176], and for the feeding-induced SREBP this number
peaked during the night, as expected [111, 211]. Finally, high conﬁdence CREB binding
sites [211] showed clearly marked and invariable footprints throughout the day, including in
Bmal1−/− mice, consistent with the ﬁnding that CREB activity is regulated post-translationally
on the DNA [94, 192, 298].
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Figure 2.13 – Time-dependent footprint of ROR, HSF, SREBP and CREB. Base-pair resolution
patterns of DNA accessibility at ROR, HSF, SREBP and CREB, were studied to reveal dynamic
changes. Using our mixture model to ﬁt the width of protected regions at transcription factor
motifs, within DHSs, overlapped by a high ChIP-seq signal (Z-score > 2) we computed the
fraction, which appeared occupied at each time point. DNase I hypersensitivity average proﬁle
around each motif bound at ZT6, ZT18 and ZT6 in Bmal1−/−. The shape of the footprint
reﬂects the protein-DNA interaction architecture. The bound fraction and the percentage of
the maximum width are represented respectively in blue and green for each motif at each time
point and at ZT6 in Bmal1−/− context.
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2.1.6 3D structure of BMAL1/CLOCK hetero-tetramer model bound on DNA
To better understand the time-varying footprint at BMAL1 sites and gain insights into how
the BMAL1/CLOCK heterodimer occupies its tandem E-box-containing target sites, we used
recently established 3D protein structures of single BMAL1/CLOCK complexes combined
with structural modeling performed by Alexandra Styliani Kalantzi from Matteo Dal Peraro’s
lab (see Methods section 4.9). Two 3D models of the hetero-tetramer conﬁguration were
constructed. In a ﬁrst model, the spacing between the two E-boxes was 6 bp (sp6) (ﬁgure 2.15
and ﬁgure 2.16) and in a second model the spacing was 7 bp (sp7). For the model of the single
CLOCK:BMAL1 complex, we used the crystal structure of the heterodimeric BMAL1/CLOCK
(pdb id: 4F3L) [141], in which we built the missing parts of the ﬂexible loops. To link the single
BMAL1/CLOCK model to the E-box, we used the complex crystal structure of BMAL1/CLOCK
basic helix-loop-helix domains bound on the E-box (CACGTG) (pdb id: 4H10) [339]. We
then superimposed the two single BMAL1/CLOCK E-box models, with the sp6 DNA and
the sp7 DNA, forming the respective symmetric hetero-tetramer models. We found that
the 6bp spacing between the two E-Boxes was suggesting an interaction between the two
BMAL1/CLOCK complexes [234], although the 7 bp spacing seemed also favorable with a
twist of 1° in the three interval base pairs. However, a conformation with base pair spacing
less than 6 or more than 7 would make complex formation difﬁcult because of conformational
constraints. Thus, we found that the dynamics of transcription factor complexes on the DNA
can change during the diurnal cycle, as reﬂected by the shape changes of DNase I footprints
(section 2.1.5).
Using our 3D structure model with a spacer of 6 bp and molecular dynamic simulations (see
Methods section 4.9), we were able to identify several residuals that are at the interface of
the two hetero-dimers. These residuals are located in the PAS-B domain of CLOCK (table
2.1, ﬁgure 2.16). We observed two symmetrical interactions implicating a glutamic acid
(E380) interacting with a glutamine (Q352) and a lysine (K335) interacting with a tyrosine (Y338)
through a hydrogen bond. Moreover, the glutamic acid is negatively charged and the lysine is
positively charged, suggesting a potential ionic interaction. There might be more hydrogen
bonds forming between the two dimers on ﬂexible loops on BMAL1 PAS-A domain. The
ﬂexible loops are more dynamic and therefore harder to characterize.
Table 2.1 – Residuals implicated in the interaction of the two hetero-dimers BMAL1:CLOCK
Residuals A Residual B Distance (Å)
E380 Q352 2.827
K335 Y338 2.835
Q352 E380 2.887
Y338 K335 2.882
Using our model with a spacer of 7bp and the molecular dynamic simulation, we calculated
the distance of the center of mass between the two dimers (ﬁgure 2.14). The initial distance
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between the two dimers is 68.3 Å and after 130 ns of simulation, the distance decreased with a
value of 62.4 Å, suggesting that the two BMAL1/CLOCK dimers are attracted by each other.
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Figure 2.14 – Molecular dynamic simulation BMAL1/CLOCK hetero-tetramer model bound
on DNA. Center of mass between the two BMAL1/CLOCK dimers calculated with a molecular
dynamic simulation on the sp7 model.
Overall, these interactions might be critical for a functional molecular clock, and they deserve
further experimental validations.
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CACGTG
BMAL1
CLOCK
BMAL1
CLOCK
CACGTG
Figure 2.15 – 3D structure of BMAL1/CLOCK hetero-tetramer model bound on DNA. Two
views of the 3D model of the CLOCK:BMAL1 hetero-tetramer based on the crystal structure of
a dimer of two CLOCK:BMAL1 heterodimers occupying an E1-E2 sp6 site. Each heterodimer
is drawn in a different color, green and blue respectively, while darker green and darker blue
correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the
DNA strands is shown in grey with highly constrained nucleotides of the motif in red. The
proximity between two heterodimers suggests strong interaction between these complexes,
and is consistent with the published data where cooperativity at tandem E-boxes has been
shown by [249, 234], which has since been further corroborated by [273].
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BMAL1CLOCK BMAL1CLOCK CLOCK CLOCK
Figure 2.16 – BMAL1/CLOCKhetero-tetramermodel bound onDNA: side viewwith interacting
residuals. Side view of the 3D model of the CLOCK:BMAL1 hetero-tetramer with a zoom on the
interface between the two CLOCK:BMAL1 hetero-dimers. The interacting residuals are mainly
located on CLOCK. These residuals were identiﬁed thanks to molecular dynamics simulation
[198] performed by Alexandra Styliani Kalantzi.
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2.2 Systemspeciﬁc chromatinaccessibility andBMAL1co-regulators
2.2.1 BMAL1 binding and DNase I hypersensitivity differ between ﬁbroblasts and
hepatocytes
As previously described, the rhythm in the core clock is produced and sustained by a transcription-
translation feedback loop (TTFL), whose main activator is a heterodimer formed by two bHLH-
PAS transcription factors, BMAL1 and CLOCK, which bind rhythmically to E-box motifs in the
regulatory regions, such as TSS or enhancers of clock controlled genes [277, 108]. Genome-
wide a large number of BMAL1-CLOCK targets have been identiﬁed by ChIP-seq in mouse
liver [171, 273]. While the core TTFL is active and rhythmic genes have been observed in most
cell types and tissues [312, 355], much less is known about the cell type-speciﬁc regulatory
network and rhythmic output functions connected to it.
In a project in collaboration with Julia Cajan (a former PhD student in the Naef lab), we
compared at BMAL1 ChIP-seq and DNase I hypersensitive sites in mouse liver and in NIH3T3
ﬁbroblasts cells [273, 311].
To further identify the extent of circadian clock-controlled genes in NIH3T3 ﬁbroblasts we
set out to study DNA-binding of BMAL1 in dexamethasone (Dex) synchronized NIH3T3 cell
cultures. Samples taken at theminimum (12h after Dex) andmaximum (20h after Dex) binding
time points were then submitted for deep sequencing (ChIP-seq). To assess similarities and
divergences in BMAL1 binding in cultured NIH3T3 cells and mouse liver tissue (ﬁgure 2.17),
the NIH3T3 ﬁbroblasts data were compared to BMAL1 binding sites in liver from Rey et al.
[273].
Figure 2.17 – Context speciﬁc binding of BMAL1/CLOCK. Examples of rhythmic BMAL1 and
CLOCK. The left panel shows an example of a shared binding site in the promoter region of
the Per1 gene; the right panel shows the Atf6b promoter as an example of ﬁbroblast-speciﬁc
binding. Modiﬁed from Cajan, Sobel et al. (in preparation)
After standard peak detection, we ﬁltered peaks that exhibited a low signal-to-noise ratio,
which we also applied to the mouse liver data in [273] We obtained a list of 463 BMAL1 binding
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sites in NIH3T3, and 1132 liver BMAL1 binding sites with an overlap of 319 shared sites. The
observation that many BMAL1 sites were bound in a liver- or ﬁbroblast-speciﬁc way raises
the question whether the unbound sites are just weakly occupied or whether the chromatin
surrounding those sites is in a poorly accessible, repressed state. We used published data sets
of DNase I hypersensitives sites (DHSs) from the ENCODE consortium [311] to address this
ambiguity. We re-analyzed DNase I signal to identify peaks in both conditions. We detected
about 82000 DHSs in liver and 78000 DHSs in ﬁbroblasts with an overlap of 26000 DHSs. This
low overlap of DHSs between Liver and NIH3T3 suggest that the cellular regulatory programs
are quite different between these two data sets. Moreover, we observed that 88% of BMAL1
binding sites were in a DHS in NIH3T3 (409/463) and 84% of BMAL1 binding sites were in a
DHS in Liver (959/1132), which indicates that the chromatin accessibility is crucial for BMAL1
binding.
2.2.2 BMAL1 co-regulators are enriched in a cell-type speciﬁc manner
To identify putative BMAL1 co-regulators that could explain how BMAL1 can bind at different
sites in hepatocytes and inNIH3T3 ﬁbroblasts, we conducted amotif scan in a ±250 bpwindow
around the center of the binding sites. Since motif searches only indicate the occurrence of a
certain sequence, but contain no information about the occupancy of the site, we also used
DHS footprints (using Wellington algorithm from [256])as a measure of bound (and hence
presumably active) sites.
To control for general liver- or ﬁbroblast-speciﬁc regulators, we used the combined set of
DHSs from liver or ﬁbroblasts [311], respectively, as input for the motif search since those
should cover most active regulatory elements. This allowed to assess which motifs found
around BMAL1 sites were associated with BMAL1 speciﬁcally in the liver or the ﬁbroblasts
(ﬁgure 2.18). As positive controls, E-box binding motifs (BHLHE40, MYC, MAX and USF) )
were clearly the dominant signal in both systems, although E-boxes seemed to be slightly
overrepresented in NIH3T3 sites compared to liver.
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Figure 2.18 – Context speciﬁc-chromatin accessibility and BMAL1 co-regulators. A motif
search using a PWM database derived from ENCODE ChIP-seq of 119 transcription factors
[338] on all DHSs, as well as BMAL1 binding sites in liver and NIH3T3 ﬁbroblasts, reveals
motifs that are preferentially enriched in one dataset or the other and differentiates between
general regulators (DHSs) or BMAL1-speciﬁc coregulatory elements. the X-axis represent the
enrichment of motifs (in a footprint) in sites of BMAL1 versus DNase I hypersensitive sites,
and the Y-axis represent the enrichment in Liver versus NIH3T3.
In the liver, we detected several motifs for known tissue-speciﬁc regulators that showed,
however, low speciﬁcity for BMAL1 sites. These include RXRA (three-fold enriched in the liver
and ﬁve-fold enriched in BMAL1 over all DHSs) or members of the FOXO family (four-fold
enriched in liver, four-fold enriched in BMAL1 over all DHSs). Other factors, notably ZEB1,
were more speciﬁcally associated with BMAL1 binding, but less speciﬁc for the liver (2.1 fold
enriched in liver, seven-fold enriched in BMAL1 over all DHSs). However, in liver, speciﬁc
recruitement of BMAL1 to DNA seems to be overall achieved mainly through general tissue-
speciﬁc regulators. This is in contrast to ﬁbroblasts where we observed stronger enrichment
of speciﬁc motifs that were preferentially associated with BMAL1 sites. These motifs pointed
to transcription factors such as E2F1 (3 fold enriched in NIH3T3, 15 fold enriched in BMAL1
over all DHSs) and NRF1 (2.1 fold enriched in NIH3T3, 15 fold enriched in BMAL1 over all
DHSs). Overall, the overrepresentation of these motifs that coincides with a DNase I footprint
indicates that a large percentage of these motif-containing sites were occupied and thus
potentially active.
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In order to conﬁrm these observations, we analyzed the motif content of 100K random ge-
nomic locations, and we computed the ratio of the number of motif match over the sum
of regions considered for several interesting candidates (ﬁgure 2.19 and 2.20). Again, we
observed that EGR1, NRF1 BHLH40 and ZEB1 are highly enriched in BMAL1 sites in both
conditions, and it seems that NRF1 and EGR1 are more enriched in ﬁbroblasts. These motifs
are not enriched in the random context which suggests a functional role of potential tissue-
speciﬁc BMAL1 co-regulators. On the other hand, we detected several potential liver-speciﬁc
co-regulators as DBP, NR3C1, HNF4, HNF1, HSF1, CEBPB, TCF7L2 and FOXO1. Interestingly
some of these factor as HNF1 and HNF4 are already known as liver-speciﬁc factors, and FOXO1
and TCF7L2 are related to feeding-fasting cycle [241]. Moreover, DBP is a direct target of
BMAL1 [278, 277] and its binding site (D-box) is upstream of many clock controlled genes,
which are implicated in hormonal and metabolic control [296]. Finally, NR3C1 (also called
Glucocorticoid receptor,GR),has been shown to synchronize hepatic circadian transcriptome
[266].
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Figure 2.19 – Enrichment of liver/NIH3T3 speciﬁc regulators in DHS and in BMAL1 binding
sites. Enrichment of TFBS in BMAL1 and DNase I hypersensitive sites, in liver or NIH3T3,
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65
Chapter 2. Results
NRF1
0.0
0.2
0.4
0.6
0.8
ZEB1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
DBP
0.00
0.02
0.04
0.06
0.08
0.10
EGR1
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
FOXO1
0.00
0.05
0.10
0.15
0.20
0.25
HNF1A
0.00
0.02
0.04
0.06
0.08
Ra
nd
om
 1
00
k
EN
CO
D
E 
N
ih
3T
3
EN
CO
D
E 
Li
ve
r
BM
A
L1
 N
ih
3T
3
BM
A
L1
 L
iv
er
Ra
nd
om
 1
00
k
EN
CO
D
E 
N
ih
3T
3
EN
CO
D
E 
Li
ve
r
BM
A
L1
 N
ih
3T
3
BM
A
L1
 L
iv
er
Ra
nd
om
 1
00
k
EN
CO
D
E 
N
ih
3T
3
EN
CO
D
E 
Li
ve
r
BM
A
L1
 N
ih
3T
3
BM
A
L1
 L
iv
er
BHLHE40
0.0
0.2
0.4
0.6
0.8
1.0
1.2
HNF4
0.0
0.1
0.2
0.3
TCF7L2
0.00
0.02
0.04
0.06
0.08
0.10
0.12CEBPB
0.00
0.02
0.04
0.06
0.08
0.10
HSF1
0.00
0.05
0.10
0.15
NR3C1
0.00
0.05
0.10
0.15
0.20
0.25
m
ot
ifs
 c
ou
nt
s 
/s
ite
s 
co
un
ts
m
ot
ifs
 c
ou
nt
s 
/s
ite
s 
co
un
ts
m
ot
ifs
 c
ou
nt
s 
/s
ite
s 
co
un
ts
m
ot
ifs
 c
ou
nt
s 
/s
ite
s 
co
un
ts
Figure 2.20 – Predicted liver/NIH3T3 speciﬁc regulators. Motif occurrence over total site counts
for several candidates TF in BMAL1 and DNase I hypersensitive sites in liver (NBMAL1,l i ver =
1132,NDHS,l i ver = 81973 ) or NIH3T3 (NBMAL1,NIH3T3 = 463,NDHS,NIH3T3 = 77618 ) and in
100K random genomic locations as control.
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2.2.3 E2F1 was identiﬁed as a putative ﬁbroblasts-speciﬁc regulator enriched in
BMAL1 sites
E2F1 was highlighted as a ﬁbroblasts-speciﬁc regulator. This is not surprising as ﬁbroblasts
are still dividing in culture, while hepatocytes are mostly not dividing in liver tissue. Indeed
hepatocytes are normally quiescent (G0 phase) in the liver [6]. In order to substantiate this
prediction, we looked at the promoter of the E2f1 gene (ﬁgure 2.21). We observed that the E2f1
promoter is less accessible in liver and there is no Pol II signal, which indicate that the gene is
not transcribed. In addition, we found several TFBS motifs that are preferentially enriched
in NIH3T3 ﬁbroblasts, suggesting that these factors might contribute to the tissue-speciﬁc
expression of E2f1.
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Figure 2.21 – Promoter state of E2f1 in ﬁbroblasts and liver. Using UCSC Genome Browser to
visualize Pol II loading at the promoter of E2f1 in ﬁbroblasts and in liver, we observed that
E2f1 is not transcribed in liver. Moreover the DNase I signal (from ENCODE) demonstrated
that in the NIH3T3 ﬁbroblasts, the promoter was more accessible than in the liver. Finally
using PWMs from the Wang et al. study [338], we showed that this promoter contains many
motifs of EGR1, E2F1 itself and NRF1 that were enriched more speciﬁcally in ﬁbroblasts. Note
that the DNase I signal is represented with full reads instead of the cleavage positions.
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2.2.4 ZEB1 was identiﬁed as a potential co-regulatory factor of BMAL1
Julia Cajan tested the potential implication of ZEB1 (Zinc Finger E-Box Binding Homeobox 1)
in circadian gene regulation using ChIP-qPCR and shRNA. She found that this protein binds
upstream and at the TSS of Nr1d1 in a rhythmic manner (28h-32h after Dex) but in anti-phase
of BMAL1 (20h after Dex) in NIH3T3 cells (ﬁgure 2.22 A and B). Moreover, the knock-down
experiment of Zeb1 mRNA using shRNA, monitored with a Dbp-luciferase reporter, resulted in
a signiﬁcantly prolonged period phenotype in NIH3T3 ﬁbroblasts (ﬁgure 2.22 C), consistent
with results of an RNAi screen in human U2OS cells [353]. In addition, ZEB1 was recently
associated with adipogenesis [118] and may represent another link between the circadian
clock and the metabolism.
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Figure 2.22 – ZEB1 was identiﬁed as a potential co-regulatory factor of BMAL1. (A) ZEB1 binds
to shared BMAL1 sites rhythmically, but in antiphase to BMAL1, peaking at 28-32h after Dex in
NIH3T3 and (B) undifferentiated 3T3-L1 cells. (C) Dbp-luc as a circadian reporter in NIH3T3
ﬁbroblasts shows substantial period elongation upon Zeb1 KD (mean for stable KD cell line:
26.1h ± 0.1h, control cell line: 25.2h ± 0.1, p-value = 5e-4, t-test, N=6). Modiﬁed from Cajan,
Sobel et al. (in preparation)
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2.2.5 Digital genomic footprinting conﬁrms predicted liver/NIH3T3 speciﬁc fac-
tor
To study the transcription factor occupancy of the above motifs in more details, we analyzed
nucleotide resolved DNase I cleavage pattern obtained for each motif (ENCODE DHS data,
[311]) (ﬁgure 2.23) using the same sites in both tissues. DHS footprints detected at E-box sites
(here BHLHE40) in liver and NIH3T3 ﬁbroblasts show similar mean DNase signals and clear
signatures of a bound protein. In contrast, footprints found at the Nuclear respiratory factor 1
(NRF1) and Hepatocyte nuclear factor 4 (HNF4) motifs show clear preferences for ﬁbroblast-
or liver-speciﬁc BMAL1 sites, respectively. Interestingly, a decrease of NRF1 expression was
associated with insulin resistance in skeletal muscle in diabetic individuals [250]. Moreover,
NRF1 targets encode key enzymes in oxidative metabolism and mitochondrial function.
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Figure 2.23 – Context-speciﬁc chromatin accessibility of E-box, NRF1 and HNF4. DNase I
footprint in Liver or NIH3T3 around E-Box (BHLH40) a motif enriched in BMAL1 binding sites,
NRF1 a motif enriched in NIH3T3 and HNF4 a liver-speciﬁc motif. These cleavage patterns
were obtained using the same sites (PWM match in DHS in liver and/or NIH3T3 ﬁbroblasts) in
both tissues.
Taken together, these observations suggest that tissue-speciﬁc programs mediated by co-
regulatory factors are necessary to support tissue-speciﬁc circadian gene regulation.
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2.3 Phenotypic consequences of whole body Bmal1 knockout
2.3.1 Phase speciﬁc regulation by transcription factors in WT and in Bmal1−/−
mouse liver under night restricted feeding
To further study how the core clock and feeding-fasting cycles regulate diurnal oscillations of
gene expression in the liver at the transcriptional level, we combined temporal Pol II loadings at
TSSs in WT and Bmal1−/− mice and transcription factor binding sites in accessible chromatin
regions. Using DHSs and a collection of about 1900 position-weight matrices for TF-DNA
afﬁnities (Methods section), we identiﬁed DNA sequence motifs that explain rhythmic Pol II
patterns in wild-type and KO. Therefore, we modiﬁed previously described linear regression
models [273, 26, 44], but used sparse regression to identify a set of transcriptional activities
(strictly speaking DNA motifs) represented by phase (time of maximal activity) and amplitude
(Methods). In this model, motif activities are linearly combined according to the presence of
the corresponding DNA motifs within DHSs, as in the phase vector model [326]. Speciﬁcally,
we ﬁtted the TSS Pol II signal of all genes using the motif content in all DHSs annotated to the
corresponding genes, as described above. This enabled us to take into account, in addition
to the proximal promoter, a collection of putative regulatory regions that may control the
expression of the focal gene at a given vicinity of their respective TSS (Figure 2.24 A). We
observed that the inclusion of Distal DHSs up to a vicinity of 50Kbp was increasing deviance
ratio in both genotypes (Figure 2.24 B). This emphasized that enhancers (as represented by
distal DHSs) play an important role in ﬁne-tuning circadian gene transcription.
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Figure 2.24 – Computational method for discovering phase speciﬁc activity of cis-regulatory
elements. A) Scheme of the penalized generalized linear model. The distance threshold is
symmetric regarding the TSS; it allows including intergenic or intragenic DHS motif content
in the linear model. A DHS might be assigned to a multiple active gene thanks to the distance
threshold around the TSS. B) Deviance ratio in WT and in Bmal1−/− for Pol II loading (at the
TSS of all actives genes) is represented in function of the distance threshold. The deviance
ratio is deﬁned as the fraction of (null) deviance explained by the model.
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In WT mice, our predictions revealed that core clock transcription factors were among the
key phase determinants, and in particular Ror responsive elements (RRE), as reﬂected by
the strong inferred activity of RRE motifs at late night using Pol II-bound regions (Figure
2.25). Other major motif groups included D-Box factors with a peak activity around ZT12 and
E-boxes around ZT8, as previously described. However, motifs for factors that are not part
of the core circadian clock also emerged in our analysis, as illustrated by Forkhead TF (FOX)
motifs around ZT3, the CREB motif at ZT7, and GR motifs around ZT10. In Bmal1−/− mice
(Figure 2.25), it was immediately apparent that the contribution from E-Box, RREs, and D-Box
motifs was greatly reduced, and that other factors were responsible for phase-speciﬁc Pol II
accumulation. One of the Forkhead box motif (FOX) appeared as the variable with the highest
coefﬁcient and a phase-speciﬁc contribution around ZT5 (FOXO). The FOX family contains
41 protein in mouse, and we can not know which protein of the family is responsible for this
important phase-speciﬁc activity. Moreover we observed that some other FOX motifs from our
database (FOXA1,FOXB1,FOXJ) had a small phase speciﬁc activity at ZT18. Interestingly, at
the nuclear protein level, two FOX proteins, namely FOXA1 and FOXA3, were detected using
mass-spectrometry with similar phase (personal communications with Jingkui Wang and
Frederic Gachon). We also noted a larger relative role for the HSF, GR and CREB motifs in
Bmal1−/−. On the other side, several motifs showed stable activity such as SREB.
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Figure 2.25 – Phase-speciﬁc activity of cis-regulatory elements in WT and Bmal1−/− mouse
liver. We performed a penalized linearmodel inWT and inBmal1−/− with a distance threshold
of 50Kbp, and with a parameter α of 0.1 (Elastic-net mode) and a λ of 0.1. We used motifs
(PWMs) from four databases, notably JASPAR, SELEX, ENCODE (ChIP-seq) and TRANSFAC. In
addition, We highlighted with the same color closely related motifs from the different sources
(CREB, D-box, E-box, FOX, GR, HSF, RRE and SREB). The 40 motifs with highest inferred
activity in WT and in Bmal1−/− are presented in table 2.2 and 2.3
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Table 2.2 – Top 40 inferred motif activity in WT mouse liver
PWM ID Activity Phase Consensus Sum in-
formation
content
Motif sum
in DHS
Target gene
sum
Source Annotated
Family
NFIL3_MA0025.1 2.826E-2 12.4 TTATGTAACGT 14.13 3597 2447 Jaspar D-box
V_RORA2_01 2.454E-2 21.7 GTAAACAT 11.92 5690 4005 Transfac RRE
NFIL3_M135 2.443E-2 11.3 AGAGATAAGA 9.8 4455 3410 Selex D-box
RORA_M208 2.268E-2 22.1 GGGGGGGGGGCCA 14.23 8234 5079 Selex RRE
V_RORA_Q4 1.937E-2 20.1 GGTAAGTA 6.50 7188 4786 Transfac RRE
V_CREBP1_01 1.877E-2 11.8 TTGACCTTTG 12.90 2287 1914 Transfac D-box
RORA_1_MA0071.1 1.847E-2 20.5 CAAACGTAAACAAT 14.82 10192 5835 Jaspar RRE
V_SOX13_03 1.710E-2 5.6 CACATTCCTCCG 15.67 3438 2546 Transfac other
V_DMRT7_01 1.579E-2 2.0 AGGTCAG 8.34 6270 4288 Transfac other
V_PAX2_01 1.471E-2 10.5 GGAGAAGCAG 6.44 5262 3781 Transfac other
Cebpb_M130 1.354E-2 7.9 GGGAACAGATGGTCTC 15.89 3776 3007 Selex other
SREBF1 1.286E-2 19.9 CTGAACTTTGACC 13.81 11144 6405 Encode SREB
V_AR_02 1.243E-2 6.6 GATGAACTTCCTGACCCGTTT 16.44 9443 5654 Transfac GR
V_CEBPE_Q6 1.226E-2 19.1 CTTTGTG 7.77 6529 4405 Transfac other
V_VDR_Q6_01 1.195E-2 12.1 ACCGTTAACGGT 15.28 14751 7165 Transfac other
V_HSF1_Q6 1.193E-2 16.8 ACCGGAAGTG 10.25 11599 6735 Transfac HSF
V_GCM1_04 1.189E-2 22.0 TTCCGAGAAGACCA 14.92 10327 6126 Transfac other
V_PBX1_01 1.172E-2 4.3 GGGGGGGGCGGGGCC 12.80 4635 3166 Transfac other
V_MYB_03 1.156E-2 6.0 ATCCACAGGTGCGAAAA 12.01 8157 5325 Transfac other
PAX1_M87 1.144E-2 13.7 GATTTAATGACC 13.62 6997 4893 Selex other
V_FOXO3A_Q1 1.133E-2 8.2 CTTTAAGTACTTAATG 13.19 10652 5524 Transfac FOX
V_CMAF_01 1.125E-2 21.0 GCCCTCCCC 13.55 9443 5708 Transfac other
V_ATF4_Q6 1.112E-2 8.5 CGGGGG 6.57 8126 5184 Transfac other
V_FOXO4_01 1.103E-2 3.8 TATTGGTAATTACCTT 10.66 10040 5771 Transfac FOX
V_MSX3_01 1.103E-2 6.9 GGTCCCGCCCCCTTCTC 14.38 3222 2558 Transfac other
V_AIRE_02 1.099E-2 20.9 AGATAAG 8.22 4206 3250 Transfac other
ZNF784_M30 1.075E-2 11.0 TACCCACAATGCATTG 22.05 7763 5056 Selex other
V_DOBOX4_01 1.073E-2 5.1 AACCCCTTTGTTATGC 13.70 3420 2758 Transfac other
FOXB1_M138 1.065E-2 3.9 GGGGAATTAGAGTTG 10.66 7497 4869 Selex FOX
V_IPF1_05 1.047E-2 16.5 ACCGGAAGTG 11.35 4420 3230 Transfac other
V_IK3_01 1.028E-2 11.7 TTGGCA 6.00 7618 5080 Transfac other
V_MYCMAX_02 1.018E-2 7.0 TTATGTACTAATAA 16.78 8613 5412 Transfac E-box
ESRRA_M190 1.012E-2 20.8 TTGGTGACGTCC 11.55 11845 6395 Selex other
PBX1_MA0070.1 1.01E-2 9.1 CCATCAATCAAA 14.64 4844 3152 Jaspar other
V_PBX1_02 1.010E-2 19.5 TTTGACCTCCAGTGACCCCC 17.17 5228 3392 Transfac other
V_IRF2_01 1.007E-2 21.1 ACCGGAAGTA 10.85 8725 5377 Transfac other
En1_MA0027.1 1.006E-2 7.2 AAGTAGTGTTC 6.42 6931 4794 Jaspar other
V_STAT5A_Q6 1.005E-2 15.0 AACCCGGAAGTG 16.25 12414 5612 Transfac other
V_HNF3B_Q6 9.7E-3 6.8 AGATAA 8.19 14860 6475 Transfac other
V_AR_Q6_01 9.6E-3 10.0 TAGCCAGACAG 9.99 14242 6919 Transfac GR
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Table 2.3 – Top 40 inferred motif activity in Bmal1−/− mouse liver
PWM ID Activity Phase Consensus Sum in-
formation
content
Motif sum
in DHS
Target gene
sum
Source Annotated
Family
V_FOXO4_01 1.664E-2 7.3 TATTGGTAATTACCTT 10.66 10040 5771 Transfac FOX
V_DMRT7_01 1.628E-2 4.1 AGGTCAG 8.34 6270 4288 Transfac other
V_SOX12_03 1.544E-2 7.1 GATTTCCCATCATGCCTTGC 17.54 4107 3065 Transfac other
V_FOXO1_Q5 1.453E-2 5.0 GAAAACTAGTTAACATC 12.86 17895 7098 Transfac FOX
Ar_M188 1.368E-2 8.2 TAAACCGGAAGTTCGT 16.94 5199 3708 Selex GR
FOXB1_M138 1.289E-2 5.0 GGGGAATTAGAGTTG 10.66 7497 4869 Selex FOX
SREBF1 1.26E-2 20.9 CTGAACTTTGACC 13.81 11144 6405 Encode SREB
V_ZEC_01 1.265E-2 17.8 AGCTCATTAT 11.69 7146 4752 Transfac other
V_COUPTF2_Q6 1.262E-2 21.3 GGTACAGGGTGTTCT 14.12 24206 8644 Transfac other
V_DOBOX4_01 1.141E-2 8.4 AACCCCTTTGTTATGC 13.70 3420 2758 Transfac other
V_FOXJ3_06 1.139E-2 4.1 AAAAGCGGATTATTG 14.29 10263 5586 Transfac FOX
Ar_MA0007.1 1.102E-2 11.8 ATAAGAACATCGTGTACCCGCC 15.70 8149 5122 Jaspar GR
V_HDX_01 1.089E-2 22.9 TCAGGAGTTCGAGACC 15.76 4598 3434 Transfac other
RARA_M207 1.072E-2 15.9 TTGTTGTTTACATA 16.38 15370 7296 Selex other
V_PITX2_Q2 1.043E-2 17.2 CATTTCCTGTT 11.63 6023 4144 Transfac other
V_PPARG_03 1.009E-2 9.3 GATTTCCGGGAAATG 15.21 17565 7729 Transfac other
V_HNF1_Q6_01 1.002E-2 23.4 CCACACCCTG 13.40 6169 4030 Transfac other
V_KAISO_01 9.879E-3 19.8 AAAGGTCAAA 9.62 15679 7585 Transfac other
NR1H2::RXRA_MA0115.1 9.4E-3 9.65 AAAGGTCAAAGGTCAAC 27.87 16448 7417 Jaspar other
V_PAX_Q6 9.425E-3 15.6 GGCCCGGGCGG 14.31 15042 7272 Transfac other
V_CDPCR3HD_01 9.385E-3 19.2 TCTACCGGAAGTGGGT 10.95 2812 2206 Transfac other
V_FOXO3A_Q1 9.345E-3 8.0 CTTTAAGTACTTAATG 13.19 10652 5524 Transfac FOX
V_XBP1_02 9.234E-3 14.4 TATTACATAACA 11.55 4097 3250 Transfac other
V_HNF3G_Q4 9.1E-3 7.4 TTGTTA 4.56 14879 6504 Transfac other
V_AR_Q6_01 9.099E-3 9.3 TAGCCAGACAG 9.99 14242 6919 Transfac GR
V_ICSBP_Q6 9.080E-3 4.9 GCCGCCATTTTG 16.30 9755 5777 Transfac other
V_SF1_Q6_01 8.629E-3 7.7 CTCAGCCAATCAGCGC 12.92 16821 7412 Transfac other
V_FOXK1_04 8.506E-3 5.1 TGAAGGGATTAATCATC 12.98 7917 4252 Transfac FOX
V_RSRFC4_01 8.430E-3 10.6 AGATAG 6.62 3075 2477 Transfac other
V_CREB_Q2_01 8.238E-3 10.0 GCTGAC 6.23 10250 5886 Transfac CREB
V_HOXA7_01 8.175E-3 5.3 ACCGGAAGTG 9.81 3810 3001 Transfac other
V_HES1_Q6 8.080E-3 13.5 CCCTCCCCCA 12.67 19505 8557 Transfac other
V_HNF6_Q6 7.906E-3 1.5 TGCGTGGGCGT 14.61 4803 3361 Transfac other
V_IRF4_04 7.569E-3 10.7 ACCGGATGTA 10.23 7264 5030 Transfac other
Ddit3::Cebpa_MA0019.1 7.2E-3 16.8 AGATGCAATCCC 11.65 4990 3756 Jaspar other
V_NFYC_Q5 7.200E-3 17.9 CGACCAACTGCCGTG 12.31 12888 6811 Transfac other
V_FREAC2_01 7.154E-3 1.9 AGTAATTAATTACTTC 13.78 6198 4334 Transfac other
V_HSF1_Q6 7.102E-3 18.2 ACCGGAAGTG 10.25 11599 6735 Transfac HSF
V_HNF4_Q6 7.021E-3 21.3 ATTGATTGACAGGG 13.90 15858 7449 Transfac other
V_ATF_01 6.963E-3 11.0 GAAGTGTTGTTTCAGAC 17.72 7111 5004 Transfac CREB
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2.3.2 CREB phosphorylation is still oscillating in Bmal1−/− mouse liver
During fasting, mammals maintain normal glucose homeostasis by stimulating hepatic gluco-
neogenesis. Hepatic gluconeogenesis is known to be regulated by hormonal cues as circulating
glucagon and more recently by the circadian clock, which coordinates glucose metabolism
with changes in the external environment [154, 162]. CREB activity during fasting was shown
to be modulated by CRY1 and CRY2, which are rhythmically expressed in the liver [354].
In our analysis, CREB was found among the most delayed TF activities inferred by the gen-
eralized linear model in Bmal1−/− mouse liver. To test this prediction, Benjamin Weger (A
post-doc from the Gachon lab) measured nuclear levels CREB and pCREB using Western blots
in nuclear extract from four independent livers every two hours in WT and Bmal1−/− mice
(ﬁgure 2.26 A and B). In this analysis we were able to replicate the pattern of CREB activity in
WT as in [354] and we showed that CREB activity is still oscillating in the Bmal1−/− context.
On average, we observed a phase delay of approximately two hours in Bmal1−/−, though this
was not signiﬁcant (p=0.5, Chow test), presumably owing to individual feeding patterns [354].
Our results conﬁrm that CREB is regulated by the food related signaling in clock impaired
mouse upon night restricted feeding regimen. The phase delay of two hours suggests that the
circadian clock is implicated in the ﬁne tuning of the hepatic glucose metabolism.
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Figure 2.26 – CREB validation by western blot in WT an in Bmal1−/−. A) Representative
Western blot of CREB and pCREB in WT and Bmal1-/- genotypes. B) Quantiﬁcation of log2
(pCREB/CREB) Western blots in WT and Bmal1-/- genotypes. Nuclear extracts from four
independent livers (n=4) were harvested every two hours. Both genotypes showed a signiﬁcant
oscillation (p<0.05, Harmonic regression) of the mean signal from the four mice. Though the
peak time in Bmal1-/- is delayed, the comparison of the rhythm in the two conditions is not
signiﬁcant (p= 0.49, Chow test).
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2.3.3 Oscillating geneexpressionand relatedpathway inWTand Bmal1−/− mouse
liver
In order to understand how the circadian clock and the feeding-fasting cycle control diurnal
gene expression in liver, we studied differences in mRNA expression and between Bmal1−/−
and wild-type mice subject to the same night restricted feeding regimen. We looked at oscil-
lating genes in WT and in Bmal1−/− (p-value < 0.05, log2 amplitude > 0.5, FDR < 0.3) and we
observed that a substantial fraction of genes is still oscillating in the Bmal1−/− genotype (ﬁg-
ure 2.27 A). In addition the overlap of genes cycling in WT and Bmal1−/− was of intermediate
size indicating that genes with a diurnal expression pattern are quite different between WT
and Bmal1−/− mice. By computing the cumulative count from the genes with the highest
amplitude to the lowest (ﬁgure 2.27 B), we observed that genes in WT had bigger amplitudes
than in Bmal1−/− as expected. The phase distribution of mRNA in WT and in Bmal1−/−
suggest a phase delay of gene expression in the absence of the clock (ﬁgure 2.27 C).
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Figure 2.27 – Rhythmicity analysis of mRNA from microarray in WT and Bmal1−/−. A) Venn
diagram of oscillating genes in WT and in Bmal1−/− using mRNA expression.B) Cumulative
count of oscillating genes (with a multi linear regression p-value below 0.05 and a log2 ampli-
tude greater than 0.5) in Bmal1−/− and WT with log2 amplitude greater or equal to x.C) Phase
histograms of oscillating genes in WT, in Bmal1−/− and in both genotypes.
Subsequently, we wanted to identify the function of genes oscillating in WT, oscillating in
Bmal1−/− and oscillating in both conditions. Therefore we did a functional pathway analysis
with g:Proﬁler [269] using Kegg and Reactome pathway annotations (ﬁgure 2.28, table 2.4). In
the WT context, genes annotated for circadian rhythm as well as lipid and sugar metabolism
related pathway annotations were enriched. In the Bmal1−/−, we observed that pathway
related to sugar, and lipid metabolism are still oscillating. We found that amplitudes of genes
related to the glucose-dependent ChREBP signaling were increased in the absence of the
clock and the amplitudes of genes annotated with bile acids secretion are decreased in the
Bmal1−/− genotype. ChREBP has emerged as a central regulator of glycolysis and de novo
fatty acid in liver [148]. Taken together, these changes proved once more that the clock is
implicated in the precise regulation of the liver metabolism.
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Figure 2.28 – Kegg and Reactome Pathway enrichment and amplitudes analysis. Boxplot of
log2 mRNA amplitude of genes from signiﬁcantly enriched Kegg or Reactome pathway in WT
and in Bmal1−/− genotypes. These pathways were retrieved using g:Proﬁler with a p-value
threshold below 0.1 in one or both genotype. Boxplots were generated with the amplitude of
each oscillating genes annotated with a speciﬁc pathway. Genes used for each annotation are
reported in the table 2.4.
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Table 2.4 – Reactome and Kegg pathway analysis of oscillating genes in WT and Bmal1−/−
mouse liver
genotype p-value Source ID Pathway Genes
WT 7.84E-8 REAC:508751 Circadian Clock CRY1, SREBF1, NAMPT, NR1D1, PER1, FBXL3, PPARA, CPT1A, NPAS2,
CLOCK, BHLHE40, BHLHE41, ELOVL3, ARNTL, PER2, DBP, CRY2
WT 4.92E-7 REAC:1368110 Bmal1:Clock,Npas2 activates cir-
cadian gene expression
CRY1, NAMPT, NR1D1, PER1, PPARA, NPAS2, CLOCK, BHLHE40,
BHLHE41, ARNTL, PER2, DBP, CRY2
WT 3.69E-5 KEGG:04710 Circadian rhythm CRY1, NR1D1, PER1, FBXL3, NPAS2, RORC, PER3, CLOCK, BHLHE40,
BHLHE41, ARNTL, PER2, CRY2
WT 3.71E-4 REAC:7083403 Triglyceride Biosynthesis ELOVL1, LPIN1, ACLY, ACOT3, ACOT12, LPIN2, FASN, AGPAT2, ACOT7,
AGK, AGPAT6, ELOVL5, AGPAT1, ELOVL3, ELOVL6, GPD1L, ACOT4,
LCLAT1, ACOT1
WT 6.92E-4 KEGG:04976 Bile secretion ADCY6, SLC10A2, ABCG8, ATP1B1, ABCB11, CAR2, NCEH1, CYP7A1,
SLC2A1, SLCO1A4, AQP8, LDLR, AQP9, ATP1A1, NR0B2, ABCG5,
ABCB1A, NR1H4, SLC4A4
WT 7.61E-4 REAC:7084372 Regulation of cholesterol biosyn-
thesis by SREBP (SREBF)
KPNB1, MVD, SREBF1, SQLE, SREBF2, FASN, PMVK, SCAP, LSS,
ELOVL6, MVK, ACACB, DHCR7
WT 1.14E-3 REAC:7084024 Nuclear Receptor transcription
pathway
PPARD, NR1I3, NR2C2, RXRG, ESR1, NR1D1, NR1D2, PPARA, NR4A1,
RORC, NR3C2, NR0B2, AR, NR1H4, THRA, NR2C2AP
WT 3.34E-3 REAC:7084371 Activation of gene expression by
SREBF (SREBP)
MVD, SREBF1, SQLE, SREBF2, FASN, PMVK, LSS, ELOVL6, MVK,
ACACB, DHCR7
WT 1.95E-2 REAC:7083346 Pyrimidine salvage reactions UPP1, TYMP, TK1, UCK2, UPP2, CDA
WT 3.07E-2 KEGG:03008 Ribosome biogenesis in eukary-
otes
NOB1, GTPBP4, RIOK2, RCL1, NOP58, NAT10, NOP56, SPATA5, POP4,
MPHOSPH10, WDR43, CIRH1A, GNL3, RPP38, HEATR1, UTP18,
UTP14B
WT 3.98E-2 REAC:1368092 Rora activates gene expression SREBF1, NR1D1, CPT1A, NPAS2, CLOCK, ARNTL
WT 4.68E-2 REAC:7083820 Cholesterol biosynthesis MVD, FDFT1, SQLE, PMVK, NSDHL, SC4MOL, LSS, MVK, DHCR7
Bmal1-/- 1.89E-13 REAC:7084372 Regulation of cholesterol biosyn-
thesis by SREBP (SREBF)
KPNB1, CYP51, MVD, NFYB, ACACA, SREBF1, SQLE, SREBF2, NFYA,
GPAM, FASN, SCD2, PMVK, RAN, SC5D, LSS, ELOVL6, MVK, ACACB,
DHCR7, FDPS
Bmal1-/- 3.52E-13 REAC:7084371 Activation of gene expression by
SREBF (SREBP)
CYP51, MVD, NFYB, ACACA, SREBF1, SQLE, SREBF2, NFYA, GPAM,
FASN, SCD2, PMVK, SC5D, LSS, ELOVL6, MVK, ACACB, DHCR7, FDPS
Bmal1-/- 9.31E-8 REAC:7083820 Cholesterol biosynthesis CYP51, MVD, FDFT1, HMGCR, SQLE, HSD17B7, PMVK, NSDHL,
SC4MOL, SC5D, LSS, MVK, DHCR7, FDPS
Bmal1-/- 1.15E-6 KEGG:00100 Steroid biosynthesis CYP51, FDFT1, SQLE, SOAT2, HSD17B7, CYP2R1, NSDHL, SC4MOL,
SC5D, LSS, DHCR7
Bmal1-/- 1.22E-6 REAC:7083228 Activation of the pre-replicative
complex
MCM2, MCM5, CDT1, POLA1, POLE, RPA3, MCM4, POLA2, PRIM1,
PRIM2, MCM6, MCM8, MCM7, MCM3
Bmal1-/- 3.70E-6 REAC:7083665 ChREBP activates metabolic gene
expression
MLXIPL, MLX, ACACA, ACLY, FASN, AGPAT1, ACACB
Bmal1-/- 6.51E-5 KEGG:03008 Ribosome biogenesis in eukary-
otes
NOB1, XPO1, GTPBP4, RCL1, GNL3L, SBDS, WDR75, NOP58, NOP56,
SPATA5, RAN, MPHOSPH10, WDR43, CIRH1A, GNL3, CSNK2A2,
RPP38, HEATR1, MDN1, UTP14B
Bmal1-/- 6.71E-5 KEGG:03030 DNA replication MCM2, MCM5, POLA1, POLE, RPA3, POLD2, MCM4, POLA2, PRIM1,
PRIM2, MCM6, MCM7, MCM3
Bmal1-/- 3.72E-3 REAC:7083225 DNA replication initiation POLA1, POLE, POLA2, PRIM1, PRIM2
Bmal1-/- 3.72E-3 REAC:7083769 Telomere C-strand synthesis initia-
tion
POLA1, POLE, POLA2, PRIM1, PRIM2
Bmal1-/- 8.09E-3 KEGG:00900 Terpenoid backbone biosynthesis MVD, HMGCR, NUS1, ACAT2, PDSS1, PMVK, MVK, FDPS
Bmal1-/- 3.88E-2 REAC:7083217 M/G1 Transition MCM2, MCM5, CDT1, POLA1, POLE, UBC, RPA3, E2F2, MCM4,
POLA2, PRIM1, PRIM2, MCM6, PSMD14, MCM8, MCM7, MCM3
Bmal1-/- 3.88E-2 REAC:7083216 DNA Replication Pre-Initiation MCM2, MCM5, CDT1, POLA1, POLE, UBC, RPA3, E2F2, MCM4,
POLA2, PRIM1, PRIM2, MCM6, PSMD14, MCM8, MCM7, MCM3
Bmal1-/- 4.15E-2 REAC:7084173 Synthesis of UDP-N-acetyl-
glucosamine
UAP1, GFPT1, GNPNAT1, PGM3
WT and Bmal1-/- 2.33E-7 REAC:7084372 Regulation of cholesterol biosyn-
thesis by SREBP (SREBF)
KPNB1, MVD, SREBF1, SQLE, SREBF2, FASN, PMVK, LSS, ELOVL6,
MVK, ACACB, DHCR7
WT and Bmal1-/- 3.13E-7 REAC:7084371 Activation of gene expression by
SREBF (SREBP)
MVD, SREBF1, SQLE, SREBF2, FASN, PMVK, LSS, ELOVL6, MVK,
ACACB, DHCR7
WT and Bmal1-/- 2.62E-5 REAC:7083820 Cholesterol biosynthesis MVD, FDFT1, SQLE, PMVK, NSDHL, SC4MOL, LSS, MVK, DHCR7
WT and Bmal1-/- 2.84E-4 KEGG:00100 Steroid biosynthesis FDFT1, SQLE, SOAT2, NSDHL, SC4MOL, LSS,DHCR7
WT and Bmal1-/- 6.35E-4 KEGG:03008 Ribosome biogenesis in eukary-
otes
NOB1, GTPBP4, RCL1, NOP58, NOP56, SPATA5, MPHOSPH10,
WDR43, CIRH1A, GNL3, RPP38, HEATR1, UTP14B
WT and Bmal1-/- 1.35E-2 REAC:7083665 ChREBP activates metabolic gene
expression
ACLY, FASN, AGPAT1, ACACB
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2.3.4 Glucose, lipids and fatty acids metabolism in WT and Bmal1−/−
During fasting, glucose homeostasis is achieved by triggering expression of gluconeogenic
genes in response to glucagon and glucocorticoids. Glucagon exerts its strongest action when
mice wake up and begin to eat. The response to glucagon by liver cells varied depending on a
direct circadian regulation of the transcriptional activity of cAMP response element–binding
protein (CREB), which was inhibited by CRYs [354]. CREB was found to induce expression of
the gluconeogenic program through the nuclear receptor coactivator PGC-1 [137].
As demonstrated in a previous section (see 2.3.2) CREB is still rhythmic in Bmal1−/− genotype
upon night restricted feeding. In addition, our analysis (section 2.3.3) showed that ChREBP
and SREBP signaling were affected by the Bmal1−/−. These two transcriptions factors are
implicated in glucose metabolism and lipid synthesis in liver [75].
Glucose metabolism in WT and Bmal1−/−
As developed in the introduction (section 1.5.2), the glucose homeostasis is controlled by the
circadian clock. Thus, during the feeding period blood glucose is mainly of dietary origin,
while during the starvation period glucose is produced in the liver through gluconeogenesis .
Therefore, we wanted to study gene related the glucose metabolism at Pol II and mRNA levels.
We looked (ﬁgure 2.29 and gluconeogenesis pathways A) at the gluconeogenesis and at the
glycolysis pathways and we labeled several irreversible steps at physiological conditions that
are speciﬁc to one or the other pathway. Indeed the conversion of the oxaloacetat to phospho-
enol pyruvate by the phosphoenolpyruvate carboxykinase (PCK1) is one key regulatory step
of the gluconeogenesis. Furthermore, the conversion of fructose 1,6-bisphosphate to β-D-
fructofuranose 6-phosphate by the enzyme fructose-1,6-bisphosphatase (FBP1,FBP2) and the
conversion of D-glucopyranose 6-phosphate to D-glucopyranose by glucose-6-phosphatase
(G6pc) are located at the end of the pathway. These two reactions are critical steps of the gluco-
neogenesis pathway. Interestingly, in the glycolysis the inverse conversion steps are regulated
by different enzymes with an irreversible action notably the β-D-glucopyranose 6-kinase (Gck)
and the 6-phosphofructokinase (Pfkm). The conversion of phospho enol pyruvate to pyruvate
by the pyruvate kinase (Pklr) is the last irreversible reaction of the glycolysis. These key regula-
tory steps are essential to allow the temporal separation of glycolysis and gluconeogenesis
in the liver. Several enzymes of these two pathways were detected with a circadian behavior
in Pol II loading at the TSS and mRNA accumulation in WT and in Bmal1−/− (ﬁgure 2.29 B).
Our data suggest that these enzymes are co-regulated by the circadian clock and by feeding
cues at the transcriptional level, as the oscillations were maintained in Bmal1−/− context but
with different amplitudes and phases compared to the WT genotype. More precisely, these
genes depict lower amplitudes in Bmal1−/− (ﬁgure 2.30), notably Gck and Pck. In addition
the phases of these genes are quite impacted by the impaired clock genotype, while the mesor
is not affected.
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Figure 2.29 – Glycolysis and gluconeogenesis pathways. A) Gluconeogenesis is a mechanism
which maintains blood glucose levels, avoiding low levels (hypoglycemia) during fasting phase.
It is a pathway consisting of a series of eleven enzyme-catalyzed reactions. Many of the
reactions are reversible steps, and irreversible steps are important regulatory steps highlighted
using red boxes. Glycolysis converts glucose to pyruvate by via a series of intermediate
metabolites. Each chemical modiﬁcation (arrows) is performed by a different enzyme encoded
by different genes (purple). B) Temporal proﬁles in mRNA (in pink) and Pol II loadings at
TSS (in blue) of key regulators of the glycolysis/gluconeogenesis in WT (dotted line) and in
Bmal1−/− (dashed line) context.
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Figure 2.30 – Effect of Bmal1 knockout on key steps of glycolysis/gluconeogenesis. A) Phase
and amplitude of key steps of the glycolysis/gluconeogenesis in WT and in Bmal1−/− reported
in a polar scatter plot. B) boxplot of log2 amplitudes and mesor in WT and in Bmal1−/−. C)
Mesor, amplitudes and phase in WT versus Bmal1−/−.
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In order to explain changes in phase and amplitude ofGck andG6pc we looked at the promoter
region of these two enzymes, which play an opposite role during glycolysis/gluconeogenesis
(ﬁgure 2.31). We did a PWM scan with FIMO and Wang PWMs [338, 114] and we overlapped
DNase I-seq signal which was analyzed with Wellington algorithm to detect TFBS footprints
[256]. We observed that Gck contained several E-box motifs (MYC/MAX) that are under an
important footprint about 100bp upstream the TSS. Moreover, in the same DHS we found a
motif of CEBPB, which was linked already with the regulation of gluconeogenesis [13] as an
essential factor underlying glucocorticoid-dependent activation of Pepck gene transcription.
In the DHS 1 Kbp upstream of Gck promoter, we found motifs of CREB, GR (NR3C1) and HSF1,
whichwere TFBS motifs with a high-activity in the Bmal1−/− whenwe did our penalized linear
model. These motifs might be responsible for the remaining oscillations in Gck transcription
and mRNA accumulation. The analysis of G6pc promoter revealed a CREB and a TCF7L2
motif a 100bp upstream of the TSS.In addition, TCF7L2 has been recently shown to inhibit
adjacent promoter occupancies of CREB, CRTC2, and FOXO1, which are critical transcriptional
modules in hepatic gluconeogenesis [241]. Taken together, our motif predictions may explain
the transcriptional regulation of Gck and G6pc. However, this analysis was centered on the
promoter of these two genes, which are regulated as well by distal cis-regulatory elements
and the phase of expression of these genes is quite difﬁcult to explain only by looking at the
TFBS in the promoter. As demonstrated before (section 2.3.1), distal sites might add useful
information to the ﬁne tuning of the gene expression. In addition some transcription factors
depict a weak footprint that might be difﬁcult to detect, such as nuclear receptors. Therefore,
some of the motifs inside DHS without footprints might play a role in the transcriptional
regulation. Moreover in glycolysis/gluconeogenesis the protein expression and activation,
such as phosphorylation of F6P during glycolysis for example, are key regulatory events of
these pathway. Therefore the results obtained at the transcriptional level are not as accurate
as at the protein activity level, although the regulation of transcription seems to play a role. In
conclusion, we conﬁrmed that the glucose metabolism is ﬁne tuned by the circadian clock
and that this regulation is performed at least partially at a transcriptional level.
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Figure 2.31 – Gck and G6pc promoter: example of transcriptional control of glucose
metabolism. Promoter structure of A) Gck and B) G6pc, two key enzymes of gluconeoge-
nesis/glycolysis. UCSC genome browser screenshot of the promoter region overlapped with
our PWM scan using Wang [338] motifs and with DNase I signal analyzed with Wellington
algorithm for digital genomic footprint detection [256].
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lipids and fatty acids metabolism in WT and Bmal1−/−
As lipid metabolism is affected by the circadian clock and the feeding-fasting cycle [111]
and as ketone bodies are produced by the liver through fatty acid oxidation during fasting
conditions [238] , we wanted to study free fatty acids (FFA), β-hydroxybutyrate (BHB) and
triglycerides (TG) temporal pattern in blood of WT and Bmal1−/− mice.
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Figure 2.32 – Free Fatty acides, triglycerides and ketone bodies in WT and in Bmal1−/−. FFA
TG and BHB were monitored in blood of n = 3 - 5 mouse per time point at ZT 2,6,10,14,18,22
and 26 in wild-type and Bmal1−/− by Dr. Federica Gilardi at UNIL. ZT0 represent the switch
between dark and light phase.
In wild-type condition FFA level in blood decreases during the light phase (ZT0-ZT12), where
the mice are fasting and sleeping, and increase during the dark phase when the mice are awake
and eating. The Bmal1−/− condition exhibits signiﬁcantly higher level of FFA (ZT10, ZT14 and
ZT22) throughout the day. BHB levels are signiﬁcantly higher in Bmal1−/− during the light
phase at ZT6 and ZT10 and the beginning of the dark phase at ZT14. The wild-type temporal
pattern of triglycerides show a low concentration during the light phase and a peak during
the dark phase at ZT18 with a rapid decrease at ZT22. Interestingly, in the Bmal1−/− context,
the level of triglycerides is slightly more elevated during the day, especially at ZT 10. During
the night phase the Bmal1−/− mice didn’t succeed to reduce the concentration of triglyceride
notably at ZT 22 and in the beginning of the light phase at ZT 26. This effect might be due to a
phase shift of the de novo lipogenesis in the Bmal1−/−.
Elevated levels of FFA are usually associated with obesity and insulin resistance. Higher BHB
levels in Bmal1−/− suggest increased FFA oxidation and diabetic ketoacidosis, leading to
reduced mitochondrial redox state [329]. Interestingly, a recent study showed that liver-
derived ketone bodies such as BHB are necessary for food anticipation. They have shown
that Per2 regulates β-hydroxybutyrate (BHB) and that food anticipation originates in the
liver [56]. Finally, the level of TG suggests a potential shift of 2h in de-novo lipogenesis in
the Bmal1−/− genotype. Potential relationships with diabetes and non-alcoholic fatty liver
disease are suggested by the literature [232, 289, 214] , but in our night restricted feeding
regimen the Bmal1−/− did not exhibit liver steatosis, as reported by Dr. Federica Gilardi.
In conclusion, the night restricted feeding regimen seems to counteract deleterious effect
induced by a defect of the molecular clock.
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3.1 Abundant diurnal DHSs in the mouse liver
This work is to our knowledge the ﬁrst study to map genome-wide DNase I hypersensitivity
(DHS) in the mouse liver as well as to proﬁle DHS sites (DHSs) around the clock with 4h
resolution. The resulting data set provides an unprecedented view of circadian chromatin
accessibility. Other studies [334, 171, 65] proﬁled the enrichment of the active chromatin
mark H3K27ac for a similar purpose. However, using new and previously published H3K27ac
enrichment data, we found that the genomic resolution and extent of regulatory insight
offered by DHS proﬁling is superior to that of H3K27ac mapping [237, 320, 311] because DHS
enables higher resolution in mapping transcription factor binding sites and allows dynamic
footprinting analyses. Nevertheless, these molecular signals are complementary, and display a
high correlation with each other and Pol II genome-wide and across circadian time. In contrast
to the observed delay between H3K4me3 enrichment and Pol II, reported previously [188],
no signiﬁcant delays are observed between accessibility as measured by DHS and H3K27ac
enrichment at a given site, which likely reﬂects the fact that histone acetylation turnover is
faster than that of histone methylation [213].
Comparing average signals, we observed that transcription start sites (TSSs) displayed higher
intensity for all marks studied compared to distal or proximal DHSs; however, relative ampli-
tudes in oscillations appeared higher in non-TSS sites. This suggests that TSS accessibility
is less variable than putative enhancer accessibility, which likely reﬂects increased protein
binding dynamics at putative enhancers compared to TSSs. This suggests that enhancers may
have a dominant role in the control of diurnal gene expression, consistent with the notion
that modulation of histone marks and accessibility of chromatin at enhancers is one of the pri-
mary regulatory mechanisms underlying cell type speciﬁcity [134]. This hypothesis is further
supported by our observation of close phase relationships between putative enhancers and
the nearest TSS. As such, our data constitute a valuable resource to explore the involvement of
putative enhancer regions in mediating cyclic recruitment of Pol II at the TSSs and subsequent
transcription of the respective target genes.
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The core clock factor BMAL1 is essential for rhythmic transcription in mammals. Liver-speciﬁc
and global Bmal1 knockout in mice lead to important effects on metabolism and behavior that
can be traced to dysregulation of BMAL1 target genes [300, 286, 251]. Importantly, comparing
clock wild-type with BMAL1 mutant suggested that feeding, rather than the clock, is the main
driver of rhythmic translation in the liver [17]. It has been suggested that BMAL1 is a pioneer-
like factor enabling easier access of regulatory sites by other TFs [222]. Its dimerization
partner CLOCK has been shown to have histone acetyltransferase activity [80]. Therefore, we
sought to verify whether its presence in the mouse liver led to large-scale differences in DNA
accessibility as measured by DNase I digestion.
3.2 Limited impact ofBMAL1 removal onto the liver chromatin land-
scape
Comparing DHS signals between wild-type and Bmal1−/− samples at ZT6 revealed relatively
few changes as the signal correlation between the two samples was above 0.8. Thus, only a
minority of DHSs appear to be affected, consistent with the limited number of target sites for
BMAL1 [171, 273]. However, the majority of these BMAL1 binding sites showed a decrease in
DHS signal, which may be consistent with a pioneer-like function for BMAL1 [222]. Higher
resolution, footprint- and protein structure-based analyses further revealed a CLOCK:BMAL1
DNA binding pattern at tandem E-box sites consistent with a hetero-tetramer conﬁguration
at peak activity of these TFs [273, 249, 234]. Interestingly, at the daily minimum of BMAL1
activity, only the strongest E-boxes still display a footprint, further supporting the notion that
other TFs, such as USF1, compete with CLOCK:BMAL1 to occupy similar target sites, although
in distinct biophysical fashion [301, 76].
In order to compare the binding pattern of BMAL1:CLOCK with another important TF in the
liver we looked at the rhythm of the CREB footprint. CERB binds to cAMP responsive elements
(CRE motif) in a strong/stable manner, which explains why we do not see any change in the
DNase I pattern during the diurnal cycle [211]. Our data support the hypothesis that CREB
is constitutively bound to its cognate DNA binding site and that its circadian activation is
mediated through other mechanisms, such as phosphorylation in a circadian manner in the
liver by PKA, PKC or CK2 [93, 107].
Studying other transcription factor binding sites such as HSF, SREBP and RRE, we found that
the number of bound targets changed diurnally, but that the footprints remained constant.
Heat shock transcription factor 1 (HSF1), which drives the expression of heat-shock proteins
at the onset of the dark phase [270, 291], had an apparent enrichment of bound sites between
ZT14 and ZT22. The number of targets of HSF1 was low, suggesting that this regulator is
highly speciﬁc for the temperature-stress-related pathway [270]. REVERBα participates
in the circadian modulation of sterol regulatory element-binding protein (SREBP) activity,
and thereby in the daily expression of SREBP target genes involved in cholesterol and lipid
metabolism [189]. The SREB motif showed a complex circadian pattern with two modes
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at ZT10 and ZT22. However, the temporal mRNA expression of SREBP1 targets was not
always synchronized with its binding pattern. In particular, different expression phases were
described for SREBP1 target genes depending on their function, indicating the implication
of other transcription factors in their regulation [111]. The DNase I footprint at RRE (ROR
responsive element) showed two modes of activity with a small peak at ZT10 (binding of the
repressor RevErb) and a higher peak at ZT22 (binding of the activator ROR). This bimodal
activity suggests a possible dynamic exchange of TFs, namely RORs and REVERBs, on their
cognate binding sites [120].
3.3 Tissue speciﬁc regulation of the circadian clock
The liver tissue, composed mainly of hepatocytes, is subject to systemic cues such as feeding/-
fasting cycle, body temperature variations and hormonal cues, while circadian oscillation in
NIH3T3 ﬁbroblasts (cultured in a dish) originate only from the endogenous molecular clock.
In our comparative study of liver tissue and NIH3T3 ﬁbroblasts, we discovered and described
the varying motif content and chromatin landscape found around BMAL1 binding sites. We
observed that BMAL1 sites are accessible, active and in turn repressed in a context-speciﬁc
manner. This observation raised the question of how tissue speciﬁc regulation of the circadian
clock is achieved.
The result of our analysis of BMAL1 sites located in accessible regions (DHS), supports the
hypothesis that the chromatin state determines context speciﬁc binding. Our motif analysis
indicated that co-regulatory elements in NIH3T3 ﬁbroblasts seemed to be more speciﬁcally
linked to BMAL1 sites rather than being overall cell-type speciﬁc factors. For instance, mem-
bers of the E2F family appear to colocalize strongly with BMAL1. E2F factors are notably
involved in cell cycle regulation [271], which is consistent with ﬁbroblasts still actively cycling,
as opposed to most of the cells in the liver. Another interesting factor enriched in ﬁborblast is
NRF1, which targets key enzymes in oxidative metabolism and mitochondrial function [293].
On the other hand, in liver we found previously reported tissue-specic regulators potentially
driving the context-specic expression of clock gene. Among the identiﬁed factors we found
FOXA, a well-known pioneer factor [61, 117, 206], HNF4 and several nuclear receptors (as
reported in [349]). Strikingly, in liver, one of the most enriched factors with a high percentage
of bound motifs was GATA1. A recent publication [220] describing the tissue-speciﬁc binding
of CLOCK and CYCLE in Drosophila identiﬁed serpent (SRP), which is a member of the GATA
family in ﬂies, as a cis-regulatory factor necessary for driving CLOCK-CYCLE mediated tran-
scriptional activation in Drosophila body. The majority of its targets is linked to metabolism
and detoxiﬁcation and is active in the fat body, midgut and Malpighian tubules. Thus, there
might be an evolutionary link to the enrichment of GATA1 in liver. In addition, several other
studies [38, 39, 341] have reported a list of motifs overrepresented in promoter regions of
clock-controlled genes, many of which were detected in our analysis. While this gives conﬁ-
dence in ourmotif ﬁnding, we further extended their analysis by appointing context-speciﬁcity
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and distal regulatory elements to the motifs discovered. In conclusion, it will be appealing
to study further the networks containing the circadian clock machinery as well as putative
co-regulatory factors, including distal regulatory elements, in their respective cell type and
possibly considering an evolutionary perspective.
3.4 Regression models uncover factors which maintain cycling pat-
terns in gene expression in the absence of BMAL1 activity
Our genome-wide study of the oscillating genes using Pol II loadings at TSSs or mRNA ex-
pression in WT and Bmal1−/− genotype revealed that a similar proportion of genes ( about
10% of genes expressed in the liver) depict a diurnal pattern in both contexts, but the overlap
is surprisingly small ( 20%). As expected, we found that amplitudes are higher in WT than
in Bmal1−/− genotype, but the number of oscillating genes is slightly more important in
Bmal1−/−. These observations were consistent between mRNA and Pol II loadings. Thereby
we observed that the molecular clock has a dual effect on gene regulation probably through
BMAL1 activation and PER1/2 repression [85] and that restricted feeding can restore circadian
expression of hundred of transcripts [333]. Using a penalized regression model, we further
uncovered an important role for the TFs FOXO1, Glucocorticoid Receptor (GR), CREB and
NFY in mediating robust cyclic transcription in mice lacking BMAL1. GR activity seemed to be
unaffected by the Bmal1−/− genotype, whereas FOX and NFY showed increased activity, with
a similar phase in WT and in Bmal1−/−. Interestingly, NFY is a binding partner of SREB and
Sp1 in the regulation of lipid metabolism and cholesterol biosynthesis [268]. Therefore, our
data suggest that lipid metabolism and cholesterol metabolism do not require a functional
clock under night restricted feeding, as previously described [333]. Moreover, restricted feed-
ing has recently been shown to counteract the effect of a high-fat diet in WT mice [130, 55].
In the case of CREB, we found an important phase delay in Bmal1−/−, implying that the
circadian clock regulates hepatic gluconeogenesis [354]. Forkhead box factors like FOXO1
have been implicated in cell cycle regulation, oxidative stress, and are negatively regulated by
insulin signaling [187]. Analogously to the core clock, FOXO1 and FOXO6 also regulate the
expression of key enzymes implicated in gluconeogenesis [166, 68], collectively supporting
our identiﬁcation of FOXO TFs as effectors of metabolic rhythms in liver cells. Similar to
FOXO TFs, Glucocorticoid hormones (GCs) also control glucose metabolism and stimulate
gluconeogenesis or fat breakdown. Interestingly, [190] showed that GCs could counter the
action of the circadian clock in resetting the phase of peripheral oscillators. Recently GR
and FOXO were shown to be common regulators of many genes involved in gluconeogenesis
and cell cycle progression, and a synergistic activity of these two TFs might exist [101]. In
Bmal1−/− mice, under a night-restricted feeding regimen, insulin release in blood is still
rhythmic [111]. In addition, [242] demonstrated that up to a hundred circadian transcripts
are under glucocorticoid control and that these are distinct from clock-controlled circadian
genes. GCs regulate the expression of the circadian TF PER2 [59], which is probably essential
in mediating this circadian transcription. Indeed, GCs have been shown in rat to synchro-
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nize circadian gene expression in cultured ﬁbroblasts and to affect the phase of circadian
gene expression in the liver [24]. Our observations could therefore be compatible with a
model in which two separate circadian signals are received from the system, resulting in
the entrainment of the core clock by GCs through PER2. However, GCs can directly affect
transcription of other targets through GR. Lastly, we observed that many diurnally transcribed
genes in Bmal1−/− mice also exhibited a one-hour delay compared to the WT condition.
This implies that a large proportion of regulatory elements would be activated sooner in the
presence of the clock, consistent with the emerging notion that the circadian clock also acts to
anticipate daily occurrences of feeding/fasting rhythms by activating relevant genes ahead of
time [251, 185]. This is further consistent with observations that restricted feeding restores
the circadian transcription of many metabolic genes [333], that feeding cues dominate light
sensing as a Zeitgeber [70, 290], and that even in Bmal1−/− mice, food anticipatory behavior
exists [51]. It is thereby interesting to note that the phase distribution in stringently selected
cyclic regions is equally polarized at the two most prominent phases of expression, ZT6-10 and
ZT18-22, in the Bmal1−/− compared to the WT condition. These observations suggest that in
the Bmal1−/− genotype the molecular clock is not able anymore to regulate the metabolism
in a proactive way whereby the production of some enzymes is initiated before the presence
of food in order to optimize the energy consumption of the cell [337]. This goes against the
idea of widespread disorganization of transcriptional control in the absence of a peripheral
clock and underlines the strong effect of nutritional synchronization.
3.5 Food entrainment and circadian regulation of lipid and sugar
metabolism in liver
The liver is a central player in adjusting metabolic processes to daily feeding–fasting cycles.
This role is demonstrated by the circadian expression of many liver genes implicated in the
metabolism of lipids, proteins, carbohydrates, and xenobiotics. The food entertainment of
the liver clock has been widely studied using restricted feeding or inverted feeding [55, 333].
The clock impaired mice depict severe metabolic disorders such as type 2 diabetes and a
reduced lifespan [102, 214]. In BMAL1 knockout mice, several studies showed that these
mice were exerting glucose intolerance, increased respiratory quotient, reduced fat storage,
increased circulating fatty acid, increased ectopic fat formation in liver and muscles, and
hypoinsulinemia [185, 300, 12, 214]. Inactivation of the known clock components Bmal1
and Clock suppress the diurnal variation in glucose and triglycerides [300, 1, 286]. However,
we observed that the feeding regimen could partially restore some of these rhythms and
counteract deleterious effect of the knockout. In the night restricted feeding Gilardi et al.
reported that the glucose and insulin levels were close to normal [111], but in our analysis,
we found that key enzymes of the glycolysis/gluconeogenesis had decreased amplitudes, and
their phases were quite impacted by the Bmal1 knockout. This almost normal glucose levels
might by explained by CREB and FOXO1 signaling as these regulators are still oscillating in
the impaired-clock genotype. Indeed, thanks to our linear model we observed that these two
89
Chapter 3. Discussion
regulators still depict an important activity in Bmal1−/− mice and we conﬁrmed by western
blot that the phosphorylation of CREB at the serine 133 is still rhythmic with a non-signiﬁcant
delay of two hours.
In addition we observed that circulating free fatty acids and β-hydroxybutyrate depict a
higher concentration in blood in Bmal1−/− mice. Moreover β-hydroxybutyrate concentration
increase during the fasting phase suggesting increased FFA oxidation and ketoacidosis, leading
to reduced mitochondrial redox state [329]. The elevated circulating free fatty acids are
consistent with previous reports on Bmal1−/− mice [286, 300, 185]. The level of triglyceride
was slightly more elevated in Bmal1−/− and suggested a potential shift of 2h in de-novo
lipogenesis.
Despite these metabolic stress, upon night restricted feeding the Bmal1−/− mice did not
exhibit liver steatosis. In conclusion, the night restricted feeding regimen seems to counteract
deleterious effect induced by a defect of the molecular clock.
3.6 Limitations of our approach
3.6.1 Enhancer-TSS mapping
A large fraction of BMAL1 binding sites (60%) is located more than 10kb away from the nearest
TSS [273], raising questions of circadian enhancers effect on transcriptional regulation. Inter-
estingly, recent RNA-sequencing experiments revealed the presence of thousands of circadian
enhancer-RNAs (eRNAs) in mouse liver [95]. As is often done in similar studies, candidate en-
hancers are assigned to target promoters according to genomic proximity. However, physical
distance (measured in 3D) would be functionally more relevant.
An important issue in genomics is to ﬁnd which enhancer regulates which promoter. In-
deed there is a "many-to-many" relationship between promoters and enhancers. Enhancers
can be associated with their target using several methods, such as nearest gene annotation
or co-variation of gene expression and enhancer-associated histone modiﬁcations dynam-
ics. However, these approaches are based on indirect evidence and are unable to detect
"long-range interactions" [92]. Chromosome conformation capture experiments, which
evaluate the frequency of cross-links between genomic regions, notably Hi-C which monitors
interactions between pairs of genomic sites genome-wide [197] could provide experimental
proofs of enhancer-promoter interaction or highlight co-regulated genes through hypothetical
"transcription factories".
Importantly, functional interactions between genomic loci, such as promoter-enhancer pairs,
mainly occur within a genomic scale typical of topologically associating domains TADs, i.e.,
dozens to hundreds of kilobases, and can be cell-type speciﬁc [142, 226, 295]. Consistently, our
analysis using the distance threshold with our penalized linear model showed that enhancers
are generally in a vicinity of 50 Kbp.
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3.6.2 Characterization of transcription factor binding sites
In mouse, about 4800 proteins are annotated with the gene ontology term "DNA binding".
On the other side, there are about 830 binding proﬁles (PWM) that have been characterized
using a high-throughput method called HT-SELEX in human [156]. In addition, the last
release of JASPAR database in 2016 contains 519 PWM for vertebrates [215]. Based on these
numbers about 15-20% of DNA-binding motifs have been characterized. Moreover, some DNA
binding proteins do not bind in a sequence speciﬁc manner [87], but they recognize open
chromatin regions (and/or histones modiﬁcation, or methylated DNA ) or speciﬁc shape of
the 3D structure of the chromatin.
In addition, ChIP-seq data set availability is quite limited in mouse liver with few dozens
of transcription factors thanks to mouse ENCODE efforts [311], and recent studies on the
transcriptional regulation of the circadian clock and the feeding-fasting cycle [171, 222, 273,
96, 95, 43, 93]. Furthermore, the data quality and the downstream analysis varies a lot between
the different labs involved in this ﬁeld. Moreover, a fraction ChIP-seq peaks frequently appear
due to indirect binding of the factor and thus doesn’t contain a DNA-binding motif [22]. Thus
ChIP-seq is an excellent high-throughput method, which allows studying the genome-wide
binding of a protein of interest, but the characterization of a DNA-binding motif using this
technique is not always straight forward.
Accordingly, our approach is limited by the knowledge of transcription factor binding sites
(PWMs). De novo motif ﬁnding cannot be applied to DNase I hypersensitivity because these
classical algorithms are not designed to ﬁnd every PWM at once. Moreover, there is an
"underdetermination" of PWMs as several proteins can bind to the same binding site.
Overall, recent efforts in the study of transcription binding sites have drastically increase our
knowledge of how proteins can bind DNA in a sequence speciﬁc manner [156]. Interestingly, a
model that combines the PWM with a DNA shape feature-based regulatory potential score has
been recently developed and improved the accuracy in detecting binding sites [347]. Another
recent strategy to improve transcription factor binding site detection is based on hidden
Markov models and called transcription factor ﬂexible models. TFFMs are ﬂexible, and can
model both position interdependence within TFBSs and variable length motifs within a single
dedicated framework [216]. A last improvement of transcription factor binding site detection
implies deep learning techniques, which offer a scalable, ﬂexible and uniﬁed computational
approach for ascertaining sequence speciﬁcities and pattern discovery from experimental
data [7].
3.7 Conclusions
At the molecular level, the relationship between the circadian cycle and nutrient response
cycle is unclear. Moreover, the role of distal regulatory elements remains elusive. Therefore, the
CycliX consortium aimed at characterizing the transcriptional programs that are implicated
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in both cycles. Thus, our study shed light on the interrelationships between the nutrient-
response cycle and the circadian clock as well as the contribution of the distal regulatory
elements to the circadian control. In addition, we investigated some aspects of the tissue-
speciﬁc regulation of the circadian cycle.
Our investigation of genome-wide DNase I hypersensitive sites (DHSs) in mouse liver led
to the discovery of 62000 accessible sites consistent with the previous reports on chromatin
accessibility [311]. In addition, 98000 footprints were detected in about 3/5 of these accessible
regions, which indicate that some of these accessible sites are potentially due to a high
transcription such as in the albumin gene. These DHSs that does not contain any footprints
and are probably not regulatory elements, despite the fact that some transcription factors
depict a weak footprint, which is difﬁcult to detect [224]. Furthermore, we observed that DHS
around TSS tend to contain more footprints, which indicates that the promoters are critical
for the control of the transcriptional regulation.
Our Study of the temporal dynamic of Pol II loadings, H3K27ac and DNase I signal at DHSs
in WT and Bmal1−/− revealed that about 10 % of the accessible sites depicted a circadian
behavior. Interestingly, this proportion is similar to the percentage of oscillating transcripts
in mouse liver [17, 188], which suggest their implication in the circadian transcriptional
regulation.
Our analysis of transcription factor binding sites using digital genomic footprinting methods
in WT and at ZT6 in Bmal1−/− showed that the chromatin accessibility was dynamically
inﬂuenced by the binding of transcription factors, as previously reported [20, 237]. In addition,
we observed that DNase I cleavage pattern reﬂected DNA binding of protein complexes such
as a BMAL1:CLOCK heterotetramer on double E-boxes. This result increases the evidence of
the functional role of these double E-boxes [273, 234].
The investigation of putative BMAL1 cooperating transcription factor and tissue-speciﬁc
factors in liver and ﬁbroblasts revealed several putative BMAL1 co-regulators such as NRF1
and ZEB1, and tissue-speciﬁc factors such as HNF4, CEBP, FOXA, and GATA1, consistently
with the promoter analysis performed by Bozek et al. [38, 39]. Our results contradict somehow
the pioneering-like function of BMAL1 proposed by Menet et al. [222]. Indeed, the circadian
clock probably requires tissue-speciﬁc pioneer factor to support tissue-speciﬁc functions.
Otherwise, the transcriptional regulation of downstream genes by the clock would be similar
in every tissues and BMAL1 would bind at the same locations.
Our study of putative circadian regulators and regulators implicated in nutrient response cycle
using a linear model approach in WT and Bmal1−/− revealed the importance of GR, FOX,
and CREB in clock impaired mice under night restricted feeding. These factors have been
already related with systemic cues that affect the liver synchronization [266, 82, 93]. Thus, we
observed a partial disorganization of transcriptional control in the absence of a peripheral
clock, which underlined the strong effect of nutritional synchronization. Besides, global Bmal1
knockouts in mice lead to important effects on metabolism and behavior that could be traced
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to dysregulation of BMAL1 target genes [273].
In this study, we accumulate some evidence of the contribution of distal regulatory element
involved in the circadian transcription regulation. Thus, we observed that about 47% of DHS
are located at more than 10 Kb from the closest active TSS. Moreover, distal DHSs up to 50
Kb improved the variance explained by our penalized linear model in WT and Bmal1−/−.
Such regulatory elements were investigated in the circadian context using maps of the activity
related chromatin mark H3K27ac [334], as well as enhancer RNAs (eRNAs) [95]. These studies
consistently identiﬁed thousands of putative enhancers with a broad range of peak activity
times, and were associated with distinct DNA regulatory motifs and TF binding patterns.
Finally, our inspection of diurnal biological processes such as lipid and sugar metabolism and
their regulation in WT and Bmal1−/− conﬁrmed the implication of SREBP, ChREB, CREB and
FOX in these processes, as previously suggested. [111, 93, 240].
3.8 Perspectives
3.8.1 Beneﬁts of chrono-nutrition and chrono-therapy
A diurnal rhythm of eating-fasting promotes health [112]. In addition, it was recently demon-
strated that the restricted feeding regimen can compensate the effect of high-fat diet in mouse
[130]. In our results, we observed that in BMAL1 knockout upon night restricted feeding, a
large part of the transcriptome still depict diurnal variations, and we did not observe pre-
viously reported hepatic steatosis [300, 324]. Overall, Well-regulated eating habits actively
contribute to better lipid metabolism, even if animals ingest a high-fat diet. Recent ﬁndings
show that time-restricted feeding during the active phase ampliﬁes circadian clocks and
decrease metabolic disorders induced by a high-fat diet without caloric reduction, whereas
irregular food intake causes various metabolic dysfunctions. Such evidence from nutritional
studies that consider circadian system (chrononutrition) has rapidly accumulated. Further-
more, in the near future, chrononutrition might eventually be used as a new tool in medical
protocols to treat metabolic syndrome or diabetes.
Epidemics ofmetabolic diseases (e.g., cardiovascular diseases, type 2 diabetes, obesity,metabolic
syndrome and certain cancers) have become major contributors to the cost of poor health,
and they are presently accelerating, in most developing countries. In addition, light at night
(or light pollution) disrupt circadian rhythms and is commonly referred to chronodisruption.
These chronodisruption might impact the hormonal signaling. Numerous hormones depict
circadian regulation that signiﬁcantly impact physiology and pharmacology [69]. Melatonin,
a circadian hormone of the pineal gland, inﬂuences various aspects of retinal [322] and
cardiovascular [81] function and affects local clocks in diverse brain regions [126]. Mela-
tonin rhythmicity has important roles in a variety of metabolic functions as an anti-oxidant,
anti-inﬂammatory chronobiotic and possibly as an epigenetic regulator [174].
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Circadian regulation of the adrenal gland leads to diurnal secretion of glucocorticoid hormone,
which impact metabolism and directly affects 60% of the liver transcriptome [266]. Circadian
control of gastrin, ghrelin, and somatostatin, along with direct regulation by autonomous
clocks within the gastrointestinal tract, enable circadian inﬂuences on digestive function [173]
Current research highlights that circadian clocks in peripheral tissue can respond to different
cues and thereby show different phase relationships. Thus, full prediction of chronophar-
macology in pathological contexts will probably require a systems biology approach that
considers chronointeractions among the various clock-regulated systems [69].
In most cases, autonomous circadian clocks not only within the gastrointestinal tract but
also in various other tissues have signiﬁcant impact on physiology and metabolism. For
instance, ablation of clocks in pancreatic islets leads to diabetes due to defects in the coupling
of β cell stimulus to insulin secretion [214], and tissue-speciﬁc targets of the clock includes
multiple ion channels and kinases in the heart that inﬂuence cardiac function and triglyceride
metabolism [169, 323] . Recent transcriptome studies have identiﬁed widespread tissue-
speciﬁc circadian regulation not only in heart but also in skeletal muscle and fat, indicating
that clocks in these tissues directly regulate physiology [40].
Considering the broad scope of circadian (patho)physiology, it is logical that the pharmacoki-
netics and pharmacodynamics of many drugs would be circadian and thus that drug efﬁcacy
and safety proﬁles would also change with time of day. Nevertheless, this variation is poorly
considered by clinicians, drug developers, and regulators. In part, this lack of interest arises
from a lack of awareness of the molecular mechanisms underlying this control. However, two
decades of intensive research have revealed - not only basic mechanisms of circadian clocks
but also about how these mechanisms impact physiology and disease [69].
3.9 More circadian layers of regulation in cells
In addition to circadian transcription, recent research has revealed extensive evidence of
circadian post-transcriptional regulation in mammals, along with translational control [157],
control of transcription termination and/or elongation [247], and circadian control of splicing
[219]. Thus, the current number of transcripts exhibiting circadian abundance is signiﬁcantly
greater than the number of genes transcribed in a circadian manner [171, 188, 223], and the
number of proteins that are expressed in a circadian manner is greater than the number of
transcripts [265]. Major signaling molecules such as cAMP show circadian variations that both
control clock output and play a role within the clock [243], and recent links between clocks
and sirtuins suggest a similar inﬂuence of redox potential [16]. Furthermore, a signiﬁcant
fraction of histone posttranslational modiﬁcations varies in a circadian fashion at a large
number of loci [171, 188]. Overall, through a collection of different mechanisms, a signiﬁcant
amount of cellular physiology is regulated by the circadian clock. However, additional reg-
ulations, such as the rhythmic degradation of intermediate products, can further modulate
gene expression, e.g., by adjusting the amplitude or shifting the phase of the driving rhythm
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[209]. For instance, MiR-122 is important for the hepatic circadian functions and targets genes
involved in cholesterol and lipid metabolism [106]. Using an inducible DICER knock out,
an recent study assessed the global contribution of miRNAs to circadian gene expression in
mouse liver [83]. Although a non-negligible fraction of circadian transcripts was affected
by miRNAs, this study emphasized the resilience of the circadian clock to perturbations in
miRNA biogenesis. Furthermore, in cultured mouse cells, the temperature entrainment of the
clock was shown to involve post-transcriptional mechanisms. Notably, the Cold-Inducible
RNA-binding protein (CIRBP), possibly by binding to transcripts encoding circadian oscillator
proteins, such as Clock [230]. Interestingly, CIRBP and RBM3, another RNA-binding protein,
guide the choice of polyadenylation sites of target transcripts in a circadian manner [201].
Nevertheless, underlying mechanisms are still poorly understood, and further efforts are
needed to appreciate better the various mechanisms controlling circadian gene expression at
multiple levels.
3.9.1 Emerging trends in functional -omics and in (chrono)biology
Fundamental research
In the post-genomic era, the circadian transcription has been systematically studied using
various experimental design, such as inverted feeding, night restricted feeding, in light-dark
(LD) or dark-dark (DD) conditions. Moreover, the availability of several mouse strain with
a defect of several core clock genes enabled the investigation of different component of
the core clock [210]. The technological improvement concerning sequencing technologies
[307] as well as mass spectrometry [9] have allowed the study of the circadian cycle with an
unprecedented throughput. Today it possible to study the whole transcriptome, as well as
a large fraction of the proteome [218] or the lipidome [1] and the metabolome in a single
experiment. In addition, transcription factor binding sites or regulatory elements , as well
as binding sites of RNA binding proteins on mRNA can be systematically investigated [53].
These experiments are a valuable source of information to understand the molecular changes
during the diurnal cycle. Cutting edge research are currently deciphering tissue or cell types
speciﬁcities [355], as well as the sub-cellular level with targeted researches on the nuclear
proteome and lipidome or in organelles such as the mitochondrial lipidome [19]. A general
trend in biology is the shift towards single cell analysis in order to study the heterogeneity of
the gene/proteins expression in a cell population or tissue. For instance, new methods allow
the investigation of mRNA [344] and chromatin accessibility [42] in single cells. Interestingly,
novel methods of microscopy allow the study of single molecules in a living cell [183]. These
techniques are critical to study biological processes such as transcription in a quantitative
manner even with "near endogenous" conditions.
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Translational research
Last but not least, the heterogeneity in a population of individuals in terms of genome se-
quences with, for instance, single nucleotide polymorphisms (SNP), might be another source
of useful information in order to associate amacroscopic phenotype tomolecularmechanisms
[63]. Recent efforts of Biobanks in terms of human sample and research agreement collection
[229] will enable population-scale analysis such as the 1000 genome project [18]. However,
the genome sequence, it-self, is not sufﬁcient and should be integrated with other data types
such as activity, medical records (diseases, response to medication) or behavior, as well as
other molecular data types (epigenetics, transcriptomics, metabolomics) in order to pave the
way for personalized medicine.
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4.1 Experimental design, protocols and data set quality control
The experimental design and the bench work was done by the Cyclix Consortium. More
precisely Nouria Hernandez Mauro Delorenzi, Bart Deplancke, Béatrice Desvergne, Nicolas
Guex, Winship Herr, Felix Naef, Jacques Rougemont and Ueli Schibler designed the experi-
ments and supervised the whole Cyclix project. The animal breeding, the conditioning and
the collections of biological material were performed by Teemu Andersin, Pascal Cousin,
Federica Gilardi, Pascal Gos, Gwendal Le Martelot and Fabienne Lammers.The chromatin
immunoprecipitations,the libraries preparation and the gene expression arrays were done by
Donatella Canella, Federica Gilardi and Sunil Raghav.
The bioinformatics analysis was mainly a collaboration between Irina Krier, and me. This
work was supervised by Felix Naef and Bart Deplancke, with the help of Jacques Rougemont.
Animals breeding and liver sample preparation
C57BL6 and Bmal1−/− male mice 12–14 weeks old (at time of sacriﬁce) were housed in a 12 h
light/12 h dark (LD) regimen. They were then entrained to a 12 h/12 h LD regimen with water
ad libitum but food access only between ZT12 and ZT24 for Pol II ChIP-seq and H3K27ac
ChIP-seq and microarray for 7 d (ZT, Zeitgeber time; ZT0 is deﬁned as the time when the
lights are turned on and ZT12 as the time when lights are turned off) for 7 days before the
sacriﬁce. Mice used for DNase I-seq were entrained to a 12 h/12 h LD regimen with water
and food ad libitum. At each ZT2, ZT06, ZT10, ZT14, ZT18, ZT22, and ZT26, 3-5 mice were
anesthetized with isoﬂurane and decapitated. The livers were perfused with 2 ml of PBS
through the spleen and immediately collected. A small piece of liver tissue (approx. 100 mg)
was snap-frozen in liquid nitrogen and kept at 80◦C for RNA extraction. The remaining liver
tissue was immediately homogenized in PBS containing 1% formaldehyde for chromatin
preparation. All animal care and handling was performed according to the State of Geneva’s
law for animal protection.
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Chromatin immuno-precipitation of RNA Polymerase II followed by sequencing
Perfused livers were processed for chromatin preparation as described in [277]. The chro-
matin samples from the ﬁve mice were then pooled, frozen in liquid nitrogen, and stored at
80◦C . For the ChIP experiments, the following antibodies were used: anti-RPB2 (Santa Cruz
Biotechnology, sc-673-18), anti-H3K4me3 (Abcam, ab8580), and anti-H3K36me3 (Abcam,
ab9050). To determine the optimal amounts of each antibody, we performed pilot ChIP assays
and determined the enrichment for a set of promoters by real-time qPCR according to [277].
A total of 1 ml of each chromatin suspension (containing about 60 μg of DNA) was incubated
with 10 μg of anti-RPB2, 1.5 μg of anti-H3K36me3, or 1.5 μg of anti-H3K4me3 in buffer A (20
mM Tris/HCl (pH 7.5), 150 mM NaCl, 2 mM EDTA) overnight at 4◦C on a rotating wheel. Ten
μl of protein A bead suspension (25% slurry in buffer A), pre-blocked with 10 μg/ml of salmon
sperm DNA and BSA at 4◦C overnight, was then added and the incubation was continued
for 1 h at room temperature on a rotating wheel. The beads were then washed with dialysis
buffer and ChIP wash buffer as described in [239]. Protein–DNA complexes were eluted from
the beads, de-cross-linked, and treated with RNase A and, subsequently, with proteinase K,
as described in [277]. The DNA concentration was determined by ﬂuorometry on the Qubit
system (Invitrogen). A total of 10–12 ng DNA were used for the preparation of the library.
Libraries for ultra-high throughput sequencing were prepared with the ChIP-Seq DNA sample
kit (Illumina) as recommended by the manufacturer.
Chromatin immuno-precipitation of Histone 3 lysine 27 acetylated followed by sequenc-
ing
ChIPs were performed according to the method described by [267] with a few modiﬁcations.
The 100 μL chromatin aliquots was used for each IP and diluted with 900 μl of RIPA buffer
(1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS in PBS at pH 7.4) and added to dynal mag-
netic beads conjugated with (Sheep-antimouse IgG dynabeads, Invitrogen, Cat no: 110-31)
pre-treated with 3 μl of polyclonal antibody for H3K27ac (Active motif, Cat no: 39135) for
immunoprecipitation of speciﬁc complexes. The samples were incubated overnight at 4◦C on
rotator, then magnetic beads washed 7 times with lithiumchloride wash buffer (100mM Tris
at pH 7.5, 500mM LiCl, 1%NP-40 and 1%sodiumdeoxycholate) and ﬁnally once with 1X TE
buffer (10mM Tris-HCl at pH 7.5, 0.1mM Na2EDTA). The chromatin complex was eluted using
elution buffer (1% SDS, 0.1MNaHCO3) for 1 h at 65◦C using eppendorf thermo-mixer. The
chromatin was then de-crosslinked overnight at 65◦C and ChIP DNA puriﬁed using Qiagen
PCR puriﬁcation kit and eluted in 50 μl of elution buffer. For qPCR reaction 1.5 μl of 1/10
diluted ChIP DNA is used. Libraries for ultra-high throughput sequencing were prepared with
the ChIP-Seq DNA sample kit (Illumina) as recommended by the manufacturer.
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DNAse I-seq
Mouse liver nuclei were prepared as described in [321]. Freshly prepared nuclei were sus-
pended in ice-cold ψ-buffer (11 mM KPO4 pH 7.4, 108 mM KCl, 22 mM NaCl, 5mM MgCl,
1 mM CaCl2, 1 mM DTT) and pelleted. 5x106 nuclei were suspended in 200 μl of ψ-buffer
supplemented with 0.2% of NP40 and 1 μ/ml of DNase I (DPFF Worthington Biochemical
Corporation). DNase I digestion was performed for 6 minutes in room temperature and the
reaction was stopped by adding 200 μ l of lysis buffer (50mM Tris-HCl pH 8, 20 mM EDTA, 1%
SDS, 200 μg/ml proteinaseK). Protease digestion was performed overnight at 55◦C . RNaseA
(100 μg/ml) was then added and samples were incubated at 37◦C for an hour. DNA was then
extracted twice with phenol-chloroform and precipitated with isopropanol in the presence of
0.5 M NaCl. DNAs were dissolved in 5 mM Tris-HCl pH 8.DNAs from 4 animals were pooled
and 75 μg of DNA was loaded on 11 ml 10%-50% sucrose gradient in STE buffer (1M NaCl,
20 mM Tris-HCl pH 8, 5 mM EDTA) and centrifuged at 30000 rpm for 16 hours at 20◦C (SW
40 Ti rotor, Beckman Coulter Inc). The sucrose gradients were then fractionated and DNA
was precipitated by two volumes of ethanol in the presence of 5 μg of glycogen. Fractions
containing DNA sized around 300bp were pooled and used for Illumina library preparation.
Quality control (QC)
Sequenced reads alignments, from our illumina libraries to mouse genome (mm9 assembly),
were performed using HTSstation [72]. This web interface enables sequencing and mapping
quality control through automatic generation of reports. The alignment software used in the
HTSstation pipeline is Bowtie, with default parameters [186]. After mapping, the number of
reads that were obtained for each sample is indicated in table 4.1. Every sample used, had
more than 70% of mapped reads (see Table 4.1).
Most of the CycliX libraries were single-end sequencing. But in few cases paired-end sequenc-
ing was used, it was processed as paired-end reads, but later quantiﬁed as single-end reads,
i.e. only the beginning of a read was used.
The Fastqc quality control report (used in HTSstation pipeline) was decent for all libraries
produced in this project, although heterogeneity in proportions of duplicated reads was
observed, especially for the H3K27ac ChIP-seq in Bmal1−/− genotype.
For high depth libraries (with more than 100 million reads), it is expected that stacking of reads
will occur independently from PCR-ampliﬁcation bias. This is in particular the case for DNase
I data, where the enzyme cleavage site determines the mapped read start and is expected to
occur preferentially at the edge of a transcription factor binding site. Cleavage efﬁciency by
the enzyme determines the read depth at these positions and constitutes the signal which we
would like to measure. Therefore, we did not apply methods to remove stacked reads. Multiply
mapping reads with more than 5 mapping positions were discarded. For quantiﬁcation, reads
with N alignments were counted as 1/N reads mapping at each position. The sequencing
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libraries used in this project were large, containing each between 100 million and 200 million
reads (see Table 4.1).
We therefore used a binary format conversion to save time for follow up computations, de-
veloped by Nicolas Guex for the CycliX consortium along with a tool for quantifying signal at
genomic locations of interest. This tool enables fast computing, thanks to Vital-it Cluster in-
frastructure, by using efﬁciently the large memory capability of the cluster and by loading each
chromosome at once. Binary ﬁles were generated using only the 5’end of reads corresponding
to the DNase I digestion position or the break induced by sonication for ChIP-seq. BigWig ﬁles
were subsequently generated using the HTSstation [72] with centering parameters computed
from forward strand versus reverse strand cross-correlation maximization on ENSEMBL67
TSS for each ChIP-seq sample separately.
In order to control and compare the quality of the DNase I time points we used the percentage
of reads in the enriched regions (called Percentage of Tags in Hot-spots, PTIH) [155]. This
control is done after the peak calling. The PTIH is simply the number of reads in peaks divided
by the number of reads that were mapped to the genome.
These quantiﬁcation are reported in table 4.2. Brieﬂy, we observed that ZT02 was of lower
quality compared to the other DNase I samples.
Several other web-interface, have been recently developed to perform quality controls, quan-
tiﬁcation and analysis of high-throughput data, as Galaxy [2], Chipster [161] or the ChIP-seq
server from the Computational Cancer Group at EPFL [10]. I was able to test as well some
open access command line tools, and R or python libraries to perform these quantiﬁcations
quite efﬁciently, notably with NGSplot [202].
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Table 4.1 – the number of reads in each sample and the number of mapped reads on the mm9
assembly are reported.
Library Number reads Numbers mapped %mapped
DNase I WT
ZT2 249350929 174147376 70
ZT6 317274205 252864063 80
ZT10 269194001 210684885 78
ZT14 204984161 159264085 78
ZT18 194932779 146829749 75
ZT22 191842671 167303697 87
ZT26 190983184 161216246 84
Pol2WT
ZT2 220172973 203597437 92
ZT6 189640820 168723064 89
ZT10 162253851 145450110 90
ZT14 196057079 176252350 90
ZT18 254879645 234013533 92
ZT22 142117355 122741922 86
ZT26 191096558 168972009 88
H3K27acWT
ZT2 552441072 476877194 86
ZT6 569270357 496184118 87
ZT10 586341426 515957037 88
ZT14 461236082 371945828 81
ZT18 568258389 492287638 87
ZT22 535729511 466984801 87
ZT26 407807224 344924054 85
Pol2 Baml1 KO
ZT2 509081190 442613199 87
ZT6 456861768 379886582 83
ZT10 615333770 560876871 91
ZT14 538202935 492830944 92
ZT18 567313327 518551916 91
ZT22 567987125 506596171 89
ZT26 605314961 424032099 70
H3K27ac Baml1KO
ZT2 208280807 158653084 76
ZT6 207101049 155183877 75
ZT10 208889844 166330282 80
ZT14 251404424 186223464 74
ZT18 206733328 166182481 80
ZT22 208941050 160127444 77
ZT26 173757120 134496020 77
DNase I Baml1-
ZT6 287086306 206398188 71
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Table 4.2 – the percentage of tags mapped in the mm9 genome that are enriched in peaks (see
peak calling section).
DNase Quality Control
Sample Percentage of tag in DHS
DNase I WT ZT2 29
DNase I WT ZT6 38
DNase I WT ZT10 57
DNase I WT ZT14 50
DNase I WT ZT18 54
DNase I WT ZT22 58
DNase I WT ZT26 46
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4.2 Peak calling optimization
State of the art
Peak calling is a critical step in the processing of ChIP-seq or DNase I-seq data. Its role is
to determine respectively the actual binding sites or accessible sites from sequenced DNA
fragments mapped onto a reference genome sequence [193, 21, 285, 315]. In ChIP-seq or
DNase I-seq experiments, only reads with a single matching locus on the genome are taken
into account. The positions of mapped reads are subsequently used as input for peak-calling
algorithms, which predict protein binding sites or accessible sites in DNase I-seq. The main
difﬁculty of peak calling is to determine the signiﬁcance of peaks. Due to a high variability in
the background distribution of reads and the relatively small amount of enriched DNA, one
strategy consists of modeling the background distribution statistically and searching the data
set for local deviations from this distribution. Several models describing reads densities in
the background have been considered including the Poisson distribution [357], the Negative
Binomial distribution [152] and Hidden Markov Models [309].
A current approach used to determine background distributions of reads, is to work with mock
immuno-precipitation, notably using a non-speciﬁc antibody or without antibody as a control
[164]. In this input DNA or control data there is no enriched binding fragments. These controls
can be used to empirically estimate false discovery rates of the real ChIP data [345].
Another important point is to exclude ’non-mappable’ regions, i.e short subsequences oc-
curring multiple times in the genome or regions containing copy number variants (CNV).
These regions may be artiﬁcial source of read densities [328]. A last point for the peak-calling
is to consider the wideness of the considered protein. For instance the shape of peaks for a
transcription factor or DNase I accessible sites can be of few hundreds of base pairs, and in the
other side the shape of peaks of histones modiﬁcation might be much larger [21]. Recent ap-
proaches imply deconvolution of overlapping peaks or modeling of peak shape and estimation
of peak parameters using an Expectation–Maximization algorithm [356, 221, 273]. A number
of recent reviews focus on ChIP-seq technology, applications and software, and several studies
worked on benchmarking the peak calling by producing gold standard ChIP-seq samples used
to compare different algorithms and software [287, 315, 125].
This study
In our study, we started with the mapping of DNAse I reads to the mm9 mouse assembly and
we merged all time points together before doing the peak calling. Then, we compared several
peak-calling tools as [357], HOMER [135], ChIP-Peak and ChIP-Part [10]. Each of these
tools was performing well with some adjustments of their parameters, but we decided to use
ChIP-Peak because we could separate efﬁciently single peaks of DNase I signal with a speciﬁed
peak width and an exclusion parameter called vicinity instead of calling large hypersensitive
regions. We found that the optimal parameter was to use a 600 bp peak width and a vicinity of
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400bp. Overall, we detected 62000 peaks in WT (C57BL6) mouse liver, which covers 1.2 % of
the mouse genome.
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Figure 4.1 – Peak calling strategy for DNase I data: A) ChIP-peak, ChIP-Part, HOMER and
MACS peak calling on DNase I-seq signal, B) parameter optimization of ChIP-Peak, C) Average
normalized DNase I signal on 62000 DHS
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4.3 Signal normalization
State of the art
The normalization is a critical step in DNase I-seq or ChIP-seq or any NGS data analysis.
Several methods have been used in recent studies, as scaling to total amounts of reads (i.e.,
normalizing for sequencing depth), quantile normalization or locally weighted regression
(LOcally WEighted Scatterplot Smoothing ,LOESS) normalization [188, 233, 195, 317, 171]. A
variation of the scaling to total amounts of reads where a scale factor is estimated in a region
( 10 Kb) using a linear regression was applied in several ChIP-seq studies and are improving
peak calling (see peak-calling section). Quantile and LOESS normalization are based on
the assumption that the effect of biological condition change does not cause global binding
alterations. This assumption might be not valid, when comparing samples with different
stages of disease progression, or on samples before and after a certain treatment.
Another scaling normalization method is widely used in RNA-seq data analysis. This method
is known as RPKM (Reads per Kilobase of sequence range per Million mapped reads). RPKM
adjusts for biases due to the higher probability of reads falling into longer regions. The
intended meaning of RPKM is a measure of relative molar RNA concentration (rmc) and [335]
showed that for each set of transcripts the average rmc is a constant, namely the inverse of the
number of transcripts mapped. A correction of the RPKM normalisation called transcripts
per million (TPM) respects the average invariance and eliminates statistical biases inherent in
the RPKM measure. Several other normalization methods have been proposed for RNA-seq
data analysis, as upper-quartile-normalized counts or Trimmed Mean of M values (TMM),
and these methods have been compared in a comprehensive study [78]. The main conclusion
of this study is that RPKM performed poorly compared to these other methods. Normalization
issues might have a substantial impact on the results and therefore should be addressed
carefully [78, 335].
More recently the CycliX consortium, and other groups tested a spike adjustment procedure
(SAP) designed to allow comparison of occupancy levels for a set of loci of interest [245, 34].
It consists of adding a constant, low amount of a single batch of foreign chromatin (e.g.,
human) as an internal control to each sample of the chromatin of interest (e.g., mouse) before
immunoprecipitation. This allows adjustment of the signals in each sample to the internal
control. The CycliX consortium showed that unlike only scaling to the total amount of aligned
sequence tags or quantile normalization, the SAP allowed the scoring of global and largely
uniform changes when they result from biological differences [34]. Nevertheless, the behavior
of spike-ins during library preparation is essential before applying any normalization method
that makes use of them [279].
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This study
In this project, we used a quantile normalization on DHSs (+/-300 bp around DHS center,
for DNase I and Pol II signal, and +/-1Kbp for H3K27ac). We applied the same procedure at
TSSs (+/- 1Kbp). Finally, in the case of the micro-array data, we used a standard micro-array
normalization procedure, namely the robust multi-array average (RMA) normalization [150].
4.4 Assessment of oscillatory signal
State of the art
Identiﬁcation of rhythmic features such as genes or regulatory elements is a decisive stage
to identify clock-controlled pathways and processes. Such features are largely detected by
searching periodic patterns in any types of data. For example, a lot of studies have been
performed using microarrays, RNA-seq or ChIP-seq data [171, 333, 334, 143, 95, 355].
In our case we were interested to detect these oscillating features using DNase I-seq, histone 3
lysine 27 acetylated (H3K27ac) and polymerase II (Pol II) ChIP-seq. In order to detect these
features several methods have been recently developed, such as COSOPT [143], ARSER [348],
JTK-cycle [145], Fisher G-test [99], RAIN [318] and linear regression based methods. These
methods are able to perform quite well on large data-sets with low sampling frequency and few
or no replicates and high levels of noise. Several study compared these different methods and
enhanced them in order to detect asymmetric patterns,non-sinusoidal periodic waveforms,
or to cope with missing values [147, 318].
This study
In this project we had a sampling of 7 time points with a 4 hour resolution on a single cycle
(ZT02-ZT26) that did not provide a high statistical power. On the other hand, we had several
marks probed on the same animals and 3 mice pooled per time points. Therefore we applied a
harmonic regression on Log2 transformed signal at DHSs or at TSSs, and we did not consider
asymmetric or non sinusoidal waveforms.
Equation 4.1 was used to perform least squared ﬁt of temporal proﬁles yt .
yt = A0+ A1 cos(ωt )+ A2 sin(ωt )+ (4.1)
where A0, A1, A2 are regression coefﬁcients and  is white noise.
ω= 2πτ is the frequency and we take a diurnal period τ= 24h.
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Once we compute the three coefﬁcients using the standard linear regression (lm function in
R), we can compute the phase φ, amplitude A24 by writing:
A1 cos(ωt )+ A2 sin(ωt )= A24 cos
(
ωt −φ) (4.2)
with
⎧⎨
⎩
A24 = 2
√
A21+ A22
φ= tan−1
(
A2
A1
) (4.3)
We then computed the p-value of the ﬁt using a F-test. The p-value associated with 24h
rhythmic proﬁles was computed for each DHS and for each mark. The Fisher combined
probability of Pol II, H3K27ac and DNase I was computed to select rhythmic DHSs. Speciﬁcally,
we computed the p-values for each of those k = 3marks and combined themusing the statistics,
which assumes a Chi-squared distribution with 2k degrees of freedom [177].
−2
k∑
i=1
ln
(
pi
)∼χ22k (4.4)
The resulting combined p-value was used to estimate False Discovery Rates (FDR) via the
linear step-up method using the Benjamini-Hochberg method in R [31].
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4.5 Motif analysis in DNase I hypersensitive sites
State of the art
Motifs analyses are frequently done after ChIP-seq experiments [21]. In the usual pipeline
there is a ﬁrst mapping of the reads to a reference genome followed by a peak calling (see peak
calling methods section 4.2). Then the sequences of these peak locations are retrieved and
used to ﬁnd enriched motifs or position weight matrix (PWM) [77]. There are two general
philosophy of ﬁnding motifs. The ﬁrst one uses de novo motif ﬁnding algorithms, such as
RSAT or MEME [319, 23], followed by motif comparisons (TOMTOM) [121] with PWMs from
databases, as Jaspar or Transfac, to identify known and unknown motifs [258, 217]. In the
second one, we can directly scan the sequences with PWM database. PWMs scanning tools,
such as FIMO, use a log-likelihood ratio score and a p-value threshold in order to ﬁnd positive
matches of PWMs in the given sequences [114].
Another common way to scan a sequence for a given set of motifs is to use a HMM as with the
MCAST motif scanning tool from MEME Suite [115].
This study
In this project we tested the two options (de novo motif ﬁnding or motif scanning) but we
ﬁnally decided to use only known motifs from databases and a straightforward motifs scan of
our 65000 peak sequences of 600bp deﬁned by our peak calling. We made this choice because
these de novo motifs ﬁnding tools can produce a lot of false positive especially in DNase I-seq
data, as accessible sites sequences are not only enriched for a single transcription factor but
for all DNA binding proteins that are expressed in the considered sample. Moreover, it is quite
difﬁcult to use unknown motifs for any interpretation without experimental validation.
In order to determine the right threshold parameter for our motif scans we did a stratiﬁcation
of the FIMO DNA motif match p-value on 3306 sequences of DHS that are oscillating for
DNase I signal in WT mice in ﬁgure 4.2. We tried several PWM related to the circadian rhythm
as E-box (CLOCKBMAL), and D-box (VBP). As expected in these oscillating accessible regions,
we had a high proportion of match for these motifs. We found that the number of match is
increasing exponentially with the p-value threshold, and we concluded from this optimization
that the threshold of FIMO p-value below 10−4 gave a reasonable amount of match with a
well-conserved motif and a visible raw footprint in DNase I signal in an average plot centered
around our motif matches. In summary we used a stringent threshold in order to favor
speciﬁcity over sensitivity and thus avoid false positives.
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Figure 4.2 – FIMO threshold stratiﬁcation for CLOCK/BMAL and VBP motifs in 3306 circadian
DHSs
4.6 DNase I-seq footprint detection
Analysis of digital genomic footprinting data can be separated roughly into two categories,
namely TFBS motif-centric and footprint-centric approaches.The ﬁrst category attempt to
quantify TF binding at deﬁned genomic locations, whereas the second category focus on de
novo detection and annotation of DNase I footprints [331]. Moreover, a pending question of
the DNase I cleavage rate bias is still debated in the literature (see section 4.6.3). Following
sub-sections will explain the different methods, as well as the one that we used in this project.
Finally, I will highlight the current controversy about the DNAse I cutting bias and brieﬂy
present the results of a comparative study of DNAse I footprint detection methods.
4.6.1 TFBS motif-centric approach
State of the art
Genomic match to position weight matrices for hundreds of TFs can be generated readily
with algorithms such as FIMO [114] in DNase I hypersensitives sites (see motif analysis sec-
tion 4.5). TF binding at these recognition sites can be quantiﬁed under the assumption that
occupied sequence speciﬁc TFBS have signiﬁcant different cleavage pattern than expected.
This strategy is quite efﬁcient because using PWM motif match as a prior provide the location
and the expected width of the of the TF-DNA interaction. Thanks to these information pro-
vided, a common strategy is to explicitly model the per-nucleotide cleavage pattern around
PWM match for a given TF and use machine-learning approaches for classiﬁcation such as
in CENTIPEDE method. This method models bound and unbound cleavage pattern using
multinomial distributions containing parameters for each nucleotide in the window surround-
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ing the motif [257].The learning strategy used by CENTIPEDE is representative of a broad
class of unsupervised methods for DNase I footprint analysis that perform model parameter
optimization and classiﬁcation simultaneously and directly using the observed data.On the
other side, supervised learning methods have been developed, such as FLR and BinDNase
[350, 184]. They require positive and negative labeled training data (based on, for example,
ChIP-seq peaks or other occupancy measures) to ﬁt model parameters that are subsequently
used for the discrimination of TF recognition sequences of unknown binding status. ChIP-seq
can be used to determine the genomic binding of a deﬁned TF, but it cannot discriminate
direct DNA binding from indirect binding. The combination of motif match and ChIP-sec
overlap might be the most performing strategy to highlight genomic footprinting data by
resolving the assignment of speciﬁc TFs to footprints in cases where distinct TFs utilize highly
similar binding sites. However, the high frequency of likely indirect binding observed with
most TFs, combined with a propensity for artifactual enrichment at highly active loci and poor
reﬂection of binding kinetics, precludes ChIP-seq from serving as a true gold standard for the
evaluation of footprinting data [331]. An other important limitation of this approach is the
the fact that current PWM databases are not complete and a lot of TF consensus recognition
sites have not been characterized.
This study
In our study we developed a mixture model that was able to optimize the footprint width
around themotif and subsequently predict bound or unbound sites (see Appendix A.1). For the
unboundmodel, we expressed the likelihood of themeasured cuts as a product of independent
Poisson variables with a common mean. On the other side, for the bound model we made the
simplifying assumption that the shape of a footprint can be approximated by a rectangular
shape, showing on average less counts in the protected regions. Therefore, we assumed two
distinct means for unprotected, and for protected sites, representing the average number
of cuts outside, and inside the footprinted region. We formulated the mixture model by
introducing a global probability (that had to be estimated) to be in the bound state. We could
then marginalize over this global probability to obtain the likelihood of the whole data with
respect to the boundaries. Finally, once we found the optimal boundaries we could estimate
the optimal global probability and also assign posterior probabilities to each region for each
of the two models. We used DNase I hypersensitive sites and overlapped by ChIP-seq peaks
(of BMAL1 in this case) in ﬁgure 4.3 containing a well conserved TFBS (FIMO PWM match
p-value < 10−4) of interest.
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Figure 4.3 – Digital genomic footprinting methods: our method consists of analyzing DNase
I tags around a motif of interest (overlapped by some ChIP-seq signal if available), in this
case BMAL1/CLOCK E-box motif in DNase I hypersensitive regions. The basic idea is to ﬁnd
regions where read counts are depleted in the center region compared to the ﬂanking regions.
We developed a method that maximize the number of bound sites by adjusting the width of
the core footprint using a mixture model.
This method was successfully used on several example in the result section 2.1.5. Moreover,
we were able to detect a change in shape around double E-box motifs with a spacer of 6-
7 bp overlapped by BMAL1 ChIP-seq that suggested a hetero-tetramer binding mode of
BMAL1/CLOCK at these sites. This method can be used to study the kinetic of binding on
DNA of other protein complexes in the future.
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4.6.2 De novo detection of footprint from DNase I signal
State of the art
In the past four years, several algorithms for de novo detection of DNase I footprints have been
published. Amain difﬁculty of de novo footprint detection is that the basic parameters deﬁning
a TF-DNA interaction are unknown a priori and must be learned simultaneously with the
footprint detection process [331]. Several strategies make use of a sliding window approach
for comparing observed cleavage rates in a central region to those within the adjacent ﬂanking
sequences and frequently work with parameters, such as footprint and ﬂanking-sequence
widths, which are entirely speciﬁed during the detection process and parsimoniously selected.
In ﬁgure 4.4,the Wellington algorithm is based on a similar windowing strategy, enhanced by
incorporating information on DNA strands and scores the central window. Wellington perform
a binomial test using the cleavage rate within the ﬂanking windows as the expected cleavage
rate [256]. Additional methods are now available that make use of probabilistic frameworks
such as hidden Markov models (HINT,Boyle) [36, 123] and dynamic Bayesian networks (DBFP)
[57] to model per-nucleotide cleavage data.
This study
In our DNase hypersensitive sites footprints detection we worked with the Wellington al-
gorithm (pyDNase library) [256] with parameters: -sh 20,36,5 -fdr 0.05 on all DNase
samples concatenated. The DHS containing at least one footprint were subsequently used for
our motif activity inference using a penalized linear model (see section 4.7).
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Figure 4.4 – Digital genomic footprinting signal centric method: the Wellington algorithm uses
a triple sliding widows to ﬁnd bound regions, taking into account the forward and the reverse
strand reads asymmetry during the footprint detection [256]. The DNase I hypesensitive site
is upstream Nr1d1 gene and contains two E-box motifs overlapped with BMAL1 ChIP-seq. We
observed that the Wellington score is maximal at these E-Box motifs.
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4.6.3 DNase I cutting bias
Despite great potential of detecting the majority of TFBSs in one assay, DNA sequence speciﬁc
biases, together with transcription factor dependent binding kinetics, have been recently
recognized as major confounding factors in DNase-seq experiments [314, 132]. An example is
the DNase I sequence cleavage bias, which is due to the different binding afﬁnities of DNase
I toward speciﬁc DNA sequences. These bias and artifacts are inherent to the experimental
protocols used [350]. Another experimental aspect affecting the computational analysis
of DNase-seq is the residence time of TF binding. Sung et al. showed that short-lived TFs
have a lower DNase I cleavage-protection pattern in a TF-speciﬁc manner. These inﬂuencing
factors were not considered by most of the previous methods for the analysis of chromatin
accessibility data [212]. He et al. suggested that sequence cleavage bias around TFBSs impacts
the performance of a computational footprinting method. There is room for improvement
in current methodologies by making use of the sequence speciﬁcity of each enzyme/assay,
including ATAC-seq, but there is no clear consensus in its importance for digital genomic
footprinting [212]. However, A contradictory studiy claims that this cleavage bias of the DNase
I dosn’t affect much the detection of footprints [184].
In our data (ﬁgure 4.5 and table 4.3), we observed a cleavage bias at the 5’end of the sequenced
reads with a maximal information content of 0.08 on a scale of 2 bits. the information content
of the base frequencies at that position of a motif is computed with the following formula:
Ii = 2+
∑
b
fb,i log2
(
fb,i
)
(4.5)
where fb,i indicates the frequency of base b at position i. Positions that are perfectly conserved
contain 2 bits of information, those where two of the four bases occur 50% of the time each
contain 1 bit, and positions where all four bases occur equally often contain no information
[77].
We saw that this bias is slightly different in each time points and that ZT2 and ZT26 cluster
together. We can conclude that this bias is protocol and enzyme speciﬁc, and that in the case
of a time series analysis this bias is partially time point dependent.
Finally a comparative analysis of Different digital genomic footprinting methods showed that
the methods that takes this bias into account with a 6-mers correction of the signal around
the cleavage position performed slightly better than the other methods (DNase2TF, HINT).
Interestingly, the wellington algorithm was the best performing method that didn’t applied a
bias correction [122], which conﬁrm the validity of our analysis.
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Figure 4.5 – Information Content per base pairs at the 5’end of our DNase I-seq libraries. This
analysis was done using the FastQC report of our DNase I-seq libraries and SeqLogo
Table 4.3 – DNase I cutting bias in our DNase I libraries. The frequency of the nine ﬁst positions
of our reads are displayed in %.
Dnase I library Base Position 1 Position 2 Position 3 Position 4 Position 5 Position 6 Position 7 Position 8 Position 9
ZT02 A 16.85 30.30 27.14 27.38 28.36 27.90 25.93 25.74 24.95
ZT02 C 26.80 26.36 25.02 21.05 21.66 24.47 24.62 24.22 24.98
ZT02 G 28.26 28.93 19.66 27.77 25.82 25.54 22.95 24.88 24.72
ZT02 T 28.09 14.41 28.18 23.80 24.17 22.09 26.49 25.16 25.35
ZT06 A 16.73 31.15 29.01 28.72 28.84 28.99 27.52 27.43 26.69
ZT06 C 26.74 25.93 24.14 20.44 20.56 22.81 23.09 22.81 23.29
ZT06 G 26.05 28.02 19.21 25.33 24.77 23.84 22.23 23.26 23.41
ZT06 T 30.48 14.90 27.65 25.51 25.83 24.35 27.16 26.50 26.62
ZT10 A 16.12 29.09 25.84 26.93 27.34 26.77 24.59 24.27 23.42
ZT10 C 27.62 27.83 27.30 20.87 21.23 25.53 25.95 26.07 26.54
ZT10 G 32.41 30.74 20.55 28.94 28.86 27.40 24.37 26.11 26.24
ZT10 T 23.86 12.35 26.31 23.26 22.56 20.30 25.10 23.54 23.80
ZT14 A 15.98 29.68 26.80 27.62 28.07 27.54 25.32 25.13 24.31
ZT14 C 26.32 27.98 27.01 20.68 20.59 24.41 25.17 25.09 25.70
ZT14 G 29.62 30.73 19.30 28.01 27.97 26.95 23.66 25.60 25.38
ZT14 T 28.08 11.61 26.88 23.69 23.37 21.10 25.85 24.18 24.60
ZT18 A 14.94 28.34 26.49 26.41 26.76 26.49 24.66 24.44 23.82
ZT18 C 28.57 28.44 28.51 22.42 22.02 25.43 26.21 25.80 26.65
ZT18 G 28.69 31.62 20.01 28.97 28.55 27.76 24.80 26.73 26.23
ZT18 T 27.80 11.59 24.98 22.20 22.66 20.32 24.33 23.03 23.31
ZT22 A 14.88 28.44 25.98 26.72 26.57 26.30 24.30 24.11 23.45
ZT22 C 27.41 28.98 28.14 21.44 21.45 25.33 26.09 26.12 26.58
ZT22 G 30.01 31.30 20.11 28.29 28.94 27.44 24.56 26.16 26.02
ZT22 T 27.71 11.28 25.77 23.55 23.04 20.92 25.05 23.61 23.95
ZT26 A 15.72 30.40 26.40 26.52 27.09 26.98 24.93 24.92 24.10
ZT26 C 27.48 26.43 25.67 21.50 22.42 25.55 25.65 25.09 25.75
ZT26 G 30.65 29.34 20.35 28.36 26.52 25.71 23.36 25.44 25.33
ZT26 T 26.15 13.83 27.59 23.63 23.96 21.76 26.05 24.55 24.81
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4.7 Linear model to infer transcription factor binding motif tempo-
ral activity
The predominant theory for circadian transcription regulation is the phase vector model,
whereby a new phase results from the combinatorial synthesis of two or more transcriptional
regulators or two clock-controlled DNA element [326]. In our circadian context, we aimed at
inferring the phase of each TF binding on DHS using Pol II loadings at TSS of active genes and
the motif content of DHS nearby (ﬁgure 4.6).
Genei
Pol II
TFBS Motif
m1 m3 m2 m4 m1m2
DHSi DHSj DHSk
Figure 4.6 – The PolII signal at TSS is used with the motif content of nearby DHSs in order to
compute the phase speciﬁc motif activity.
We ﬁtted the following linear model to infer motif activities Am :
Yg =
∑
m
NgmAm + (4.6)
Here Yg is a complex amplitude summarizing the oscillation with a period of 24 h, i.e. Yg =∑
t e
iωt Yt , Am is the corresponding complex motif activity, Ngm is a regression matrix deﬁned
below and  is a noise term. In practice we can represent the complex numbers Yg and Am as
two-dimensional vectors.
For this regression a matrix Ngm , was built which contains motif m for every DHS d in a
given vicinity of active gene g. More precisely, we simply sum the motif content of DHSs in
a given proximity of a gene. To obtain this Ngm matrix, FIMO [114] was used to scan our
DHSs sequences and different sets of position weight matrices (PWM), such as JASPAR [258],
TRANSFAC [217], SELEX [156] and WANG [338] with a detection threshold p-value below
10−4. We used a set of approximately 1900 PWM.
The maximum likelihood estimates of unknown activities Aˆm can be computed as follow using
least squares method:
Aˆm =
(
NTgmNgm
)−1
NTgmYg (4.7)
However,to avoid overﬁtting and control for the redundant motifs, we used a penalized linear
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regression model developed by T. Hastie [100]. This method is available as an R package
called GLMNET and uses the elastic-net penalized regression. This penalized linear regression
model is deﬁned as follows:
βˆα,λ = ar g min
β
[∥∥y −Xβ∥∥22+λ
(
α
∥∥β∥∥22+ (1−α)
∥∥β∥∥1
)]
(4.8)
where we have switch to the standard notation for linear regression, i.e. using X for the design
matrix, y for the data, and β for the regression variable.
The elastic net regression is a method that allows regularization and variable selection simul-
taneously. It includes the Lasso penalty l1 =
∥∥β∥∥1 that ensure the sparsity of the solution. The
caveat of Lasso penalty implies that the solution is bounded by the number of ’samples’ and
that it tends to select one variable from a group and ignore the others. To overcome these limi-
tations the elastic-net includes a second part of the penalty. it’s the quadratic term l2 =
∥∥β∥∥22
called the Ridge penalty. α is for the elastic-net mixing parameter with range α ∈ (0,1), where
α= 1 is the lasso and α= 0 is the ridge. λ is a vector of values, which allows to progressively
decrease the penalty in the "Pathwise Coordinate Descent algorithm" [100].
We tested several other motifs databases as well, like HOCOMOCO [181], Swiss Regulon
[246] or Jaspar 2016 [215], and we observed that we had similar predictions for E-Box motifs,
RRE-motifs or D-box. A major conclusion of this database comparison is that motifs quality of
the database, and the redundancy affect slightly the analysis. A data cleaning effort improve
drastically subsequent interpretation of the biological signiﬁcance of the outcome of the
model (ﬁgure 4.7). Brieﬂy, we clustered the PWMs based on their matches on DHSs and we
selected for each representative cluster the PWM with the highest circadian activity using our
penalized linear model with 1900 PWMs (Table 4.4).
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Table 4.4 – Selected non-redundant PWMs from different sources
Original ID Clean ID Source
V_E4BP4_01 D_Box Transfac
V_RORA2_01 RRE Transfac
V_CREBATF_Q6 CREB Transfac
BHLHE40 E_Box Wang
V_AR_Q6_01 GR Transfac
V_FOXO1_Q5 FOX Transfac
SP1 SP1 Wang
V_ZF5_01 ZF5 Transfac
V_PPARG_01 PPAR Transfac
V_AP2_Q3 AP2 Transfac
V_ZIC2_04 ZIC2 Transfac
V_PU1_Q4 PU1 Transfac
V_RXRA_03 RXR Transfac
V_ERR1_Q2_01 ERE Transfac
V_MITF_Q6 MITF Transfac
HNF1A_M161 HNF1 Selex
V_NFY_01 NFY Transfac
V_SREBP1_02 SREB Transfac
V_GABPAGABPB_Q6 GABP Transfac
Jdp2_M131 JDP2 Selex
V_SMAD_Q6 SMAD Transfac
V_HNF4A_02 HNF4 Transfac
V_NKX62_Q2 NKX6 Transfac
V_EKLF_Q5 KLF Transfac
V_GATA3_05 GATA3 Transfac
V_OCT1_01 OCT1 Transfac
V_LXRDR4_Q3 LXR Transfac
V_MAF_Q6_01 MAF Transfac
HSF1_M61 HSF Selex
V_MEF2A_Q6 MEF2A Transfac
V_FXR_Q2 FXR Transfac
V_MTF1_02 MTF1 Transfac
EGR1_M3 EGR1 Selex
MA0080.2 ETS Jaspar
V_CEBP_C CEBP Transfac
V_GFI1B_01 GFI1 Transfac
NFIA_M238 NFIA Selex
V_E2F_02 E2F Transfac
V_MYB_Q6 MYB Transfac
V_YY1_01 YY1 Transfac
GLI2_M4 GLI2 Selex
NFAT5_M80 NFAT5 Selex
V_ACAAT_B SOX Transfac
V_TBP_01 TBP Transfac
TEAD1_M113 TEAD Selex
RFX5 RFX Wang
SRF SRF Wang
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Figure 4.7 – Penalized linear model with four different motif databases. Pol II loading at TSS
of active genes (in WT mice) was ﬁtted with DHS motif content in a vicinity of 50 Kb. The
parameters used for these penalized linear model were λ = 0.1 and α = 0
We optimized our linear model to estimate the βˆ (in our notation the unknown activities
estimates Aˆm), by doing a parameter space exploration in ﬁgure 4.8, and we found that an α
of 0.1 was performing well. We tested our model with the motif occurrence in the Ngm matrix,
or a boolean representing the presence or the absence of the motif, and we observed that the
motif occurrence had a higher deviance ratio (equivalent to the variance explained by the
linear model). Moreover, the Glmnet package has a k-fold cross validation implemented. We
used a 10-fold cross-validation for our ﬁnal set of motifs that explain a part of the circadian
oscillation in our data.
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Figure 4.8 – The elastic-net has been performed with various α and λ in order to determine
the optimal parameters that will select a minimal set of motif with a minimum mean-squared
error
In summary, our penalized linear model was accomplished using the 1900 PWM on a common
selection active genes detected using a SVM (see Section 4.8 of DHS to active transcripts) using
Pol II loading at TSS in the WT or Bmal1−/− context. Phase and amplitude of Pol II loadings at
TSS was ﬁtted with the motif matrix to infer motif activity in WT and Bmal1−/−. DHS motif
content was included in Ngm matrix within a given proximity (distance threshold) with their
closest active genes with one or more footprints, detected using Wellington algorithm from
pyDNase Library [256].
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4.8 Annotation of DHS to active transcripts and enrichment analy-
sis
Using ChIP-seq data for Pol II, H3K4me3, H3K36me3 and H3K27ac from CycliX [188] in the WT
condition, a support vector machine classiﬁer (SVM) was developed by Irina Krier to detect
active transcripts among all Ensembl annotated transcript (version NCBIM37). The goal was
to use a classiﬁer that would recognize the shape of signals typical of active transcription [27]
based on histone modiﬁcations, Pol II and DNAse I. We selected regions of interests to be +/-
300 bp around the TSS for Pol II and H3k4me3, and also +/-300 bp around the TES for DNAse
I, and the last 600 bp of each transcript for H3K36me3. Read counts on the same strand as the
transcript annotation were counted per 10 bp and quantile-normalized across time. To correct
for relative difference in signal between marks, correction coefﬁcients were applied based on
the sum of each signal. A set of active and inactive transcripts were extracted consisting in the
top 10% and bottom 10% respectively, as determined by Pol II RPKMalong each transcript. Our
SVM was trained on these active versus inactive transcripts, and subsequently applied to all
transcripts at each time point. Cross-validation indicated that the SVM had satisfactory False
Positive and False Negative results for very high or very low Pol II signals (98% of test transcripts
were correctly classiﬁed either active or inactive at ZT10). Classiﬁer predictions for all time
points were very similar, with more than 80% correlation. Transcripts shorter than 600bp
were set to “active” if they had higher Pol II RPKM than the lower quartile of active transcripts.
Transcripts were considered active when they were classiﬁed as active in at least one time
point. This classiﬁcation resulted in 51’947 out of the 97’214 transcripts to be classiﬁed as
active (17’467 out of 37’583 genes). The active transcripts list (51’947 transcripts) was used to
associate DHS with the closest active transcription start site (TSS) using the Chippeakanno R
package [359] from Bioconductor. The annotation result provided 13’457 unique active genes
linked with at least one DHS. These active genes were subsequently used in our gene centric
analysis with our penalized linear regression. Basically a DHS could regulate all active genes
that are in a certain proximity deﬁned by our so called distance threshold (see section 4.7).
Finally, we performed pathway enrichment analysis using gproﬁleR [269] on rhythmic mRNA
in WT and/or in Bmal1−/− genotype. We then used amplitudes of genes annotated in a given
signiﬁcant pathway for downstream analysis that revealed important changes in the clock
impaired genotype.
4.9 3D structure of the heterotetramer BMAL1/CLOCK and molec-
ular dynamics
For the single BMAL1/CLOCK, the crystal structure of the heterodimeric BMAL1/CLOCK (pdb
id: 4F3L) was used as an initial model [141]. In this structure there are 5 ﬂexible loops lacking
density. The residues in positions 129-134 (length 6 residues), 212-237 (26 residues), 257-275
(19 residues), 291-309 (19 residues) were missing from BMAL1, and the residues 224-247 (24
residues) were missing from CLOCK. These missing parts were computed by Rosetta’s loop
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modeling application (v3.5); an application that extensively remodels the backbone of the
loops [261]. The loops were remodeled and reﬁned by the CCD (Cyclic Coordinate Descent)
algorithm [49]. The fragment ﬁles, used by CCD were made by Robetta Server [165]. The
BMAL1/CLOCK structure, as a unique chain, was used as Rosseta input and from the output
we selected the lowest energy loops for the single BMAL1/CLOCK model. In order to bind the
single BMAL1/CLOCK model to the E-box, the complex crystal structure of BMAL1/CLOCK
basic helix-loop-helix domains bonded on the E-box (CACGTG) (pdb id: 4H10) was used
[339] . This structure was superimposed to the single BMAL1/CLOCK model with the UCSF
Chimera visualization program (v1.5.3) [253]. In accordance to this super-position the single
BMAL1/CLOCK model the N-terminal helices of CLOCK and BMAL1 was replaced by the
helices in the 4H10 structure from the protein data bank. The base-pair geometry of the DNA
in the 4H10 structure was analyzed by the 3DNA software (v2.0) [205]. Two double-strandDNA
models, spacing 6 (sp6) and spacing 7 (sp7), with sequence 5’-CACGTGAAAAAA(A)CACGTG-3’,
were generated by 3DNA. The CACGTG parts were rebuilding based on the analysis of the DNA
in the 4H10 structure. The interval base pairs of sp6 were building with the standard B-DNA
backbone conformation for A-T pairs. For the ﬁnal models two BMAL1/CLOCK models were
bound to the DNA models with a spacer of 6 bp (sp6) or 7bp (sp7), by superimposing them
with UCSF Chimera.
On the 2 heterotetramer models, molecular dynamics simulations were performed with the
NAMD program (v2.8) [255] in order to explore the various structural conformations. Each
of the models was placed in an explicit solvent box with 0.15 M NaCl concentration under
periodic boundary conditions. The models were parameterized using the AMBER force ﬁeld
(ff99bsc0) and the TIP3P model was used for water molecules (LeaP program) [52]. Initially,
geometry optimization via energy minimization to reﬁne DNA backbone and base pairing
geometry was performed for 12500 steps, followed by an NPT phase of 90ns and 130ns for the
sp6 and sp7 model respectively. In all phases a time step of 1 fs was used, the covalent bonds
involving hydrogen atoms were constrained by the RATTLE algorithm [11] and the Van der
Waals interaction cutoff distances was set at 12 Å.
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A.1 Mixture model for DNase I footprint detection
This mixture model for DNaseI data footprint detection around transcription factor binding
sites has been developed by Felix Naef. I was implicated in the development of the visual output
as well as the parameter optimization and the analysis of different TFBS,such as BMAL1, CREB,
SREB, FOXA2 HSF1, and REVERBα
For this model, we assume to have DNase1 cuts nr i ∈N for regions r ∈ {1, . . . ,R} at positions
i ∈ {1, . . . ,L}, where R is the number of regions and L the length of the regions (all assumed
to be of the same length). Indices iL and iR refer to boundary positions (the left and right
boundaries of a protected sequence motif) and we assume that the cuts are all aligned with
respect to some ankor, for example the position of a sequence motif reﬂecting the speciﬁcity
of a known protein-DNA interaction. We deﬁne J = {iL , . . . , iR } and I = {1, . . . ,L}\J .
The goal is to calibrate a mixture model from the data, such that we can learn which sites are
bound (showing footprints), and which are not. While similar approaches have been proposed
[257], we are interested in additionally learning the optimal boundary positions, such that
we can detect if a footprint changes shape (in our case its width) in different conditions (for
example at different time points). To make the model tractable, we make the simplifying
assumption that the shape of a footprint can be approximated by a rectangular shape, showing
on average less counts in the protected regions. While it was shown previously that the
signal within the protected region can be nonuniform for some factors [237, 320, 338], the
rectangular model is a simple generic model that captures the essential properties of DNase1
signals around bound sites in many cases. Speciﬁcally, we express the probability (likelihood)
of the measured cuts n = (n1, . . . ,nL) (here for a single region or one row in the matrix nr i ) as a
product of independent Poisson variables with a common mean λwhen the site is not bound
P1(n|λ)=
L∏
i=1
Poi s(ni |λ)=M (n|p,N )Poi s(N |Λ)≡Q1(n;Λ) , (A.1)
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where we used the property that products of independent Poisson variable can be factored
into a multinomial (M ) and one Poisson distribution, and deﬁned N =∑i ni ,Λ=∑i λi = Lλ,
pi = 1L . The notationQ1 emphasises that this is now a function ofΛ.
For the second (bound) model we assume two distinct means λI for unprotected, and λJ for
protected sites, representing the average number of cuts outside (i ∈ I ), and inside ( j ∈ J ) the
footprinted region, respectively. This leads to
P2(n|λI ,λJ , iL , iR ) =
∏
i∈I
P (ni |λI )
∏
j∈J
P (nj |λJ ) (A.2)
= M (n|q,N )Poi s(N |Λ)≡Q2(n; iL , iR ,qJ ,Λ) , (A.3)
where here Λ =∑i λi = L1λI +L2λJ with L1 = |I |, L2 = |J |, qi = λI /Λ ≡ qI for i ∈ I and qi =
λJ/Λ≡ qJ for i ∈ J . The notationQ2 shows the dependencies in the new variables.
We then marginalize the probabilities over the unknownΛ (using an improper ﬂat prior, such
that
∫∞
0 Poi s(N |Λ)dΛ= P (N )= 1, and thus equivalent to making no assumption on the total
number of cuts). After some straightforward algebra, this leads to
F1(n)=
∫∞
0
dΛQ1(n;Λ)= N !∏
i (ni !)
L−N (A.4)
where N =∑i ni , and
F2(n|iL , iR ) = L
∫1/L
0
dqJ
∫
dΛQ2(n;iL , iR ,qJ ,Λ) (A.5)
= 1
N +1
N1!∏
i∈I (ni !)
N2!∏
j∈J (nj !)
L−N11 L
−N2
2
1
r
Ir (N2+1,N1+1) (A.6)
where N1 = ∑i∈I ni , N2 = ∑ j∈J n j , r = L2L , and Ir (α,β) is the regularized incomplete Beta
function (I1(α,β)= 1) that comes form the qJ integral. Note that since the same improper (not
normalized) prior onΛ is used for both models, this does not pose any difﬁculties. The upper
integration bound on the qJ integral uses the assumption that qJ ≤ qI ≤ 1/L, reﬂecting that
the probability of cuts is reduced inside J due to protection from the bound protein.
We can now formulate the mixture model by introducing a global probability q (to be esti-
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mated) to be in the bound state, such that
P (n|iL , iR ,q)= (1−q)F1(n)+q F2(n|iL , iR ) , (A.7)
or since q is assumed to be common to all regions
P ({nr i }|iL , iR ,q)=
∏
r
P (nr•|iL , iR ,q) . (A.8)
Finally we can marginalize over q to obtain the likelihood of the whole data with respect to
the indices I :
P ({nr i }|iL , iR )=
∫1
0
dq P ({nr i }|iL , iR ,q) , (A.9)
where we have assumed a uniform prior on q. The interesting aspect is that this likelihood
calculation requires only doing a one-dimensional numerical integral, and one can then
maximize with respect to the discrete indices iL and iR to ﬁnd the optimal boundaries. Once
these have been found, it is straightforward to estimate the optimal q using Eq. 8, and also to
assign posterior probabilities to each region for each of the two models using Eqs. 4 and 6.
125
Appendix A. Appendix
A.2 Circadian life, a smartphone app
to monitor our circadian activity
A.2.1 Introduction
Since the dawn of time, the earth rotation on its axis and around the sun imposes to all
living creatures daily changes and seasonal variations. These changes imply light-dark cycles,
temperatures changes, and food availability or predators presence. In an evolutionary scale,
all living creatures needed to anticipate those changes in order to develop an efﬁcient survival
strategy. In humans, our internal clock controls several behaviors, such as sleep-wake cycle,
food intake, hormonal cycle, and immunity. Despite this circadian control, humans often use
alarm clocks and medication to align their sleep and wake times with social obligations (e.g.,
work and school schedules or other social events) [281]. Activity varies between work and free
days due to a changing in sleep duration but also in sleep timing. In order to recover from sleep
deﬁciency accumulated over the working period, people commonly oversleep on free days
[281]. Current methods to monitor human activity are subjective (such as questionnaires),
providing only a general overview of daytime activity [282]. The availability of smartphones
represents an opportunity to monitor human activity objectively. Moreover, the wide-ranging
adoption of smartphones across age, gender, and socioeconomic segments is critical to study
the behaviors of free-living representative individuals at a population scale [336, 112]. Thus,
it is essential to understand our rhythm on a daily basis for increasing our ability to live in
a healthy state. Recent breakthroughs of chronobiology are signiﬁcant in chronotherapy –
e.g., when should one take a particular drug to cure a disease more efﬁciently [178] – and in
chrononutrition, as when should one eat to stay in a healthy state [112].
A.2.2 Goal of the project
We aimed at gathering data on daily activity of users and had access to various information
such as their locations, ages, gender andmore, thanks to our smartphone app, calledCircadian
Life. Using these data, we will be able to study different chronobiology-related features
including jet-lag, chronotype, light entrainment (seasonal changes, effect of latitude) and
social entrainment at the population level.
In collaboration with Jonathan Baeriswyl (a "civiliste" in the Naef lab), we developed the ﬁrst
version of Circadian Life, a smartphone app to record the activity of users at a population
scale. The goal of the app is to record user activity through phone sensors (e.g., accelerometer,
light and GPS) and possibly wearable gadgets, smart watch or wristband, in an automated
manner. Users will have access to their personal data via a web interface and through the app
interface (ﬁgure A.1). In addition, surveys will be designed in a progressive manner, starting
with a few simple questions, the app will ask further questions as users are better engaged.
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Figure A.1 – The app structure includes an SQL database and a server storing the results of
surveys and sensor from smartphones. Users can have access to their data thanks to their
phone or a website.
A.2.3 Preliminary results
The Circadian Life app is based on the recording of sampled activity using the accelerometer
of the phone. The measures are sampled each ﬁve minutes (one minute of recording), and
an average of those measures is calculated for each hour. Data Cleansing starts with the
subtraction of the gravity acceleration detected by the accelerometer, to all the measures
recorded. Thus, the cleaned data provide us the activity of the user per hour.
In a ﬁrst experiment, 36 users were recruited in November 2015, mostly students from Felix
Naef class. Several participants were recorded for more than three months. This allowed us to
explore several visualizations and statistics to analyze users’ data.
A ﬁrst visualization of the data using actograms revealed that users were well entrained to the
daylight cycle (ﬁgure A.2), with an expected period of 24h computed with a Fourier analysis.
Indeed, we did not observe a drift of the active period as reported in the FASPS subjects [260].
As it was reported, activity varies between work and free days due to a changing in sleep
duration but also in sleep timing [281]. Therefore, we wanted to quantify these differences
using theweekday and theweekends averaged data from a single user over thewhole recording
(ﬁgure A.3). With these averaged activity proﬁles, we quantiﬁed the difference between work
days and free days. Interestingly, work day activity pattern reﬂected habits of the user. Thus,
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Figure A.2 – Double-plotted actograms of two users of "Circadian life" recorded for several
months.
we observed three peaks of activity during the workdays (arrival/departure from work and
lunch break).
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Figure A.3 – Average activity was computed for weeks and weekends separately for a single
user of our smartphone app. Using this type of visualization, we can observe a pattern in the
signal as the arrival and the departure from work as well as the lunch break. Moreover, the
analysis of work days and free days allows the quantiﬁcation of the social jet-lag.
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A.2.4 Sleep-wake cycle analysis
Sleep-wake cycle is critical for a healthy state of life. Therefore, we developed in collaboration
with Etienne Dubois (a bachelor student who completed an internship in the Naef lab) a
Hidden Markov Model (HMM) to extract, from the activity data, sleep-wake measurements as
the sleep length, the activity length, the wake-up time and the bedtime (the time at which the
user goes to bed).
The data was analyzed using a two-state HMM, that allowed ﬁnding a pattern of activity/inac-
tivity (the hidden states) using the binarized recorded data (ﬁgure A.4 A). We performed the
Viterbi algorithm to ﬁnd the most probable path through a two state model (active/inactive)
on the activity (ﬁgure A.4 B). We observed that our minimal model with two states could ﬁnd
most of the active/inactive periods. Thanks to our HMM, we noted that the distribution of
wake-up time of the user had a single mode at 8 AM, and the distribution of bedtime was
bimodal with one peak at 10 PM and another at 1 AM (ﬁgure A.4 C). On the other side, the
distribution of sleep length had a mode of 10 hours of sleep. In addition, the distribution of
activity length had a mode at 14h. The distribution of activity revealed that some sleep periods
are missed by our HMM. Thus, we observed that 5% of actives periods are longer than 30
hours.
In summary, our app allowed a decent monitoring of the users that have participated in our
study. Further explorations of the data are needed in order to evaluate the discrepancies
between different users from a biological perspective as well as from a technical point of view.
Furthermore, we have to assess differences due to various phone sensors and phone brand
and we should compare our measurements to wearable in order to improve our data sampling
and calibration, in addition, minimizing battery consumption.
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Figure A.4 – HMM for Smartphone app data analysis. A The two state model with the transition
and the emission probabilities. B Viterbi path overlapped on activity data. C Distributions of
sleep length, activity length, wake-up time and bedtime estimated from the Viterbi path of a
single user.
130
A.2. Circadian life, a smartphone app
to monitor our circadian activity
A.2.5 Perspectives
This project of smartphone app will continue with a new collaboration with the HES-SO
Valais. Alexis Murciano (a student supervised by Dr. Pierre-Andre Mudry) is already working
on the second version of the app. His goal is to produce a user-friendly and researcher-
friendly interface that allows more ﬂexibility for the app content (ﬁgure A.5). We will include
some educational material about the circadian rhythm, such as information on mechanisms,
hormonal regulation, structure of the clock and more. We will have as well a better control on
survey inside of the app, and we will add new functionalities. A second round of experiments
on students will start in October 2016.
Figure A.5 – User-friendly app interface developed in collaboration with Alexis Murciano from
the HESSO Valais under the supervision of Dr Pierre-Andre Mudry.
This app might serve later on for chrono-therapeutical studies on drugs (side effects and
pharmaco-vigilance) or chrono-nutrition studies depending on the add-on that we will be
able to develop. We might be able in the future to use these activity data integrated with other
medical data. For instance, heartbeats and blood glucose level, or even biological data such
as genome sequences, epigenetic marks, chromatin accessibility, protein and mRNA levels
from users could be integrated in order to improve diagnosis and prognosis and anticipate
diseases or seizure. The app market is growing exponentially, and health-related applications
are necessary to improve the well-being of individuals.
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